Profile image
Professor

Professor Andrew Lloyd

Phone
+61 (2) 9385 2534
E-mail
a.lloyd@unsw.edu.au
Sheehan Y; Grebely J; Lloyd AR, 2024, 'Reply to: “ ‘One-stop-shop’ point-of-care hepatitis C RNA testing intervention in the prison – some issues”', Journal of Hepatology, 80, pp. e107 - e108, http://dx.doi.org/10.1016/j.jhep.2023.10.020
2024
Hajarizadeh B; Carson JM; Byrne M; Grebely J; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Lloyd AR; Dore GJ, 2024, 'Incidence of hepatitis C virus infection in the prison setting: The SToP-C study', Journal of Viral Hepatitis, 31, pp. 21 - 34, http://dx.doi.org/10.1111/jvh.13895
2024
Weickert TW; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks WS; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd AR; Stanton C; O'Donnell M; Liu D; Galletly C; Shannon Weickert C, 2024, 'Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial', Brain, Behavior, and Immunity, 115, pp. 191 - 200, http://dx.doi.org/10.1016/j.bbi.2023.10.012
2024
Wood JG; Heywood AE; Dennington PM; Lloyd AR; Ziegler JB, 2024, 'Trends in intravenous immunoglobulin use in New South Wales, Australia', Internal Medicine Journal, 54, pp. 149 - 156, http://dx.doi.org/10.1111/imj.16175
2024
Shih STF; Stone J; Martin NK; Hajarizadeh B; Cunningham EB; Kwon JA; McGrath C; Grant L; Grebely J; Dore GJ; Lloyd AR; Vickerman P; Chambers GM, 2024, 'Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofad637
2024
Adhikari A; Abayasingam A; Brasher NA; Kim HN; Lord M; Agapiou D; Maher L; Rodrigo C; Lloyd AR; Bull RA; Tedla N, 2024, 'Characterization of antibody-dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes', Journal of Medical Virology, 96, http://dx.doi.org/10.1002/jmv.29381
2024
Walker SJ; Shrestha LB; Lloyd AR; Dawson O; Sheehan Y; Sheehan J; Maduka NBC; Cabezas J; Akiyama MJ; Kronfli N, 2024, 'Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit', International Journal of Drug Policy, 126, http://dx.doi.org/10.1016/j.drugpo.2024.104386
2024
Winter RJ; Griffin S; Sheehan Y; Nguyen W; Stoové M; Lloyd AR; Thompson AJ, 2024, 'People in community corrections are a population with unmet need for viral hepatitis care', eClinicalMedicine, 70, http://dx.doi.org/10.1016/j.eclinm.2024.102548
2024
Kwon JA; Bretaña NA; Kronfli N; Dussault C; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd AR; Gray RT, 2024, 'Preparing correctional settings for the next pandemic: a modeling study of COVID-19 outbreaks in two high-income countries', Frontiers in Public Health, 12, http://dx.doi.org/10.3389/fpubh.2024.1279572
2024
Underwood AP; Gupta M; Wu B-R; Eltahla AA; Boo I; Wang JJ; Agapiou D; Abayasingam A; Reynaldi A; Keoshkerian E; Zhao Y; Brasher N; Walker MR; Bukh J; Maher L; Gordon T; Davenport MP; Luciani F; Drummer HE; Lloyd AR; Bull RA, 2024, 'B cell characteristics define HCV reinfection outcome.', J Hepatol, http://dx.doi.org/10.1016/j.jhep.2024.04.004
2024
Thilakanathan C; Kayes T; Di Girolamo J; Nguyen V; Glass A; Manandhar S; Lawler J; Meredith C; Maley M; Lloyd A; Levy MT, 2023, 'Predicting hepatitis B e Antigen seroconversion after pregnancy—The SydPregScore', Liver International, 43, pp. 69 - 76, http://dx.doi.org/10.1111/liv.15372
2023
Gupta M; Balachandran H; Louie RHY; Li H; Agapiou D; Keoshkerian E; Christ D; Rawlinson W; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Bartlett AW; Sasson SC; Ahlenstiel G; Dwyer D; Lloyd AR; Martinello M; Luciani F; Bull RA, 2023, 'High activation levels maintained in receptor-binding domain–specific memory B cells in people with severe coronavirus disease 2019', Immunology and Cell Biology, 101, pp. 142 - 155, http://dx.doi.org/10.1111/imcb.12607
2023
Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C, 2023, 'Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework', Addiction, 118, pp. 1153 - 1160, http://dx.doi.org/10.1111/add.16137
2023
Stone J; Lim AG; Dore GJ; Borquez A; Geddes L; Gray R; Grebely J; Hajarizadeh B; Iversen J; Maher L; Valerio H; Martin NK; Hickman M; Lloyd AR; Vickerman P, 2023, 'Prison-based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study', Liver International, 43, pp. 569 - 579, http://dx.doi.org/10.1111/liv.15469
2023
Shih STF; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon JA; Lloyd AR; Dore GJ; Wiseman V; Grebely J, 2023, 'Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis', The Lancet Regional Health - Western Pacific, 36, http://dx.doi.org/10.1016/j.lanwpc.2023.100750
2023
Grebely J; Markus C; Causer LM; Silk D; Comben S; Lloyd AR; Martinez M; Cunningham EB; O'Flynn M; Dore GJ; Matthews S, 2023, 'A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia', The Lancet Gastroenterology and Hepatology, 8, pp. 204 - 207, http://dx.doi.org/10.1016/S2468-1253(22)00355-7
2023
Underwood AP; Gupta M; Wu B-R; Eltahla AA; Boo I; Wang JJ; Agapiou D; Abayasingam A; Reynaldi A; Keoshkerian E; Zhao Y; Brasher N; Walker MR; Bukh J; Maher L; Gordon T; Davenport M; Luciani F; Drummer HE; Lloyd AR; Bull RA, 2023, 'B Cell Signatures and Antibody Imprinting Define HCV Reinfection Outcome', , http://dx.doi.org/10.2139/ssrn.4418620
2023
Selvakumar J; Havdal LB; Drevvatne M; Brodwall EM; Lund Berven L; Stiansen-Sonerud T; Einvik G; Leegaard TM; Tjade T; Michelsen AE; Mollnes TE; Lund-Johansen F; Holmøy T; Zetterberg H; Blennow K; Sandler CX; Cvejic E; Lloyd AR; Wyller VBB, 2023, 'Prevalence and Characteristics Associated with Post-COVID-19 Condition among Nonhospitalized Adolescents and Young Adults', JAMA Network Open, 6, pp. E235763, http://dx.doi.org/10.1001/jamanetworkopen.2023.5763
2023
Winter RJ; Sheehan Y; Papaluca T; Macdonald GA; Rowland J; Colman A; Stoove M; Lloyd AR; Thompson AJ, 2023, 'Consensus recommendations on the management of hepatitis C in Australia's prisons', Medical Journal of Australia, 218, pp. 231 - 237, http://dx.doi.org/10.5694/mja2.51854
2023
Sheehan Y; Cunningham EB; Cochrane A; Byrne M; Brown T; McGrath C; Lafferty L; Tedla N; Dore GJ; Lloyd AR; Grebely J, 2023, 'A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study', Journal of Hepatology, 79, pp. 635 - 644, http://dx.doi.org/10.1016/j.jhep.2023.04.019
2023
Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fichter C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Britton W; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett NW; Darley D; Matthews G; Stark DJ; Petoumenos K; Rawlinson WD; Murrell B; Brilot F; Cunningham AL; Kelleher AD; Aggarwal A; Turville SG, 2023, 'Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level', eBioMedicine, 90, http://dx.doi.org/10.1016/j.ebiom.2023.104545
2023
Maduranga S; Valencia BM; Sigera C; Adikari T; Weeratunga P; Fernando D; Rajapakse S; Lloyd AR; Bull RA; Rodrigo C; Wijethunga Arachchige S; Valencia Arroyo BM, 2023, 'Genomic Surveillance of Recent Dengue Outbreaks in Colombo, Sri Lanka', Viruses, 15, pp. 1408, http://dx.doi.org/10.3390/v15071408
2023
White P; Abbey S; Angus B; Ball HA; Buchwald DS; Burness C; Carson AJ; Chalder T; Clauw DJ; Coebergh J; David AS; Dworetzky BA; Edwards MJ; Espay AJ; Etherington J; Fink P; Flottorp S; Garcin B; Garner P; Glasziou P; Hamilton W; Henningsen P; Hoeritzauer I; Husain M; Huys ACML; Knoop H; Kroenke K; Lehn A; Levenson JL; Little P; Lloyd A; Madan I; Van Der Meer JWM; Miller A; Murphy M; Nazareth I; Perez DL; Phillips W; Reuber M; Rief W; Santhouse A; Serranova T; Sharpe M; Stanton B; Stewart DE; Stone J; Tinazzi M; Wade DT; Wessely SC; Wyller V; Zeman A, 2023, 'Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitis', Journal of Neurology, Neurosurgery and Psychiatry, 94, pp. 1056 - 1063, http://dx.doi.org/10.1136/jnnp-2022-330463
2023
Barrios MH; Nicholson S; Bull RA; Martinello M; Rawlinson W; Mina M; Post JJ; Hudson B; Gilroy N; Lloyd AR; Konecny P; Mordant F; Catton M; Subbarao K; Caly L; Druce J; Netter HJ, 2023, 'Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19', Microorganisms, 11, http://dx.doi.org/10.3390/microorganisms11081985
2023
Rockstroh JK; Swan T; Chang J; Elamouri F; Lloyd AR, 2023, 'The path to hepatitis C elimination: who are we leaving behind and why?', Journal of the International AIDS Society, 26, http://dx.doi.org/10.1002/jia2.26136
2023
Jones MD; Casson SM; Barry BK; Li SH; Valenzuela T; Cassar J; Lamanna C; Lloyd AR; Sandler CX, 2023, 'eLearning improves allied health professionals' knowledge and confidence to manage medically unexplained chronic fatigue states: A randomized controlled trial', Journal of Psychosomatic Research, 173, pp. 111462, http://dx.doi.org/10.1016/j.jpsychores.2023.111462
2023
Baird S; Ashley CL; Marsh-Wakefield F; Alca S; Ashhurst TM; Ferguson AL; Lukeman H; Counoupas C; Post JJ; Konecny P; Bartlett A; Martinello M; Bull RA; Lloyd A; Grey A; Hutchings O; Palendira U; Britton WJ; Steain M; Triccas JA, 2023, 'A unique cytotoxic CD4+ T cell-signature defines critical COVID-19', Clinical and Translational Immunology, 12, http://dx.doi.org/10.1002/cti2.1463
2023
Moallemi S; Lloyd AR; Rodrigo C, 2023, 'Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta-analysis', Scientific Reports, 13, pp. 17485, http://dx.doi.org/10.1038/s41598-023-44559-9
2023
Ng WH; Liu X; Ling ZL; Santos CNO; Magalhães LS; Kueh AJ; Herold MJ; Taylor A; Freitas JR; Koit S; Wang S; Lloyd AR; Teixeira MM; Merits A; Almeida RP; King NJC; Mahalingam S, 2023, 'FHL1 promotes chikungunya and o’nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design', Nature Communications, 14, http://dx.doi.org/10.1038/s41467-023-42330-2
2023
Grebely J; Robaeys G; Bruggmann P; Aghemo A; Backmund M; Bruneau J; Byrne J; Dalgard O; Feld JJ; Hellard M; Hickman M; Kautz A; Litwin A; Lloyd AR; Mauss S; Prins M; Swan T; Schaefer M; Taylor LE; Dore GJ, 2023, 'Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2015.11.011
2023
Grebely J; Robaeys G; Bruggmann P; Aghemo A; Backmund M; Bruneau J; Byrne J; Dalgard O; Feld JJ; Hellard M; Hickman M; Kautz A; Litwin A; Lloyd AR; Mauss S; Prins M; Swan T; Schaefer M; Taylor LE; Dore GJ, 2023, 'Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection', International Journal of Drug Policy, 111, pp. 101669, http://dx.doi.org/10.1016/j.drugpo.2015.11.009
2023
Verveen A; Müller F; Lloyd A; Moss-Morris R; Omland T; Penninx B; Raijmakers RPH; van der Schaaf M; Sandler CX; Stavem K; Wessely S; Wyller VBB; Nieuwkerk P; Knoop H, 2022, 'A research agenda for post-COVID-19 fatigue', Journal of Psychosomatic Research, 154, http://dx.doi.org/10.1016/j.jpsychores.2022.110726
2022
Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson SC; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer DE; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2022, 'Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses', Cell Reports, 38, pp. 110345, http://dx.doi.org/10.1016/j.celrep.2022.110345
2022
Murphy CE; Walker AK; O’Donnell M; Galletly C; Lloyd AR; Liu D; Weickert CS; Weickert TW; ODonnell M, 2022, 'Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases', Translational Psychiatry, 12, pp. 21, http://dx.doi.org/10.1038/s41398-021-01764-2
2022
Riaz N; Leung P; Bull RA; Lloyd AR; Rodrigo C, 2022, 'Evolution of within-host variants of the hepatitis C virus', Infection, Genetics and Evolution, 99, pp. 105242, http://dx.doi.org/10.1016/j.meegid.2022.105242
2022
Mostafavi H; Tharmarajah K; Vider J; West NP; Freitas JR; Cameron B; Foster PS; Hueston LP; Lloyd AR; Mahalingam S; Zaid A, 2022, 'Interleukin-17 contributes to Ross River virus-induced arthritis and myositis', PLoS Pathogens, 18, http://dx.doi.org/10.1371/journal.ppat.1010185
2022
Howe AYM; Rodrigo C; Cunningham EB; Douglas MW; Dietz J; Grebely J; Popping S; Sfalcin JA; Parczewski M; Sarrazin C; de Salazar A; Fuentes A; Sayan M; Quer J; Kjellin M; Kileng H; Mor O; Lennerstrand J; Fourati S; Di Maio VC; Chulanov V; Pawlotsky JM; Harrigan PR; Ceccherini-Silberstein F; Garcia F; Martinello M; Matthews G; Fernando FF; Esteban JI; Müllhaupt B; Wiesch JSZ; Buggisch P; Neumann-Haefelin C; Berg T; Berg CP; Schattenberg JM; Moreno C; Stauber R; Lloyd A; Dore G; Applegate T; Ignacio J; Garcia-Cehic D; Gregori J; Rodriguez-Frias F; Rando A; Gozlan Y; Angelico M; Andreoni M; Babudieri S; Bertoli A; Cento V; Coppola N; Craxì A; Paolucci S; Parruti G; Pasquazzi C; Perno CF; Teti E; Vironet C; Lannergård A; Duberg AS; Aleman S; Gutteberg T; Soulier A; Gourgeon A; Chevaliez S; Pol S; Carrat F; Salmon D; Kaiser R; Knopes E; Gomes P; de Kneght R; Rijnders B; Poljak M; Lunar M; Usubillaga R; Seguin_Devaux C; Tay E; Wilson C; Wang DS; George J; Kok J; Pérez AB; Chueca N; García-Deltoro M; Martínez-Sapiña AM; Lara-Pérez MM; García-Bujalance S; Aldámiz-Echevarría T; Vera-Méndez FJ; Pineda JA; Casado M; Pascasio JM; Salmerón J; Alados-Arboledas JC; Poyato A; Téllez F; Rivero-Juárez A, 2022, 'Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals', JHEP Reports, 4, pp. 100462, http://dx.doi.org/10.1016/j.jhepr.2022.100462
2022
Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR, 2022, '“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103456
2022
Carson JM; Dore GJ; Lloyd AR; Grebely J; Byrne M; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Matthews GV; Hajarizadeh B, 2022, 'Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study', Clinical Infectious Diseases, 75, pp. 1809 - 1819, http://dx.doi.org/10.1093/cid/ciac246
2022
Sandler CX; Cvejic E; Valencia BM; Li H; Hickie IB; Lloyd AR, 2022, 'Predictors of Chronic Fatigue Syndrome and Mood Disturbance After Acute Infection', Frontiers in Neurology, 13, http://dx.doi.org/10.3389/fneur.2022.935442
2022
Cai C; Samir J; Pirozyan MR; Adikari TN; Gupta M; Leung P; Hughes B; Van der Byl W; Rizzetto S; Elthala A; Keoshkerian E; Palgen JL; Peters T; Nguyen THO; Louie R; Kedzierska K; Gaudieri S; Bull RA; Lloyd AR; Luciani F, 2022, 'Identification of human progenitors of exhausted CD8+ T cells associated with elevated IFN-γ response in early phase of viral infection', Nature Communications, 13, http://dx.doi.org/10.1038/s41467-022-35281-7
2022
Adhikari A; Abayasingam A; Rodrigo C; Agapiou D; Pandzic E; Brasher NA; Fernando BSM; Keoshkerian E; Li H; Kim HN; Lord M; Popovic G; Rawlinson W; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson SC; Grubor-Bauk B; Lloyd AR; Martinello M; Bull RA; Tedla N; Lloyd AR; Kaldor J; Dore G; Sorrell T; Hudson B; Bartlett A; Lemberg D; Di Girolamo N; Byrne M; Hammoud M; Lloyd AR; Sultan R; Hudson B; Konecny P; Matthews G; Shek D; Holdaway S; Mitsa-Kos K; How-Chow D; Lagunday R; Robinson S; Terrill L; Joshi N; Li Y; Gill S; Sevehon A, 2022, 'Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 Infection', Journal of Immunology, 209, pp. 1499 - 1512, http://dx.doi.org/10.4049/jimmunol.2200272
2022
Casson S; Jones MD; Cassar J; Kwai N; Lloyd AR; Barry BK; Sandler CX, 2022, 'The effectiveness of activity pacing interventions for people with chronic fatigue syndrome: a systematic review and meta-analysis', Disability and Rehabilitation, 45, pp. 3788 - 3802, http://dx.doi.org/10.1080/09638288.2022.2135776
2022
Valencia BM; Sigera PC; Weeratunga P; Tedla N; Fernando D; Rajapakse S; Lloyd AR; Rodrigo C; Valencia Arroyo BM, 2022, 'Effect of prior Zika and dengue virus exposure on the severity of a subsequent dengue infection in adults', Scientific Reports, 12, pp. 17225, http://dx.doi.org/10.1038/s41598-022-22231-y
2022
Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2022, '“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting', International Journal of Drug Policy, 106, http://dx.doi.org/10.1016/j.drugpo.2022.103746
2022
Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Scheibe A; Brahni T; Naik K; Mashabela P; Chan P; Luhmann N; Lloyd AR, 2022, 'The role of low-income and middle-income country prisons in eliminating hepatitis C', The Lancet Public Health, 7, pp. e578 - e579, http://dx.doi.org/10.1016/S2468-2667(22)00119-0
2022
Akiyama MJ; Kronfli N; Cabezas J; Sheehan Y; Thurairajah PH; Lines R; Lloyd AR, 2021, 'Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework', The Lancet Gastroenterology and Hepatology, 6, pp. 391 - 400, http://dx.doi.org/10.1016/S2468-1253(20)30365-4
2021
Kwon JA; Chambers GM; Luciani F; Zhang L; Kinathil S; Kim D; Thein HH; Botha W; Thompson S; Lloyd A; Yap L; Gray RT; Butler T, 2021, 'Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis', PLoS ONE, 16, pp. e0245896, http://dx.doi.org/10.1371/journal.pone.0245896
2021
Riaz N; Leung P; Barton K; Smith MA; Carswell S; Bull R; Lloyd AR; Rodrigo C, 2021, 'Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants', BMC Genomics, 22, pp. 148, http://dx.doi.org/10.1186/s12864-021-07460-1
2021
Sandler CX; Wyller VBB; Moss-Morris R; Buchwald D; Crawley E; Hautvast J; Katz BZ; Knoop H; Little P; Taylor R; Wensaas KA; Lloyd AR, 2021, 'Long COVID and post-infective fatigue syndrome: A review', Open Forum Infectious Diseases, 8, http://dx.doi.org/10.1093/ofid/ofab440
2021
Cameron B; Webber K; Li H; Bennett BK; Boyle F; de Souza P; Wilcken N; Lynch J; Friedlander M; Goldstein D; Lloyd AR, 2021, 'Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study', Brain, Behavior, and Immunity - Health, 10, pp. 100189, http://dx.doi.org/10.1016/j.bbih.2020.100189
2021
Zhao Y; Cai C; Samir J; Palgen JL; Keoshkerian E; Li H; Bull RA; Luciani F; An H; Lloyd AR, 2021, 'Human CD8 T-stem cell memory subsets phenotypic and functional characterization are defined by expression of CD122 or CXCR3', European Journal of Immunology, 51, pp. 1732 - 1747, http://dx.doi.org/10.1002/eji.202049057
2021
Brasher NA; Adhikari A; Lloyd AR; Tedla N; Bull RA, 2021, 'Hepatitis c virus epitope immunodominance and b cell repertoire diversity', Viruses, 13, pp. 983, http://dx.doi.org/10.3390/v13060983
2021
Seddiki N; Zaunders J; Phetsouphanh C; Brezar V; Xu Y; McGuire HM; Bailey M; McBride K; Hey-Cunningham W; Munier CML; Cook L; Kent S; Lloyd A; Cameron B; De St Groth BF; Koelsch K; Danta M; Hocini H; Levy Y; Kelleher AD, 2021, 'CD73+ CD127high long-term memory CD4 T cells are highly proliferative in response to recall antigens and are early targets in hiv-1 infection', International Journal of Molecular Sciences, 22, pp. 1 - 28, http://dx.doi.org/10.3390/ijms22020912
2021
Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C, 2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277
2021
Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ project (SToP-C)', Harm Reduction Journal, 18, pp. 46, http://dx.doi.org/10.1186/s12954-021-00494-4
2021
Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477
2021
Lim AG; Stone J; Hajarizadeh B; Byrne M; Chambers GM; Martin NK; Grebely J; Dore GJ; Lloyd AR; Vickerman P, 2021, 'Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in Prisons', Hepatology, 74, pp. 2366 - 2379, http://dx.doi.org/10.1002/hep.32002
2021
Abayasingam A; Balachandran H; Agapiou D; Hammoud M; Rodrigo C; Keoshkerian E; Li H; Brasher NA; Christ D; Rouet R; Burnet D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Stella AO; Fichter C; Brilot F; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson SC; Tea F; Pilli D; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA; Burnett D, 2021, 'Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection', Cell Reports Medicine, 2, pp. 100228, http://dx.doi.org/10.1016/j.xcrm.2021.100228
2021
Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Loveday S; Tamaddoni M; Obeid S; Estivill Mercade G; Martinez M; Donnelly R; Bowman J; Trevethan L; Lagios K; Murrell T; Bath N; Tawil V; Stevens A; Topp L; Churchill A; Pinnock K; Martin N; Drew S; Harrod M; Smith A; Williams R; Cooper B; Somes K; Burns C; Kaur A; Lobo C; Conroy K; McCredie L; Café C; Anlezark J; Rawlinson W; Yeang M; Wynn M; Willenborg C, 2021, 'Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study', The Lancet Gastroenterology and Hepatology, 6, pp. 533 - 546, http://dx.doi.org/10.1016/S2468-1253(21)00077-7
2021
Li SH; Lloyd AR; Graham BM, 2021, 'Subjective sleep quality and characteristics across the menstrual cycle in women with and without Generalized Anxiety Disorder', Journal of Psychosomatic Research, 148, http://dx.doi.org/10.1016/j.jpsychores.2021.110570
2021
Valencia BM; Cvejic E; Vollmer-Conna U; Hickie IB; Wakefield D; Li H; Pedergnana V; Rodrigo C; Lloyd AR; Valencia Arroyo BM, 2021, 'The severity of the pathogen-induced acute sickness response is affected by polymorphisms in genes of the NLRP3 inflammasome pathway', Brain, Behavior, and Immunity, 93, pp. 186 - 193, http://dx.doi.org/10.1016/j.bbi.2021.01.005
2021
Miller K; Treloar C; Lloyd AR, 2021, 'People in prison who inject drugs: who is trusted when it comes to information about hepatitis C?', Addiction Research and Theory, 29, pp. 247 - 254, http://dx.doi.org/10.1080/16066359.2021.1879058
2021
Adhikari A; Eltahla A; Lloyd AR; Rodrigo C; Agapiou D; Bull RA; Tedla N, 2021, 'Optimisation and validation of a new method for antibody dependent cellular phagocytosis in hepatitis C virus infection', Journal of Immunological Methods, 495, http://dx.doi.org/10.1016/j.jim.2021.113087
2021
Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, 98, http://dx.doi.org/10.1016/j.drugpo.2021.103379
2021
Li H; Cvejic E; Gu B; Vollmer-Conna U; Hickie I; Wakefield D; Davenport T; Wiley J; Lloyd AR, 2021, 'Regulation of the Acute Sickness Response by the P2RX7 Receptor', Journal of Infectious Diseases, 224, pp. 914 - 920, http://dx.doi.org/10.1093/infdis/jiab027
2021
Sandler CX; Lloyd AR, 2020, 'Chronic fatigue syndrome: progress and possibilities', Medical Journal of Australia, 212, pp. 428 - 433, http://dx.doi.org/10.5694/mja2.50553
2020
Li H; Cameron B; Douglas D; Stapleton S; Cheguelman G; Butler T; Luciani F; Lloyd AR, 2020, 'Incident hepatitis B virus infection and immunisation uptake in Australian prison inmates', Vaccine, 38, pp. 3255 - 3260, http://dx.doi.org/10.1016/j.vaccine.2020.02.076
2020
Tran B; Vajdic CM; Webber K; Laaksonen MA; Stavrou EP; Tiller K; Suchy S; Bosco AM; Harris MF; Lloyd AR; Goldstein D, 2020, 'Self-reported health, lifestyle and social circumstances of Australian adult cancer survivors: A propensity score weighted cross-sectional study', Cancer Epidemiology, 67, http://dx.doi.org/10.1016/j.canep.2020.101773
2020
Geddes L; Iversen J; Wand H; Esmaeili A; Tsui J; Hellard M; Dore G; Grebely J; Dietze P; Bruneau J; Prins M; Morris MD; Shoukry NH; Lloyd AR; Kim AY; Lauer G; Cox AL; Page K; Maher L; Lloyd A; Dore G; Dietze P, 2020, 'Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection', Clinical Infectious Diseases, 70, pp. 123 - 131, http://dx.doi.org/10.1093/cid/ciz162
2020
Fatt SJ; Beilharz JE; Joubert M; Wilson C; Lloyd AR; Vollmer-Conna U; Cvejic E, 2020, 'Parasympathetic activity is reduced during slow-wave sleep, but not resting wakefulness, in patients with chronic fatigue syndrome', Journal of Clinical Sleep Medicine, 16, pp. 19 - 28, http://dx.doi.org/10.5664/JCSM.8114
2020
Beilharz JE; Paterson M; Fatt S; Wilson C; Burton A; Cvejic E; Lloyd A; Vollmer-Conna U, 2020, 'The impact of childhood trauma on psychosocial functioning and physical health in a non-clinical community sample of young adults', Australian and New Zealand Journal of Psychiatry, 54, pp. 185 - 194, http://dx.doi.org/10.1177/0004867419881206
2020
Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693
2020
Walker MR; Eltahla AA; Mina MM; Li H; Lloyd AR; Bull RA, 2020, 'Envelope-specific IgG3 and IgG1 responses are associated with clearance of acute hepatitis C virus infection', Viruses, 12, pp. 75, http://dx.doi.org/10.3390/v12010075
2020
Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR, 2020, 'Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study', Addiction, 115, pp. 901 - 913, http://dx.doi.org/10.1111/add.14830
2020
Li SH; Lloyd AR; Graham BM, 2020, 'Physical and mental fatigue across the menstrual cycle in women with and without generalised anxiety disorder', Hormones and Behavior, 118, http://dx.doi.org/10.1016/j.yhbeh.2019.104667
2020
Brasher NA; Eltahla AA; Underwood A; Boo I; Rizzetto S; Walker MR; Rodrigo C; Luciani F; Maher L; Drummer HE; Tedla N; Lloyd AR; Bull RA, 2020, 'B cell immunodominance in primary hepatitis C virus infection', Journal of Hepatology, 72, pp. 670 - 679, http://dx.doi.org/10.1016/j.jhep.2019.11.011
2020
Douglas MW; Tay ESE; Wang DS; Ong ATL; Wilson C; Phu A; Kok J; Dwyer DE; Bull RA; Lloyd AR; Applegate TL; Dore GJ; Howe AY; Harrigan R; George J, 2020, 'Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance', Hepatology Communications, 4, pp. 904 - 915, http://dx.doi.org/10.1002/hep4.1496
2020
Adikari TN; Riaz N; Sigera C; Leung P; Valencia BM; Barton K; Smith MA; Bull RA; Li H; Luciani F; Weeratunga P; Thein TL; Lim VWX; Leo YS; Rajapakse S; Fink K; Lloyd AR; Fernando D; Rodrigo C; Valencia Arroyo BM, 2020, 'Single molecule, near full-length genome sequencing of dengue virus', Scientific Reports, 10, pp. 18196, http://dx.doi.org/10.1038/s41598-020-75374-1
2020
Dore G; Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Mcmanus H; Butler T; Vickerman P; Martin N; Mchutchison J; Brainard D; Treloar C; Lloyd A, 2020, 'Declining HCV incidence following rapid HCV treatment scale-up in a prison network in Australia: Evidence of treatment as prevention from the SToP-C study', JOURNAL OF HEPATOLOGY, 73, pp. S127 - S127, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000786587000206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2020
Mina M; Underwood A; Eltahla A; Wu BR; Walker MR; Bull RA; Lloyd AR, 2020, 'Anti-envelope antibody responses in highly exposed seronegative individuals may be associated with protection from HCV infection', Journal of Viral Hepatitis, 27, pp. 1012 - 1021, http://dx.doi.org/10.1111/jvh.13339
2020
Fatt SJ; Beilharz JE; Joubert M; Wilson C; Lloyd AR; Vollmer-Conna U; Cvejic E, 2020, 'Parasympathetic activity is reduced during slow-wave sleep, but not resting wakefulness, in patients with chronic fatigue syndrome.', J Clin Sleep Med, 16, pp. 19 - 28, http://dx.doi.org/10.5664/jcsm.8114
2020
Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L, 2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', PLoS ONE, 15, pp. e0243106, http://dx.doi.org/10.1371/journal.pone.0243106
2020
Vollmer-Conna U; Joubert M; Fatt S; Beilharz J; Lloyd A; Cvejic E, 2019, 'Abstract # 3251 You sleep, but your heart is not in it - the importance of nocturnal autonomic signalling', Brain, Behavior, and Immunity, 81, pp. 12 - 12, http://dx.doi.org/10.1016/j.bbi.2019.08.045
2019
Papaluca T; McDonald L; Craigie A; Gibson A; Desmond P; Wong D; Winter R; Scott N; Howell J; Doyle J; Pedrana A; Lloyd A; Stoove M; Hellard M; Iser D; Thompson A, 2019, 'Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care', Journal of Hepatology, 70, pp. 839 - 846, http://dx.doi.org/10.1016/j.jhep.2019.01.012
2019
Chiong F; Lloyd AR; Post JJ, 2019, 'Severe Eosinophilic Meningoencephalitis Secondary to Suspected Neuroangiostrongyliasis with a Good Clinical Outcome', Case Reports in Infectious Diseases, 2019, pp. 4037196, http://dx.doi.org/10.1155/2019/4037196
2019
Papaluca T; Hellard ME; Thompson AJV; Lloyd AR, 2019, 'Scale-up of hepatitis C treatment in prisons is key to national elimination', Medical Journal of Australia, 210, pp. 391 - 393.e1, http://dx.doi.org/10.5694/mja2.50140
2019
Overton K; Clegg J; Pekin F; Wood J; McGrath C; Lloyd A; Post JJ, 2019, 'Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting', International Journal of Drug Policy, 72, pp. 123 - 128, http://dx.doi.org/10.1016/j.drugpo.2019.02.013
2019
Mekonnen ZA; Grubor-Bauk B; English K; Leung P; Masavuli MG; Shrestha AC; Bertolino P; Bowen DG; Lloyd AR; Gowans EJ; Wijesundara DK, 2019, 'Single-dose vaccination with a hepatotropic adeno-associated virus efficiently localizes T cell immunity in the liver with the potential to confer rapid protection against hepatitis C virus', Journal of Virology, 93, http://dx.doi.org/10.1128/JVI.00202-19
2019
Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J, 2019, 'Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework', Liver International, 39, pp. 20 - 30, http://dx.doi.org/10.1111/liv.13949
2019
Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013
2019
Fatt SJ; Cvejic E; Lloyd AR; Vollmer-Conna U; Beilharz JE, 2019, 'The Invisible Burden of Chronic Fatigue in the Community: a Narrative Review', Current Rheumatology Reports, 21, pp. 5, http://dx.doi.org/10.1007/s11926-019-0804-2
2019
Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135
2019
Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FMJ; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2019, 'A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015', Journal of the International AIDS Society, 22, pp. e25222, http://dx.doi.org/10.1002/jia2.25222
2019
Rodrigo C; Leung P; Lloyd AR; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Cox AL; Osburn W; Kim AY; Shoukry NH; Lauer GM; Maher L; Schinkel J; Prins M; Hellard M; Eltahla AA, 2019, 'Genomic variability of within-host hepatitis C variants in acute infection', Journal of Viral Hepatitis, 26, pp. 476 - 484, http://dx.doi.org/10.1111/jvh.13051
2019
Pirozyan MR; Nguyen N; Cameron B; Luciani F; Bull RA; Zekry A; Lloyd AR, 2019, 'Chemokine-Regulated Recruitment of Antigen-Specific T-Cell Subpopulations to the Liver in Acute and Chronic Hepatitis C Infection', Journal of Infectious Diseases, 219, pp. 1430 - 1438, http://dx.doi.org/10.1093/infdis/jiy679
2019
Walker MR; Leung P; Eltahla AA; Underwood A; Abayasingam A; Brasher NA; Li H; Wu BR; Maher L; Luciani F; Lloyd AR; Bull RA, 2019, 'Clearance of hepatitis C virus is associated with early and potent but narrowly-directed, Envelope-specific antibodies', Scientific Reports, 9, pp. 13300, http://dx.doi.org/10.1038/s41598-019-49454-w
2019
Mekonnen ZA; Grubor-Bauk B; Masavuli MG; Shrestha AC; Ranasinghe C; Bull RA; Lloyd AR; Gowans EJ; Wijesundara DK, 2019, 'Toward DNA-based T-cell mediated vaccines to target HIV-1 and hepatitis C virus: Approaches to elicit localized immunity for protection', Frontiers in Cellular and Infection Microbiology, 9, pp. 91, http://dx.doi.org/10.3389/fcimb.2019.00091
2019
Keck ZY; Pierce BG; Lau P; Lu J; Wang Y; Underwood A; Bull RA; Prentoe J; Velázquez-Moctezuma R; Walker MR; Luciani F; Guest JD; Fauvelle C; Baumert TF; Bukh J; Lloyd AR; Foung SKH, 2019, 'Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis c virus infections uncover molecular determinants for E2 targeting and vaccine design', PLoS Pathogens, 15, pp. e1007772, http://dx.doi.org/10.1371/journal.ppat.1007772
2019
Wu BR; Eltahla AA; Keoshkerian E; Walker MR; Underwood A; Brasher NA; Agapiou D; Lloyd AR; Bull RA, 2019, 'A method for detecting hepatitis C envelope specific memory B cells from multiple genotypes using cocktail E2 tetramers', Journal of Immunological Methods, 472, pp. 65 - 74, http://dx.doi.org/10.1016/j.jim.2019.06.016
2019
Abayasingam A; Leung P; Eltahla A; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Cox AL; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Lloyd A; Rodrigo C, 2019, 'Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing', Infection, Genetics and Evolution, 71, pp. 36 - 41, http://dx.doi.org/10.1016/j.meegid.2019.02.032
2019
Cvejic E; Li H; Hickie IB; Wakefield D; Lloyd AR; Vollmer-Conna U, 2019, 'Contribution of individual psychological and psychosocial factors to symptom severity and time-to-recovery after naturally-occurring acute infective illness: The Dubbo Infection Outcomes Study (DIOS)', Brain, Behavior, and Immunity, 82, pp. 76 - 83, http://dx.doi.org/10.1016/j.bbi.2019.07.034
2019
Beilharz JE; Fatt SJ; Cvejic E; Lloyd AR; Vollmer-Conna U, 2019, 'Response to Commentary: ‘Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, and Chronic Fatigue: Three Distinct Entities Requiring Complete Different Approaches’', Current Rheumatology Reports, 21, http://dx.doi.org/10.1007/s11926-019-0824-y
2019
Shepherd SJ; McDonald SA; Palmateer NE; Gunson RN; Aitken C; Dore GJ; Goldberg DJ; Applegate TL; Lloyd AR; Hajarizadeh B; Grebely J; Hutchinson SJ, 2018, 'HCV avidity as a tool for detection of recent HCV infection: Sensitivity depends on HCV genotype', Journal of Medical Virology, 90, pp. 120 - 130, http://dx.doi.org/10.1002/jmv.24919
2018
Kelly ML; Riordan SM; Bopage R; Lloyd AR; Post JJ, 2018, 'Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study', PLoS ONE, 13, pp. e0192763, http://dx.doi.org/10.1371/journal.pone.0192763
2018
Overton K; Mennon V; Mothobi N; Neild B; Martinez E; Masters J; Grant P; Akhunji Z; Su WY; Torda A; Whyte CM; Lloyd A; Weatherall C; Hofmeyr A; Foo H; Brookes K; Marriott D; Sintchenko V; Clezy K; Konecny P; Post JJ, 2018, 'Cluster of invasive Mycobacteria chimaera infections following cardiac surgery demonstrating novel clinical features and risks of aortic valve replacement', Internal Medicine Journal, 48, pp. 1514 - 1520, http://dx.doi.org/10.1111/imj.14093
2018
Underwood AP; Walker MR; Brasher NA; Eltahla AA; Maher L; Luciani F; Lloyd AR; Bull RA, 2018, 'Understanding the determinants of BnAb induction in acute HCV infection', Viruses, 10, pp. 659, http://dx.doi.org/10.3390/v10110659
2018
Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987
2018
Macnamara CL; Cvejic E; Parker GB; Lloyd AR; Lee G; Beilharz JE; Vollmer-Conna U, 2018, 'Personalised relaxation practice to improve sleep and functioning in patients with chronic fatigue syndrome and depression: Study protocol for a randomised controlled trial', Trials, 19, pp. 371, http://dx.doi.org/10.1186/s13063-018-2763-8
2018
Esmaeili A; Mirzazadeh A; Morris MD; Hajarizadeh B; Sacks HS; Maher L; Grebely J; Kim AY; Lauer G; Cox AL; Hellard M; Dietze P; Bruneau J; Shoukry NH; Dore GJ; Lloyd AR; Prins M; Page K, 2018, 'The Effect of Female Sex on Hepatitis C Incidence among People Who Inject Drugs: Results from the International Multicohort InC3 Collaborative', Clinical Infectious Diseases, 66, pp. 20 - 28, http://dx.doi.org/10.1093/cid/cix768
2018
Rizzetto S; Koppstein DNP; Samir J; Singh M; Reed JH; Cai CH; Lloyd AR; Eltahla AA; Goodnow CC; Luciani F, 2018, 'B-cell receptor reconstruction from single-cell RNA-seq with VDJPuzzle', Bioinformatics, 34, pp. 2846 - 2847, http://dx.doi.org/10.1093/BIOINFORMATICS/BTY171
2018
Cunningham EB; Hajarizadeh B; Amin J; Bretana N; Dore GJ; Degenhardt L; Larney S; Luciani F; Lloyd AR; Grebely J; Dolan K, 2018, 'Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study', International Journal of Drug Policy, 54, pp. 18 - 25, http://dx.doi.org/10.1016/j.drugpo.2017.12.013
2018
Katz BZ; Collin SM; Murphy G; Moss-Morris R; Wyller VB; Wensaas KA; Hautvast JLA; Bleeker-Rovers CP; Vollmer-Conna U; Buchwald D; Taylor R; Little P; Crawley E; White PD; Lloyd A, 2018, 'The international collaborative on fatigue following infection (COFFI)', Fatigue: Biomedicine, Health and Behavior, 6, pp. 106 - 121, http://dx.doi.org/10.1080/21641846.2018.1426086
2018
Cunningham E; Amin J; Bretana NA; Luciani F; Degenhardt L; Larney S; Hajarizadeh B; Dore GJ; Lloyd A; Grebely J, 2017, 'P10 Injecting risk behaviours among people who inject drugs in an Australian prison setting, 2005–2014: the HITS-p study', Journal of Virus Eradication, 3, pp. 15 - 16, http://dx.doi.org/10.1016/s2055-6640(20)30751-2
2017
Bartlett SR; Applegate T; Jacka B; Lamoury F; Bull R; Danta M; Bradshaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2017, 'P6 Phylogenetic clustering of recent hepatitis C virus infection between 2004 and 2015', Journal of Virus Eradication, 3, pp. 14 - 15, http://dx.doi.org/10.1016/s2055-6640(20)30747-0
2017
Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore GJ, 2017, 'O6 Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the StoP-C study', Journal of Virus Eradication, 3, pp. 2 - 3, http://dx.doi.org/10.1016/s2055-6640(20)30889-x
2017
Li SH; Sandler CX; Casson SM; Cassar J; Bogg T; Lloyd AR; Barry BK, 2017, 'Randomised controlled trial of online continuing education for health professionals to improve the management of chronic fatigue syndrome: A study protocol', BMJ Open, 7, pp. e014133, http://dx.doi.org/10.1136/bmjopen-2016-014133
2017
Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe AYM; Miller V; Ceccherini-Silberstein F; Bull RA; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky JM; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review', Hepatology Communications, 1, pp. 379 - 390, http://dx.doi.org/10.1002/hep4.1050
2017
Rizzetto S; Eltahla A; Lin P; Bull R; Lloyd A; Ho J; Venturi V; Luciani F, 2017, 'Impact of sequencing depth and read length on single cell RNA sequencing data: lessons from T cells', , http://dx.doi.org/10.1101/134130
2017
Rizzetto S; Eltahla AA; Lin P; Bull R; Lloyd AR; Ho JWK; Venturi V; Luciani F, 2017, 'Impact of sequencing depth and read length on single cell RNA sequencing data of T cells', Scientific Reports, 7, pp. 12781, http://dx.doi.org/10.1038/s41598-017-12989-x
2017
McBride RL; Horsfield S; Sandler CX; Cassar J; Casson S; Cvejic E; Vollmer-Conna U; Lloyd AR, 2017, 'Cognitive remediation training improves performance in patients with chronic fatigue syndrome', Psychiatry Research, 257, pp. 400 - 405, http://dx.doi.org/10.1016/j.psychres.2017.08.035
2017
Roerink ME; Buckland M; Lloyd AR; Van Der Meer JWM, 2017, 'Cytokine signature in chronic fatigue syndrome', Proceedings of the National Academy of Sciences of the United States of America, 114, pp. E9435, http://dx.doi.org/10.1073/pnas.1714011114
2017
Grebely J; Bruneau J; Lazarus JV; Dalgard O; Bruggmann P; Treloar C; Hickman M; Hellard M; Roberts T; Crooks L; Midgard H; Larney S; Degenhardt L; Alho H; Byrne J; Dillon JF; Feld JJ; Foster G; Goldberg D; Lloyd AR; Reimer J; Robaeys G; Torrens M; Wright N; Maremmani I; Norton BL; Litwin AH; Dore GJ, 2017, 'Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs', International Journal of Drug Policy, 47, pp. 51 - 60, http://dx.doi.org/10.1016/j.drugpo.2017.05.019
2017
Rodrigo C; Walker MR; Leung P; Eltahla AA; Grebely J; Dore GJ; Applegate T; Page K; Dwivedi S; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Luciani F; Lloyd AR; Bull RA, 2017, 'Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection', Infection, Genetics and Evolution, 49, pp. 88 - 96, http://dx.doi.org/10.1016/j.meegid.2017.01.006
2017
Morris MD; Shiboski S; Bruneau J; Hahn JA; Hellard M; Prins M; Cox AL; Dore G; Grebely J; Kim AY; Lauer GM; Lloyd A; Rice T; Shoukry N; Maher L; Page K, 2017, 'Geographic differences in temporal incidence trends of hepatitis C virus infection among people who inject drugs: The InC3 collaboration', Clinical Infectious Diseases, 64, pp. 860 - 869, http://dx.doi.org/10.1093/cid/ciw869
2017
Cvejic E; Sandler CX; Keech A; Barry BK; Lloyd AR; Vollmer-Conna U, 2017, 'Autonomic nervous system function, activity patterns, and sleep after physical or cognitive challenge in people with chronic fatigue syndrome', Journal of Psychosomatic Research, 103, pp. 91 - 94, http://dx.doi.org/10.1016/j.jpsychores.2017.10.010
2017
Sandler CX; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; segelov E; Boyle FM; Chin MT; webber K; Barry BK; Lloyd AR, 2017, 'Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue.', Journal of Pain and Symptom Management, http://dx.doi.org/10.1016/j.jpainsymman.2017.03.015
2017
Rizzetto S; Koppstein DNP; Samir J; Singh M; Reed J; Cai C; Lloyd A; Eltahla A; Goodnow C; Luciani F, 2017, 'B-cell receptor reconstruction from single-cell RNA-seq with VDJPuzzle', , http://dx.doi.org/10.1101/181156
2017
Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J; Haber P; Rawlinson W; Treloar C; Maher L, 2017, 'Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study', Journal of Viral Hepatitis, 24, pp. 733 - 741, http://dx.doi.org/10.1111/jvh.12701
2017
Moalem-Taylor G; Baharuddin B; Bennett B; Krishnan AV; Huynh W; Kiernan MC; Shin-Yi Lin C; Shulruf B; Keoshkerian E; Cameron B; Lloyd A; Lin C, 2017, 'Immune dysregulation in patients with carpal tunnel syndrome', Scientific Reports, 7, pp. 8218, http://dx.doi.org/10.1038/s41598-017-08123-6
2017
Eltahla AA; Rodrigo C; Betz-Stablein B; Grebely J; Applegate T; Luciani F; Schinkel J; Dore GJ; Page K; Bruneau J; Morris MD; Cox AL; Kim AY; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Lloyd AR; Bull RA, 2017, 'Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents', Journal of Viral Hepatitis, 24, pp. 37 - 42, http://dx.doi.org/10.1111/jvh.12615
2017
Rodrigo C; Eltahla AA; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Shoukry NH; Lauer GM; Maher L; Schinkel J; Prins M; Hellard M; Lloyd AR, 2017, 'Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study', Journal of Viral Hepatitis, 24, pp. 43 - 52, http://dx.doi.org/10.1111/jvh.12616
2017
Leung P; Eltahla AA; Lloyd AR; Bull RA; Luciani F, 2017, 'Understanding the complex evolution of rapidly mutating viruses with deep sequencing: Beyond the analysis of viral diversity', Virus Research, 239, pp. 43 - 54, http://dx.doi.org/10.1016/j.virusres.2016.10.014
2017
Eltahla AA; Leung P; Pirozyan MR; Rodrigo C; Grebely J; Applegate T; Maher L; Luciani F; Lloyd AR; Bull RA, 2017, 'Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment', Scientific Reports, 7, pp. 41719, http://dx.doi.org/10.1038/srep41719
2017
Bartlett SR; Wertheim JO; Bull RA; Matthews GV; Lamoury FMJ; Scheffler K; Hellard M; Maher L; Dore GJ; Lloyd AR; Applegate TL; Grebely J, 2017, 'A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies', Journal of Viral Hepatitis, 24, pp. 404 - 411, http://dx.doi.org/10.1111/jvh.12652
2017
Harrison F; Aerts L; Seeher KM; Lloyd A; Trollor JN; Guastella A; Brodaty H, 2017, '[P3–225]: SYSTEMATIC REVIEW OF ASSOCIATIONS BETWEEN BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA AND CYTOKINES', Alzheimer's & Dementia, 13, http://dx.doi.org/10.1016/j.jalz.2017.06.1438
2017
Sandler CX; Lloyd AR; Barry BK, 2016, 'Fatigue Exacerbation by Interval or Continuous Exercise in Chronic Fatigue Syndrome', Medicine and Science in Sports and Exercise, 48, pp. 1875 - 1885, http://dx.doi.org/10.1249/MSS.0000000000000983
2016
Treloar C; McCredie L; Lloyd AR; Maher L, 2016, 'The prison economy of needles and syringes: What opportunities exist for blood borne virus risk reduction when prices are so high?', PLoS ONE, 11, pp. e0162399, http://dx.doi.org/10.1371/journal.pone.0162399
2016
Asimakopoulos A; Mangia A; Dore GJ; Lloyd AR; George J; Eslam M, 2016, 'Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans', Hepatology, 64, pp. 2264 - 2265, http://dx.doi.org/10.1002/hep.28626
2016
Doyle JS; Grebely J; Spelman T; Alavi M; Matthews GV; Thompson AJ; Dore GJ; Hellard ME; Kaldor J; Marks P; Lloyd A; Haber P; French R; White P; Rawlinson W; Day C; Van Beek I; McCaughan G; Madden A; Dolan K; Farrell G; Crofts N; Sievert W; Baker D, 2016, 'Quality of life and social functioning during treatment of recent hepatitis C infection: A multi-centre prospective cohort', PLoS ONE, 11, pp. e0150655, http://dx.doi.org/10.1371/journal.pone.0150655
2016
Hajarizadeh B; Grebely J; Martinello M; Matthews GV; Lloyd AR; Dore GJ, 2016, 'Hepatitis C treatment as prevention: evidence, feasibility, and challenges', The Lancet Gastroenterology and Hepatology, 1, pp. 317 - 327, http://dx.doi.org/10.1016/S2468-1253(16)30075-9
2016
Page K; Mirzazadeh A; Rice TM; Grebely J; Kim AY; Cox AL; Morris MD; Hellard M; Bruneau J; Shoukry NH; Dore GJ; Maher L; Lloyd AR; Lauer G; Prins M; McGovern BH, 2016, 'Interferon lambda 4 genotype is associated with jaundice and elevated aminotransferase levels during acute hepatitis C virus infection: Findings from the InC3 collaborative', Open Forum Infectious Diseases, 3, pp. ofw024, http://dx.doi.org/10.1093/ofid/ofw024
2016
Sheridan DA; Hajarizadeh B; Fenwick FI; Matthews GV; Applegate T; Douglas M; Neely D; Askew B; Dore GJ; Lloyd AR; George J; Bassendine MF; Grebely J, 2016, 'Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection', Liver International, 36, pp. 1774 - 1782, http://dx.doi.org/10.1111/liv.13176
2016
Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2016, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies', ANTIVIRAL THERAPY, 21, pp. 425 - 434, http://dx.doi.org/10.3851/imp3035
2016
Tsui JI; Mirzazadeh A; Hahn JA; Maher L; Bruneau J; Grebely J; Hellard M; Kim AY; Shoukry NH; Cox AL; Prins M; Dore GJ; Lauer G; Lloyd AR; Page K, 2016, 'The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males', Drug and Alcohol Dependence, 169, pp. 156 - 162, http://dx.doi.org/10.1016/j.drugalcdep.2016.10.024
2016
Cvejic E; Lloyd AR; Vollmer-Conna U, 2016, 'Neurocognitive improvements after best-practice intervention for chronic fatigue syndrome: Preliminary evidence of divergence between objective indices and subjective perceptions', Comprehensive Psychiatry, 66, pp. 166 - 175, http://dx.doi.org/10.1016/j.comppsych.2016.02.002
2016
Mina MM; Cameron B; Luciani F; Vollmer-Conna U; Lloyd AR; Dolan K; Maher L, 2016, 'Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users', Journal of Viral Hepatitis, 23, pp. 464 - 472, http://dx.doi.org/10.1111/jvh.12511
2016
Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FMJ; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection', Infection, Genetics and Evolution, 37, pp. 252 - 258, http://dx.doi.org/10.1016/j.meegid.2015.11.028
2016
Hajarizadeh B; Lamoury FMJ; Feld JJ; Amin J; Keoshkerian E; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection', Virology Journal, 13, pp. 32, http://dx.doi.org/10.1186/s12985-016-0482-x
2016
Bull RA; Eltahla AA; Rodrigo C; Koekkoek SM; Walker M; Pirozyan MR; Betz-Stablein B; Toepfer A; Laird M; Oh S; Heiner C; Maher L; Schinkel J; Lloyd AR; Luciani F; Rasoli Pirozyan M, 2016, 'A method for near full-length amplification and sequencing for six hepatitis C virus genotypes', BMC Genomics, 17, pp. 247, http://dx.doi.org/10.1186/s12864-016-2575-8
2016
Lamoury FMJ; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Applegate TL; Grebely J; Dolan K, 2016, 'HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection', BMC Infectious Diseases, 16, pp. 241, http://dx.doi.org/10.1186/s12879-016-1567-2
2016
Day CA; Shanahan M; Wand H; Topp L; Haber PS; Rodgers C; Deacon R; Walsh N; Kaldor J; van Beek I; Maher L; Day C; Lloyd A; Dore GJ; Walsh N, 2016, 'Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial', Journal of Clinical Virology, 74, pp. 66 - 72, http://dx.doi.org/10.1016/j.jcv.2015.11.031
2016
Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2016, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies', Antiviral therapy, 21, pp. 465, http://dx.doi.org/10.3851/IMP3073
2016
Eltahla AA; Rizzetto S; Pirozyan MR; Betz-Stablein BD; Venturi V; Kedzierska K; Lloyd AR; Bull RA; Luciani F; Maher L, 2016, 'Linking the T cell receptor to the single cell transcriptome in antigen-specific human T cells', Immunology and Cell Biology, 94, pp. 604 - 611, http://dx.doi.org/10.1038/icb.2016.16
2016
Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576
2016
Walker MR; Li H; Teutsch S; Betz-Stablein B; Luciani F; Lloyd AR; Bull RA; Dolan K; Maher L, 2016, 'Incident hepatitis c virus genotype distribution and multiple infection in australian prisons', Journal of Clinical Microbiology, 54, pp. 1855 - 1861, http://dx.doi.org/10.1128/JCM.00287-16
2016
Rodrigo C; Eltahla AA; Bull RA; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Estes C; Razavi H; Lloyd AR; Luciani F, 2016, 'Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia', Journal of Infectious Diseases, 214, pp. 1383 - 1389, http://dx.doi.org/10.1093/infdis/jiw389
2016
Mina MM; Herawati L; Butler T; Lloyd A, 2016, 'Hepatitis C in Australian prisons: A national needs assessment', International Journal of Prisoner Health, 12, pp. 3 - 16, http://dx.doi.org/10.1108/IJPH-08-2015-0025
2016
Hopper B; Cameron B; Li H; Graves S; Stenos J; Hickie I; Wakefield D; Vollmer-Conna U; Lloyd AR, 2016, 'The natural history of acute Q fever: A prospective Australian cohort', QJM: An International Journal of Medicine, 109, pp. 661 - 668, http://dx.doi.org/10.1093/qjmed/hcw041
2016
Keech A; Vollmer-Conna U; Barry BK; Lloyd AR, 2016, 'Gene expression in response to exercise in patients with chronic fatigue syndrome: A pilot study', Frontiers in Physiology, 7, pp. 421, http://dx.doi.org/10.3389/fphys.2016.00421
2016
Sandler CX; Hamilton BA; Horsfield SL; Bennett BK; Vollmer-Conna U; Tzarimas C; Lloyd AR, 2016, 'Outcomes and predictors of response from an optimised, multidisciplinary intervention for chronic fatigue states', Internal Medicine Journal, 46, pp. 1421 - 1429, http://dx.doi.org/10.1111/imj.13251
2016
Cvejic E; Lloyd AR; Vollmer-Conna U, 2016, 'Differential speed of recovery across symptom domains after naturally-occurring viral infections: Preliminary genetic associations', BRAIN BEHAVIOR AND IMMUNITY, 57, pp. E9 - E10, http://dx.doi.org/10.1016/j.bbi.2016.07.035
2016
Maher L; White B; Dore G; Lloyd A; Rawlinson W, 2015, 'Opioid substitution treatment protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study', Drug and Alcohol Dependence, 146, pp. e191 - e191, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.435
2015
Treloar C; Baldry E; Higgs P; Dietze P; Stoove M; Lloyd A, 2015, 'Going Tobacco Free in Australian Prisons - increasing tattoing harm?', International Journal of Prisoner Health, 11, http://dx.doi.org/10.1108/IJPH-04-2015-0011
2015
Casson S; Sandler C; Horsfield S; Lloyd A; Barry B, 2015, 'Measuring activity pacing in patients with chronic fatigue syndrome', Physiotherapy, 101, pp. e202 - e203, http://dx.doi.org/10.1016/j.physio.2015.03.366
2015
Sandler C; Hamilton B; Horsfield S; Bennett B; Casson S; Vollmer-Conna U; Tzarimas C; Lloyd A, 2015, 'Development of an optimised, multi-disciplinary intervention for chronic fatigue states', Physiotherapy, 101, pp. e1333 - e1334, http://dx.doi.org/10.1016/j.physio.2015.03.1262
2015
Marsden V; Donaghy H; Bertram KM; Harman AN; Nasr N; Keoshkerian E; Merten S; Lloyd AR; Cunningham AL, 2015, 'Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells', Journal of Immunology, 194, pp. 4438 - 4445, http://dx.doi.org/10.4049/jimmunol.1401706
2015
Masi A; Quintana DS; Glozier N; Lloyd AR; Hickie IB; Guastella AJ, 2015, 'Cytokine aberrations in autism spectrum disorder: A systematic review and meta-analysis', Molecular Psychiatry, 20, pp. 440 - 446, http://dx.doi.org/10.1038/mp.2014.59
2015
Lloyd AR; Van Der Meer JWM, 2015, 'The long wait for a breakthrough in chronic fatigue syndrome: Not over yet', BMJ (Online), 350, http://dx.doi.org/10.1136/bmj.h2087
2015
Treloar C; McCredie L; Lloyd AR; Dolan K, 2015, 'Acquiring hepatitis C in prison: the social organisation of injecting risk', Harm Reduction Journal, 12, pp. 10, http://dx.doi.org/10.1186/s12954-015-0045-2
2015
Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J; Marks P; Amin J; Doab A; Carroll T; Teutsch S; Li H; Oon A; Cameron B; Lloyd A; White P; Rawlinson W; Jacqueline Flynn ; Goy K; Nguyen O; von Bibra S; Ffrench R; McCaughan G; Madden A; Farrell G; Crofts N; Sievert W; Baker D; Jacka B; Pan Y; Shaw D; Sasadeusz J; Crawford D; Phung N; George J; Bloch M; Hughes B; Mollison L; Roberts S; Desmond P; Acraman B, 2015, 'Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C', International Journal of Drug Policy, 26, pp. 976 - 983, http://dx.doi.org/10.1016/j.drugpo.2015.05.003
2015
Sacks-Davis R; Grebely J; Dore GJ; Osburn W; Cox AL; Rice TM; Spelman T; Bruneau J; Prins M; Kim AY; Mcgovern BH; Shoukry NH; Schinkel J; Allen TM; Morris M; Hajarizadeh B; Maher L; Lloyd AR; Page K; Hellard M; Matthews G, 2015, 'Hepatitis c virus reinfection and spontaneous clearance of reinfection - The InC3 study', Journal of Infectious Diseases, 212, pp. 1407 - 1419, http://dx.doi.org/10.1093/infdis/jiv220
2015
Grebely J; Robaeys G; Bruggmann P; Aghemo A; Backmund M; Bruneau J; Byrne J; Dalgard O; Feld JJ; Hellard M; Hickman M; Kautz A; Litwin A; Lloyd AR; Mauss S; Prins M; Swan T; Schaefer M; Taylor LE; Dore GJ, 2015, 'Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden', International Journal of Drug Policy, 111, pp. 101670, http://dx.doi.org/10.1016/j.drugpo.2015.11.010
2015
Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Dore GJ; Grebely J, 2015, 'Patterns of hepatitis C Virus RNA levels during acute infection: The InC3 study', PLoS ONE, 10, pp. e0122232, http://dx.doi.org/10.1371/journal.pone.0122232
2015
Grebely J; Robaeys G; Bruggmann P; Aghemo A; Backmund M; Bruneau J; Byrne J; Dalgard O; Feld JJ; Hellard M; Hickman M; Kautz A; Litwin A; Lloyd AR; Mauss S; Prins M; Swan T; Schaefer M; Taylor LE; Dore GJ, 2015, 'Recommendations for the management of hepatitis C virus infection among people who inject drugs', International Journal of Drug Policy, 26, pp. 1028 - 1038, http://dx.doi.org/10.1016/j.drugpo.2015.07.005
2015
Cunningham EB; Applegate TL; Lloyd AR; Dore GJ; Grebely J, 2015, 'Mixed HCV infection and reinfection in people who inject drugs-impact on therapy', Nature Reviews Gastroenterology and Hepatology, 12, pp. 218 - 230, http://dx.doi.org/10.1038/nrgastro.2015.36
2015
Spelman T; Morris MD; Zang G; Rice T; Page K; Maher L; Lloyd A; Grebely J; Dore GJ; Kim AY; Shoukry NH; Hellard M; Bruneau J; Cox AL; Lauer G; McGovern BH; Prins M; Hahn J; Shiboski S; Mirzazadeh A; Alavi M; Bouchard R; Evans J; Grady B; Aneja J; Sacks-Davis R; Teutsch S; White B; Wells B; Applegate T; Matthews G; Yeung B; Schinkel J; Prince LE; Roy E; Bates A; Enriquez J; Chow S; McCredie L; Aitken C; Doyle J, 2015, 'A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs', Journal of Epidemiology and Community Health, 69, pp. 745 - 752, http://dx.doi.org/10.1136/jech-2014-205224
2015
Keech A; Sandler CX; Vollmer-Conna U; Cvejic E; Lloyd AR; Barry BK, 2015, 'Capturing the post-exertional exacerbation of fatigue following physical and cognitive challenge in patients with chronic fatigue syndrome', Journal of Psychosomatic Research, 79, pp. 537 - 549, http://dx.doi.org/10.1016/j.jpsychores.2015.08.008
2015
Narayana SK; Helbig KJ; McCartney EM; Eyre NS; Bull RA; Eltahla A; Lloyd AR; Beard MR, 2015, 'The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis C virus entry', Journal of Biological Chemistry, 290, pp. 25946 - 25959, http://dx.doi.org/10.1074/jbc.M115.657346
2015
Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J; InC , 2015, 'Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study', Journal of Viral Hepatitis, 22, pp. 708 - 717, http://dx.doi.org/10.1111/jvh.12384
2015
Bretaña N; Boelen L; Bull R; Teutsch S; White P; Lloyd A; Luciani F; Bretana N; Dolan K; Rawlinson W; Dore G; Maher L, 2015, 'Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012.', Emerging Infectious Diseases, 21, pp. 765 - 774, http://dx.doi.org/10.3201/eid2105.141832
2015
Doyle JS; Deterding K; Grebely J; Wedemeyer H; Sacks-Davis R; Spelman T; Matthews G; Rice TM; Morris MD; McGovern BH; Kim AY; Bruneau J; Lloyd AR; Page K; Manns MP; Hellard ME; Dore GJ; Maher L, 2015, 'Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort', Journal of Viral Hepatitis, 22, pp. 1020 - 1032, http://dx.doi.org/10.1111/jvh.12429
2015
Mina MM; Luciani F; Cameron B; Bull RA; Beard MR; Booth D; Lloyd AR, 2015, 'Resistance to hepatitis C virus: Potential genetic and immunological determinants', The Lancet Infectious Diseases, 15, pp. 451 - 460, http://dx.doi.org/10.1016/S1473-3099(14)70965-X
2015
Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Maher L, 2015, 'Transmitted/founder viruses rapidly escape from CD8+ T cell responses in acute hepatitis C virus infection', Journal of Virology, 89, pp. 5478 - 5490, http://dx.doi.org/10.1128/JVI.03717-14
2015
Gidding HF; Mahajan D; Reekie J; Lloyd AR; Dwyer DE; Butler T, 2015, 'Hepatitis B immunity in Australia: A comparison of national and prisoner population serosurveys', Epidemiology and Infection, 143, pp. 2813 - 2821, http://dx.doi.org/10.1017/S0950268814003914
2015
Eltahla AA; Luciani F; White PA; Lloyd AR; Bull RA, 2015, 'Inhibitors of the hepatitis C virus polymerase; mode of action and resistance', Viruses, 7, pp. 5206 - 5224, http://dx.doi.org/10.3390/v7102868
2015
Sandler C; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; Segelov E; Boyle FM; Chin MTM; Barry BK; Webber K; Lloyd AR, 2015, 'TOPS: A randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue.', Journal of Clinical Oncology, 33, pp. 9571 - 9571, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.9571
2015
Keech A; Vollmer-Conna U; Barry B; Lloyd A, 2015, 'Physical Activity And Sleep Patterns Following Physical And Cognitive Challenge In Patients With Chronic Fatigue Syndrome', MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 47, pp. 58 - 58, http://dx.doi.org/10.1249/01.mss.0000476560.85673.81
2015
Bennett BK; Goldstein D; Chen M; Davenport TA; Vollmer-Conna U; Scott EM; Hickie IB; Lloyd AR, 2014, 'Characterization of fatigue states in medicine and psychiatry by structured interview', Psychosomatic Medicine, 76, pp. 379 - 388, http://dx.doi.org/10.1097/PSY.0000000000000061
2014
Sugden PB; Cameron B; Mina M; Lloyd AR; Luciani F; Maher L; Dolan K, 2014, 'Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users', Journal of Hepatology, 61, pp. 738 - 745, http://dx.doi.org/10.1016/j.jhep.2014.05.013
2014
Grebely J; Page K; Sacks-Davis R; van der Loeff MS; Rice TM; Bruneau J; Morris MD; Hajarizadeh B; Amin J; Cox AL; Kim AY; Mcgovern BH; Schinkel J; George J; Shoukry NH; Lauer GM; Maher L; Lloyd AR; Hellard M; Dore GJ; Prins M, 2014, 'The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection', Hepatology, 59, pp. 109 - 120, http://dx.doi.org/10.1002/hep.26639
2014
Grebely J; Dore GJ; Kim AY; Lloyd A; Shoukry NH; Prins M; Page K, 2014, 'Genetics of spontaneous clearance of hepatitis C virus infection: A complex topic with much to learn', Hepatology, 60, pp. 2127 - 2128, http://dx.doi.org/10.1002/hep.27163
2014
Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J; Lauer G; Shoukry NH; Hahn J; Shiboski S; Rice TM; Alavi M; Bouchard R; Aneja J; Teutsch S; White B; Wells B; Zang G; Matthews G; Marks P; Yeung B; Prince LE; Roy E; Bates A; Enriquez J; Chow S; McCredie L; Aitken C; Doyle J; Spelman T; Evans J, 2014, 'Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC3 Study', Journal of Clinical Virology, 61, pp. 430 - 434, http://dx.doi.org/10.1016/j.jcv.2014.08.027
2014
Cvejic E; Lemon J; Hickie IB; Lloyd AR; Vollmer-Conna U, 2014, 'Neurocognitive disturbances associated with acute infectious mononucleosis, Ross River fever and Q fever: A preliminary investigation of inflammatory and genetic correlates', Brain, Behavior, and Immunity, 36, pp. 207 - 214, http://dx.doi.org/10.1016/j.bbi.2013.11.002
2014
Sugden PB; Cameron B; Luciani F; Lloyd AR; Maher L, 2014, 'Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users', Journal of Viral Hepatitis, 21, pp. e65 - e73, http://dx.doi.org/10.1111/jvh.12232
2014
Boelen L; Teutsch S; Wilson DP; Dolan K; Dore GJ; Lloyd AR; Luciani F; Maher L, 2014, 'Per-event probability of hepatitis C infection during sharing of injecting equipment', PLoS ONE, 9, pp. e100749, http://dx.doi.org/10.1371/journal.pone.0100749
2014
Luciani F; Bretaña NAR; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR; Bretana N, 2014, 'A prospective study of hepatitis C incidence in Australian prisoners', Addiction (Abingdon, England), 109, pp. 1695 - 1706, http://dx.doi.org/10.1111/add.12643
2014
Nguyen N; de Esch C; Cameron B; Kumar RK; Zekry A; Lloyd AR, 2014, 'Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 860 - 869, http://dx.doi.org/10.1111/jgh.12462
2014
Hajarizadeh B; Grebely J; Applegate T; Matthews GV; Amin J; Petoumenos K; Hellard M; Rawlinson W; Lloyd A; Kaldor J; Dore GJ; Dolan K, 2014, 'Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection', Journal of Medical Virology, 86, pp. 1722 - 1729, http://dx.doi.org/10.1002/jmv.24010
2014
Yap L; Carruthers S; Thompson S; Cheng W; Jones J; Simpson P; Richards A; Thein HH; Haber P; Lloyd A; Butler T, 2014, 'A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners.', PLoS One, 9, pp. 1 - 11, http://dx.doi.org/10.1371/journal.pone.0087564
2014
Hovey E; De Souza P; Marx G; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft P; Abdi E; Lloyd A, 2014, 'Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy', Supportive Care in Cancer, 22, pp. 1233 - 1242, http://dx.doi.org/10.1007/s00520-013-2076-0
2014
Hartfield M; Bull R; White PA; Lloyd A; Luciani F; Alizon S; Maher L, 2014, 'Evidence that hepatitis C virus genome partly controls infection outcome', Evolutionary Applications, 7, pp. 533 - 547, http://dx.doi.org/10.1111/eva.12151
2014
Martinez D; Palmer C; Simar D; Cameron B; Nguyen N; Aggarwal V; Lloyd A; Zekry A, 2014, 'Characterization of the cytokine milieu associated with the upregulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders', Liver International, http://dx.doi.org/10.1111/liv.12473
2014
Mina MM; Clark PJ; Beasley HM; Herawati L; Butler TG; Lloyd AR, 2014, 'Enhancing hepatitis C treatment in the custodial setting: A national roadmap', Medical Journal of Australia, 200, pp. 15 - 16, http://dx.doi.org/10.5694/mja13.10654
2014
Nguyen N; Hampartzoumian T; Cameron B; Palmer C; O'Toole S; Post J; Zekry A; Lloyd A, 2014, 'Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 1535 - 1543, http://dx.doi.org/10.1111/jgh.12543
2014
Leung P; Bull R; Lloyd A; Luciani F, 2014, 'Erratum: "A bioinformatics pipeline for the analyses of viral escape dynamics and host immune responses during an infection" (BioMed Research International)', BioMed Research International, 2014, http://dx.doi.org/10.1155/2014/680249
2014
Leung P; Bull R; Lloyd A; Luciani F, 2014, 'A bioinformatics pipeline for the analyses of viral escape dynamics and host immune responses during an infection', BioMed Research International, 2014, pp. 264519, http://dx.doi.org/10.1155/2014/264519
2014
Luciani F; Bretaña NAR; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR; Bretana N, 2014, 'A prospective study of hepatitis C incidence in Australian prisoners', Addiction (Abingdon, England), 109, pp. 1695 - 1706, http://dx.doi.org/10.1111/add.12643
2014
Raghuraman S; Lloyd AR; Zekry A, 2014, 'Obese visceral adipose tissue exhibits altered T cell trafficking patterns and confers a unique phenotype to tissue-resident T cells', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
White B; Dore GJ; Lloyd AR; Rawlinson WD; Maher L, 2014, 'Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study', Medical Journal of Australia, 201, pp. 326 - 329, http://dx.doi.org/10.5694/mja13.00153
2014
Cvejic E; Lloyd A; Vollmer-Conna U, 2014, '43. Neurocognitive disturbances associated with acute infections: An investigation of inflammatory and genetic correlates', Brain, Behavior, and Immunity, 40, pp. e13 - e13, http://dx.doi.org/10.1016/j.bbi.2014.06.063
2014
Vollmer-Conna U; Cvejic E; Gunawardane U; Hadzi-Pavlovic D; Cameron B; Lloyd A, 2014, '42. Post-infective fatigue syndrome: Immunological and autonomic findings', Brain, Behavior, and Immunity, 40, pp. e13 - e13, http://dx.doi.org/10.1016/j.bbi.2014.06.062
2014
Vollmer-Conna U; Piraino B; Lloyd A, 2014, '41. Immunogenetic and phenotypic explorations of the acute sickness response to common infections', Brain, Behavior, and Immunity, 40, pp. e12 - e13, http://dx.doi.org/10.1016/j.bbi.2014.06.061
2014
Lloyd AR, 2013, 'Fatigue after infection: aetiology and pathophysiology', MICROBIOLOGY AUSTRALIA, 34, pp. 142 - 144, http://dx.doi.org/10.1071/MA13047
2013
Vollmer-Conna U; Gunawardane U; Patel V; Cvejic E; Lloyd AR, 2013, '39. Vagus nerve activity, a good night’s sleep, and recovery from acute infection', Brain, Behavior, and Immunity, 32, pp. e11 - e12, http://dx.doi.org/10.1016/j.bbi.2013.07.051
2013
Vollmer-Conna U; Piraino B; Lloyd AR, 2013, '26. Polymorphisms in both immune and behavioural genes affect mood as part of the acute sickness response to infection', Brain, Behavior, and Immunity, 32, pp. e8 - e8, http://dx.doi.org/10.1016/j.bbi.2013.07.038
2013
Lloyd AR; Clegg J; Lange J; Stevenson A; Post JJ; Lloyd D; Rudge G; Boonwaat L; Forrest G; Douglas J; Monkley D, 2013, 'Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis c in the custodial setting', Clinical Infectious Diseases, 56, pp. 1078 - 1084, http://dx.doi.org/10.1093/cid/cis1202
2013
Chang CC; Crane M; Zhou J; Mina M; Post JJ; Cameron BA; Lloyd AR; Jaworowski A; French MA; Lewin SR, 2013, 'HIV and co-infections', Immunological Reviews, 254, pp. 114 - 142, http://dx.doi.org/10.1111/imr.12063
2013
Post JJ; Arain A; Lloyd AR, 2013, 'Enhancing assessment and treatment of hepatitis c in the custodial setting', Clinical Infectious Diseases, 57, http://dx.doi.org/10.1093/cid/cit265
2013
Grebely J; Matthews GV; Lloyd AR; Dore GJ, 2013, 'Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: Feasibility and future requirements', Clinical Infectious Diseases, 57, pp. 1014 - 1020, http://dx.doi.org/10.1093/cid/cit377
2013
Grebely J; Feld JJ; Applegate T; Matthews GV; Hellard M; Sherker A; Petoumenos K; Zang G; Shaw I; Yeung B; George J; Teutsch S; Kaldor JM; Cherepanov V; Bruneau J; Shoukry NH; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection', Hepatology, 57, pp. 2124 - 2134, http://dx.doi.org/10.1002/hep.26263
2013
Feld JJ; Grebely J; Matthews GV; Applegate T; Hellard M; Sherker A; Cherepanov V; Petoumenos K; Yeung B; Kaldor JM; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection', PLoS ONE, 8, pp. e80003, http://dx.doi.org/10.1371/journal.pone.0080003
2013
Gunaratne P; Lloyd AR; Vollmer-Conna U, 2013, 'Mood disturbance after infection', Australian and New Zealand Journal of Psychiatry, 47, pp. 1152 - 1164, http://dx.doi.org/10.1177/0004867413503718
2013
Ahmadzai H; Cameron B; Chui J; Lloyd A; Wakefield D; Thomas PS, 2013, 'Measurement of neopterin, TGF-β1 and ACE in the exhaled breath condensate of patients with sarcoidosis', Journal of Breath Research, 7, http://dx.doi.org/10.1088/1752-7155/7/4/046003
2013
Flynn JK; Dore GJ; Hellard M; Yeung B; Rawlinson WD; White PA; Kaldor JM; Lloyd AR; Ffrench RA; Dolan K, 2013, 'Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment', Journal of Gastroenterology and Hepatology (Australia), 28, pp. 1770 - 1781, http://dx.doi.org/10.1111/jgh.12265
2013
Lloyd AR, 2013, 'Apology', Journal of Internal Medicine, 273, pp. 628 - 628, http://dx.doi.org/10.1111/joim.12074
2013
Post JJ; Lloyd AR; Monkley D, 2013, 'Treatment outcomes for indigenous and non-indigenous inmates with hepatitis C in New South Wales prisons', Medical Journal of Australia, 199, pp. 464, http://dx.doi.org/10.5694/mja13.10925
2013
Sugden PB; Pham TN; Ratnarajah S; Cameron B; Bull R; White PA; Michalak TI; Lloyd AR, 2013, 'Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two-centre, masked, case-control study', J Viral Hepat, 20, pp. 725 - 728, http://dx.doi.org/10.1111/jvh.12098
2013
Cameron B; Galbraith S; Li H; Lloyd A; HITS investigators , 2013, 'Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates', Journal of Viral Hepatitis, 20, pp. e96 - e106, http://dx.doi.org/10.1111/jvh.12016
2013
Post J; Arain A; Lloyd AR; Grebely J; Dore G, 2013, 'Enhancing Assessment and Treatment Hepatitis C in the Custodial Setting', Clinical Infectious Diseases, 57, pp. S70 - S74, http://dx.doi.org/10.1093/cid/cit264
2013
Goldstein D; Bennett BK; Webber K; Boyle F; De Souza P; Wilcken NRC; Scott E; Toppler R; Murie P; O''Malley L; Mccourt J; Friedlander M; Hickie IB; Lloyd AR, 2012, 'Cancer-related fatigue in women with breast cancer: outcomes of a 5 year prospective cohort study.', Journal of Clinical Oncology, 30, pp. 1805 - 1812, http://dx.doi.org/10.1200/JCO.2011.34.6148
2012
Van Der Meer J; Lloyd AR, 2012, 'A controversial consensus – comment on article by Brodericket al', Internal Medicine Journal, 271, pp. 29 - 31, http://dx.doi.org/10.1111/j.1365-2796.2011.02468.x
2012
Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M; Van Beek I; Amin J; Dolan K; Rawlinson W; Flynn J; Marks P; Acraman B; Bloch M; Li H; Madden A; George J, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x
2012
Grebely J; Prins M; Hellard M; Cox AL; Osburn WO; Lauer G; Page K; Lloyd AR; Dore GJ; Maher L, 2012, 'Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine', Lancet Infectious Diseases, 12, pp. 408 - 414, http://dx.doi.org/10.1016/s1473-3099(12)70010-5
2012
Keoshkerian E; Helbig K; Beard M; Zaunders J; Seddiki N; Kelleher AD; Hampartzoumian T; Zekry A; Lloyd AR, 2012, 'A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134', Journal of Immunological Methods, 375, pp. 148 - 158, http://dx.doi.org/10.1016/j.jim.2011.10.004
2012
Grebely J; Hellard M; Applegate TL; Petoumenos K; Yeung B; Feld J; Rawlinson WD; Lloyd AR; George J; Kaldor JM; Dore GJ; Matthews G; Dolan K, 2012, 'Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV/HIV co-infection', AIDS, 26, pp. 1653 - 1661, http://dx.doi.org/10.1097/QAD.0b013e3283553719
2012
Scott GM; Chow SS; Craig ME; Pang CN; Hall B; Wilkins MR; Jones C; Lloyd AR; Rawlinson WD; hall B, 2012, 'Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid', Journal of Infectious Diseases, 205, pp. 1305 - 1310, http://dx.doi.org/10.1093/infdis/jis186
2012
Goldstein D; Bennett BK; Webber K; Lloyd AR, 2012, 'Reply to A. Giacalone et al', Journal of Clinical Oncology, 30, pp. 4175 - 4176, http://dx.doi.org/10.1200/JCO.2012.45.6269
2012
Luciani F; Bull RA; Lloyd AR; Bull , 2012, 'Next generation deep sequencing and vaccine design: Today and tomorrow', Trends in Biotechnology, 30, pp. 443 - 452, http://dx.doi.org/10.1016/j.tibtech.2012.05.005
2012
Grebely J; Pham ST; Matthews G; Petoumenos K; Bull RA; Yeung B; Rawlinson WD; Kaldor JM; Lloyd AR; Hellard M; Dore GJ; White PA; Bull ; Dolan K, 2012, 'Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection', Hepatology, 55, pp. 1058 - 1069, http://dx.doi.org/10.1002/hep.24754
2012
Ahmadzai H; Cameron B; Chui JJ; Lloyd A; Wakefield D; Thomas PS, 2012, 'Peripheral blood responses to specific antigens and CD28 in sarcoidosis', Respir Med, 106, pp. 701 - 709, http://dx.doi.org/10.1016/j.rmed.2012.01.012
2012
Flynn J; Dore GJ; Matthews G; Hellard M; Yeung B; Rawlinson W; White PA; Kaldor JM; Lloyd AR; Ffrench RA; Dolan K, 2012, 'Impaired hepatitis C virus (HCV)-specific interferon-responses in individuals with HIV who acquire HCV infection: Correlation with CD4 + T-cell counts', Journal of Infectious Diseases, 206, pp. 1568 - 1576, http://dx.doi.org/10.1093/infdis/jis544
2012
Hovey EJ; De Souza PL; Marx GM; Rapke T; Parente P; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA; Lloyd AR, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.', Journal of Clinical Oncology, 30, pp. e15152 - e15152, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e15152
2012
Bennett BK; Lloyd AR; Webber K; Friedlander M; Goldstein D, 2012, 'Predictors of resilience in women treated for breast cancer: A prospective study.', Journal of Clinical Oncology, 30, pp. 9044 - 9044, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9044
2012
Sugden PB; Cameron B; Bull RA; White PA; Lloyd AR, 2012, 'Occult infection with hepatitis C virus: friend or foe?', , http://dx.doi.org/10.1038/icb.2012.20
2012
Hovey EJ; De Souza PL; Marx GM; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA; Lloyd AR, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.', J Clin Oncol, 30, pp. 211, http://www.ncbi.nlm.nih.gov/pubmed/27967925
2012
Hovey E; de Souza P; Marx G; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Kraft P; Lloyd A, 2012, 'PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MODAFINIL FOR FATIGUE IN PATIENTS TREATED WITH DOCETAXEL-BASED CHEMOTHERAPY', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, pp. 44 - 44, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Mccredie L; Luciani F; Teutsch S; Amin J; Topp L; Dolan K; Lloyd A, 2012, 'BLOODY PRISONS: INCIDENCE OF RISK BEHAVIOURS AND HEPATITIS C VIRUS TRANSMISSION IN AN AUSTRALIAN PRISONER COHORT', DRUG AND ALCOHOL REVIEW, 31, pp. 57 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Piraino BF; Vollmer-Conna US; Lloyd AR, 2012, 'Genetic associations of fatigue and other symptom domains of the acute sickness response to infection', Brain Behavior and Immunity, 26, pp. 552 - 558, http://dx.doi.org/10.1016/j.bbi.2011.12.009
2012
Beaumont A; Burton AR; Lemon JA; Bennett BK; Lloyd AR; Vollmer-Conna US, 2012, 'Reduced Cardiac Vagal Modulation Impacts on Cognitive Performance in Chronic Fatigue Syndrome', PLoS One, 7, pp. e49518, http://dx.doi.org/10.1371/journal.pone.0049518
2012
Hovey EJ; De Souza PL; Marx GM; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA; Lloyd AR, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial', JOURNAL OF CLINICAL ONCOLOGY, 30, http://dx.doi.org/10.1200/jco.2012.30.5_suppl.211
2012
Nguyen N; Luciani F; Cameron B; Keoshkerian E; Zekry A; Lloyd A, 2012, '801 T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', Journal of Hepatology, 56, pp. S313 - S313, http://dx.doi.org/10.1016/s0168-8278(12)60813-7
2012
Webber K; Mok K; Bennett BK; Juraskova I; Goldstein D; Friedlander M; Lloyd AR; FOLCAN study group , 2011, 'Cancer-related fatigue and sexual functioning in women with early breast cancer: Is there a link?', J Clin Oncol, 29, pp. 9072, http://www.ncbi.nlm.nih.gov/pubmed/28021533
2011
Cameron B; Emerson C; Workman C; Kelly M; Lloyd A; Post J, 2011, 'Alterations in Immune Function are Associated with Liver Enzyme Elevation in HIV and HCV Co-infection after Commencement of Combination Antiretroviral Therapy', Journal of Clinical Immunology, 31, pp. 1079 - 1083, http://dx.doi.org/10.1007/s10875-011-9587-6
2011
Webber K; Mok K; Bennett BK; Lloyd AR; Friedlander M; Juraskova I; Goldstein D, 2011, 'If I Am in the Mood, I Enjoy It: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer', Oncologist, 16, pp. 1333 - 1344
2011
Catano G; Chykarenko ZA; Mangano A; Anaya J-M; He W; Smith A; Bologna R; Sen L; Clark RA; Lloyd AR; Shostakovich-koretskaya R; Ahuja SK, 2011, 'Concordance of CCR5 Genotypes that Influence Cell-Mediated Immunity and HIV-1 Disease Progression Rates', Journal of Infectious Diseases, 203, pp. 263 - 272, http://dx.doi.org/10.1093/infdis/jiq023
2011
Grebely J; Matthews G; Hellard M; Shaw D; van Beek I; Petoumenos K; Alavi M; Yeung B; Haber P; Lloyd AR; Kaldor JM; Dore GJ; Dolan K, 2011, 'Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users', Journal of Hepatology, 55, pp. 76 - 85, http://dx.doi.org/10.1016/j.jhep.2010.10.033
2011
Rahman K; Burton AR; Galbraith SA; Lloyd AR; Vollmer-Conna U, 2011, 'Sleep-wake behaviour in chronic fatigue syndrome', Sleep, 34, pp. 671 - 678
2011
Galbraith S; Cameron B; Li H; Lau D; Vollmer-Conna U; Lloyd AR, 2011, 'Peripheral Blood Gene Expression in Postinfective Fatigue Syndrome Following From Three Different Triggering Infections', Journal of Infectious Diseases, 204, pp. 1632 - 1640, http://dx.doi.org/10.1093/infdis/jir612
2011
Boonwaat L; Haber PS; Levy M; Lloyd AR, 2010, 'Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C', Medical Journal of Australia, 192, pp. 496 - 500
2010
Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A, 2010, 'Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome', Journal of Medical Virology, 82, pp. 1684 - 1688, http://dx.doi.org/10.1002/jmv.21873
2010
Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ; Amin J; Cameron B; Acraman B; Dolan K; Bloch M; Van Beek I; Li H; Madden A, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850
2010
Teutsch S; Luciani F; Scheuer N; McCredie L; Hosseiny P; Rawlinson WD; Kaldor JM; Dore GJ; Dolan K; Ffrench R; Lloyd AROLA; Haber P; Levy MH, 2010, 'Incidence of primary Hepatitis C infection and risk factors for transmission in an Australian prisoner cohort', BMC Public Health, 10, pp. 1 - 9, http://dx.doi.org/10.1186/1471-2458-10-633
2010
Palmer C; Corpuz T; Guirgis M; O'Toole S; Yan KK; Bu Y; Jorgenson J; Talbot ML; Loi K; Lloyd AROLA; Zekry A, 2010, 'The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection', Gut, 59, pp. 397 - 404, http://dx.doi.org/10.1136/gut.2008.165316
2010
Grebely J; Petoumenos K; Matthews G; Haber PS; Marks P; Lloyd AROLA; Kaldor JM; Dore GJ; Hellard M; Dolan K, 2010, 'Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study', Drug and Alcohol Dependence, 107, pp. 244 - 249, http://dx.doi.org/10.1016/j.drugalcdep.2009.09.015
2010
Pham STP; Bull RA; Bennett JM; Rawlinson WD; Lloyd AR; Dore GJD; White PA; Bull , 2010, 'Frequent multiple hepatitis C virus infections among injection drug users in a prison setting', Hepatology, 52, pp. 1564 - 1572, http://dx.doi.org/10.1002/hep.23885
2010
Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; Van Beek IA; McCaughan G; White PA; French R; Rawlinson WD; Lloyd AROLA; Kaldor JM; Dolan K, 2010, 'Effective treatment of injecting drug users with recently acquired hepatitis C virus infection', Gastroenterology, 138, pp. 123 - 135, http://dx.doi.org/10.1053/j.gastro.2009.09.019
2010
Webber K; Goldstein D; Bennett BK; Boyle FM; De Souza PL; Wilcken N; Friedlander M; Lloyd AR, 2010, 'Influence of fatigue after breast cancer adjuvant theraphy on health care utilization and percieved needs', JOURNAL OF CLINICAL ONCOLOGY, 28, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.9047
2010
Cameron B ; Hirschberg D ; Rosenberg-Hassan Y ; Ablashi D ; Lloyd A , 2010, 'Serum cytokine levels in post-infective fatigue syndrome', Clin Infect Dis
2010
Palmer CS; Dehart M; Zhang X; Feilotter H; Lloyd A; Zekry A, 2010, 'miR-135a*plays a key role in regulating lipogenesis and inflammation in liver diseases', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, pp. A128 - A128, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Lloyd A, 2010, 'Halting hepatitis', Australian Life Scientist, 7, pp. 32
2010
Burton AR; Rahman K; Kadota Y; Lloyd AROLA; Vollmer-Conna US, 2010, 'Reduced heart rate variability predicts poor sleep quality in a case–control study of chronic fatigue syndrome', Experimental Brain Research, 204, pp. 71 - 78, http://dx.doi.org/10.1007/s00221-010-2296-1
2010
Dolan K; Teutsch S; Scheuer N; Levy M; Rawlinson WD; Kaldor JM; Lloyd AROLA; Haber P, 2010, 'Incidence and risk for acute hepatitis C infection during imprisonment in Australia', European Journal of Epidemiology, 25, pp. 143 - 148, http://dx.doi.org/10.1007/s10654-009-9421-0
2010
Lloyd A; White P; Wessely S; Sharpe M; Buchwald D, 2010, 'Comment on "Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome"', Science, 328, http://dx.doi.org/10.1126/science.1183706
2010
Kadota Y; Cooper G; Burton AR; Lemon J; Schall U; Lloyd AROLA; Vollmer-Conna US, 2010, 'Autonomic hyper-vigilance in post-infective fatigue syndrome', Biological Psychology, 85, pp. 97 - 103
2010
Nguyen N; Palmer C; Hampartzoumian T; Post J; Zekry A; Lloyd A, 2009, 'Intrahepatic chemokine expression and CD8+T cells in HIV/HCV co-infection compared to HCV mono-infection', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A289 - A289, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Palmer C; Zhang X; Feilotter H; Lloyd A; Zekry A, 2009, 'Hepatic micrornas expression in obese subjects with chronic HCV', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A285 - A285, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Nguyen N; De Esch C; Hampartzoumian T; Zekry A; Lloyd A, 2009, 'Fine positioning of T cell sub-populations in the chronic HCV-infected liver', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A284 - A284, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Hickie IB; Banati R; Stewart C; Lloyd AR, 2009, 'Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders?', Medical Journal of Australia, 190
2009
Post JJ; Ratnarajah S; Lloyd AR, 2009, 'Immunological determinants of the outcomes from primary hepatitis C infection', CMLS - Cellular and Molecular Life Sciences, 66, pp. 733 - 756
2009
Hickie IB; Davenport T; Vernon S; Nisenbaum R; Reeves W; Hadzi-Pavlovic D; Lloyd AR, 2009, 'Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and healthcare settings?', Australian and New Zealand Journal of Psychiatry, 43, pp. 25 - 35
2009
Matthews G; Hellard M; Haber P; Yeung B; Marks PB; Baker D; McCaughan G; Sasadeusz J; White PA; Rawlinson WD; Lloyd AR; Kaldor JM; Dore GJ; Dolan K, 2009, 'Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in acute hepatitis C', Clinical Infectious Diseases, 48, pp. 650 - 658, http://dx.doi.org/10.1086/596770
2009
Everts R; Lloyd A; Meech R; Speers D, 2009, 'Chronic fatigue syndrome complicating leptospirosis', Journal of Occupational Health and Safety - Australia and New Zealand, 25, pp. 209 - 212
2009
Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; van Beek I; McCaughan G; White PA; Ffrench R; Rawlinson W; Lloyd A; Kaldor J; Dore GJ, 2009, 'Treatment of recent hepatitis C virus infection in a predominantly injection drug user cohort: the ATAHC Study', The Canadian Journal of Addiction, 1, pp. 33 - 33, http://dx.doi.org/10.1097/02024458-200912000-00072
2009
Vollmer-Conna US; Chen M; Lloyd A; Donovan BJ, 2008, 'Emotional dysfunction may be linked to immune activation in patients with genital herpes', ACTA Neuropsychiatrica, 20, pp. 145 - 151
2008
Goldstein D; Bennett B; Cameron B; Boyle F; DeSouza P; Wilcken N; Friedlander M; Scott E; Hickie I; Lloyd AAM, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer: Association with hematologic, endocrine, and immune parameters', JOURNAL OF CLINICAL ONCOLOGY, 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.9596
2008
Palmer C; Hampartzoumian T; Lloyd AR; Zekry A, 2008, 'A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection', Hepatology, 48, pp. 374 - 384, http://dx.doi.org/10.1002/hep.22387
2008
Chow SS; Craig ME; Jones C; Hall B; Catteau J; Lloyd AR; Rawlinson WD, 2008, 'Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection', Cytokine, 44, pp. 78 - 84
2008
Vollmer-Conna U ; Piraino B ; Cameron B ; Davenport T ; Hickie I ; Wakefield D ; Lloyd A , 2008, 'Cytokine Polymorphisms Have a Synergistic Effect on Severity of the Acute Sickness Response to Infection', Clinical Infectious Diseases, 47, pp. 1418 - 1425, http://dx.doi.org/10.1086/592967
2008
Ng W; Hampartzoumian T; Lloyd AR; Grimm M, 2007, 'A murine model of appendicitis and the impact of inflammation on appendiceal lymphocyte constituents', Clinical and Experimental Immunology, 150, pp. 169 - 178
2007
Bennett BK; Goldstein D; Lloyd AROLA; Friedlander ML; Hickie IB, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135
2007
Bennett BK; Goldstein D; Friedlander ML; Hickie IB; Lloyd AR, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: A qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135
2007
Dolan M; Kulkarni H; Camargo J; He W; Smith A; Anaya J; Miura T; Hecht FM; Mamtani M; Pereyra F; Marconi V; Mangano A; Sen L; Bologna R; Clark RK; Anderson S; Delmar J; O Connell R; Lloyd AR; Martin JL; Ahuja S; Agan B; Walker BD; Deeks S; Ahuja S, 2007, 'CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms', Nature Immunology, 8, pp. 1324 - 1336
2007
Lloyd AR; Jagger E; Post JJ; Crooks L; Rawlinson WD; Hahn Y; Ffrench R, 2007, 'Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection', Immunology and Cell Biology, 85, pp. 24 - 32
2007
Xue ML; Thakur A; Cole NA; Lloyd AR; Stapleton FJ; Wakefield D; Willcox MD, 2007, 'A critical role for CCL2 and CCL3 chemokines in the regulation of polymorphonuclear neutrophil recruitment during corneal infection in mice', Immunology and Cell Biology, 85, pp. 525 - 531
2007
Vollmer-Conna U ; Cameron B ; Hadzi-Pavlovic D ; Singletary K ; Davenport T ; Vernon S ; Reeves WC ; Hickie I ; Wakefield D ; Lloyd AR ; Dubbo Infection Outcomes Study Group , 2007, 'Post-infective fatigue syndrome is not associated with altered cytokine production', Clin Infect Dis., 45, pp. 732 - 735
2007
Everett B ; Cameron B ; Li H ; Vollmer-Conna U ; Davenport T ; Hickie I ; Wakefield D ; Vernon S ; Reeves WC ; Lloyd AR , 2007, 'Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever', Genes Immun, 8, pp. 699 - 702, http://dx.doi.org/10.1038/sj.gene.6364428
2007
Dyer W; Pett SL; Sullivan JS; Emery S; Cooper DA; Kelleher AD; Lloyd AR; Lewin S, 2007, 'Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples', Clinical and Vaccine Immunology, 14, pp. 52 - 59
2007
Jones J; Kohl K; Ahmadipour N; Bleijenberg G; Buchwald D; Evengard B; Jason L; Klimas N; Lloyd AR; McCleary K; Oleske J; White P, 2007, 'Fatigue: Case definition and guidelines for collection, analysis, and presentation of immunization safety data', Vaccine, 25, pp. 5685 - 5696, http://dx.doi.org/10.1016/j.vaccine.2007.02.065
2007
Chang JH; Hampartzoumian T; Everett BJ; Lloyd AR; McCluskey PJ; Wakefield D, 2007, 'Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis', Investigative Ophthalmology and Visual Science, 48, pp. 1711 - 1717
2007
Palmer C; Lloyd AR; Zekry A, 2007, 'Effect of adiponectin on the cellular immune response in chronic HCV infection', Hepatology, 46, pp. 440A - 440A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249910400459&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2007
Matthews G; Hellard M; Kaldor JM; Lloyd AR; Dore GJ, 2007, 'Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al', AIDS, 21, pp. 2112 - 2113, http://dx.doi.org/10.1097/qad.0b013e3282ef3873
2007
Dore GJ; Hellard M; Matthews G; Haber PS; Shaw D; Yeung B; Petoumenos K; Van Beek IA; Mccaughan GW; Pan Y; Ffrench R; Rowlinson W; Lloyd AR; Kaldor JM, 2007, 'Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the Australian trial in acute hepatitis C (ATAHC)', Hepatology, 46, pp. 358A - 358A
2007
Haber PS; Cameron BA; Elliott LN; Teutsch S; Ffrench R; Dolan K; Rawlinson B; Levy MH; Kaldor JM; Lloyd AR, 2007, 'Correlates of incident HCV infection and seronegative-immune status in high risk, IDU prisoners', Hepatology, 46, pp. 630A - 630A
2007
Cameron B ; Galbraith S ; Zhang Y ; Davenport T ; Vollmer Conna U ; Wakefield D ; Hickie I ; Dunsmuir WTM; Whistler T ; Vernon S ; Reeves W ; Lloyd A , 2007, 'Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis', The Journal of Infectious Diseases, 196, pp. 56 - 66, http://dx.doi.org/10.1086/518614
2007
Goldstein D; Bennett BK; Friedlander ML; Davenport TA; Hickie IB; Lloyd AR, 2006, 'Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study', BMC Cancer, 6, pp. 240 - 240, http://dx.doi.org/10.1186/1471-2407-6-240
2006
Fostel J; Boneva R; Lloyd AR, 2006, 'Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis', Pharmacogenomics, 7, pp. 441 - 454
2006
Elliott LN; Lloyd AR; Ziegler JB; Ffrench RA, 2006, 'Protective immunity against hepatitis C virus infection', Immunology and Cell Biology, 84, pp. 239 - 249
2006
Vernon S ; Whistler T ; Cameron B ; Hickie I ; Reeves W ; Lloyd A ; Cameron B; Lloyd A; Hickie I, 2006, 'Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus', BMC Infect Dis, 6, pp. 15, http://dx.doi.org/10.1186/1471-2334-6-15
2006
Hickie I; Davenport TA; Wakefield D; Vollmer-Conna US; Cameron BA; Vernon S; Reeves W; Lloyd AR, 2006, 'Postinfective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: porspective cohort study', British Medical Journal: International, Sep, pp. 1 - 6
2006
Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A, 2006, 'Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load', J Infect Dis, 193, pp. 664 - 671, http://dx.doi.org/10.1086/500248
2006
Ng WW; Lloyd AR; Grimm M, 2006, 'Appendicitis protects against colitis: an exploration of immune mechanisms', Journal of Gastroenterology and Hepatology, 21, pp. A263 - A263
2006
Vernon SD; Nicholson A; Rajeevan M; Dimulescu I; Cameron B; Whistler T; Lloyd A, 2006, 'Correlation of psycho-neuroendocrine-immune (PNI) gene expression with symptoms of acute infectious mononucleosis', Brain Res, 1068, pp. 1 - 6, http://dx.doi.org/10.1016/j.brainres.2005.11.013
2006
Palmer C; Lloyd AR; Yan KK; Hampartzoumian T; Zekry A, 2006, 'Effect of adipokines on T-CELL mediated anti-HCV immune responses', Hepatology, 44, pp. 297A - 298A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241362300290&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2006
Vernon SD; Whistler T; Cameron B; Hickie IB; Reeves WC; Lloyd A, 2006, 'Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus.', BMC infectious diseases, 6
2006
Elliott LN; Hossieny P; Lloyd AR; Ffrench RA, 2006, 'High prevalence of broadly reactive HCV-specific cellular immune responses in antibody and PCR negative prisoners reporting injecting drug use', Journal of Clinical Virology, 36, pp. S122 - S122
2006
Wallace C; Hailstone S; Lloyd A, 2005, 'Bug Breakfast in the Bulletin: Blood-borne viruses in correctional facilities.', New South Wales public health bulletin, 16, pp. 166 - 167
2005
Flynn J; Goy K; Woollard D; Lloyd AR; Ffrench R, 2005, 'Multi-specific IFN-gamma and IL-2 T cell responses in chronic HCV infection', Tissue Antigens, 66, pp. 419 - 419, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700212&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Jagger E; Hettiaratchi A; Carol H; Cameron BA; Vollmer-Conna US; Davenport T; Hickie IB; Wakefield D; Lloyd AR, 2005, 'Polymorphisms in the interleukin-10 gene are associated with duration of illness following primary Epstein-Barr virus infection', Tissue Antigens, 66, pp. 452 - 453, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700302&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Newman R; Cuan N; Hampartzoumian T; Connor SJ; Lloyd AR; Grimm M, 2005, 'Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis', Clinical and Experimental Immunology, 139, pp. 411 - 420
2005
Helbig K; Ayres J; Dunckley H; Lloyd AR; Robson J; Marmion BP; Harris R, 2005, 'Immune response genes in the post-Q-fever fatigue syndrome, Q fever endocarditis and uncomplicated acute primary Q fever', QJM - an International Journal of Medicine, 98, pp. 565 - 574
2005
Freeman AJ; Marinos G; Ffrench R; Lloyd AR, 2005, 'Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyteactivity is associated with a response to combination IFN-alpha andribavirin treatment among patients with chronic hepatitis C virusinfection', Journal of Viral Hepatitis, 12, pp. 125 - 129
2005
Harvey CE; Lloyd AR; Post JJ, 2005, 'Loss of CCR5+ T cells in the liver of HCV infected individuals co-infected with HIV', Tissue Antigens, 66, pp. 437 - 438, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700261&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Smith A; Vollmer-Conna US; Geczy A; Dunckley H; Bennett BK; Hickie IB; Lloyd AR, 2005, 'Does genotype mask the relationship between psychological factors and immune function?', Brain Behavior and Immunity, 19, pp. 147 - 152
2005
Elliott LN; Ziegler JB; Palasanthiran P; Giles ME; Lloyd AR; Ffrench R, 2005, 'Infrequent detection of HCV-specific cellular immune responses in infants born to HCV-positive mothers', Tissue Antigens, 66, pp. 405 - 406, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2005
Bennett BK; Goldstein D; Lloyd AR; Davenport T; Hickie IB, 2004, 'Fatigue and psychological distress - exploring the relationship in women treated for breast cancer', European Journal of Cancer, 40, pp. 1689 - 1695
2004
Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber P; Marinos G; Levy MH; Kaldor JM; Dolan K; Ffrench R; Lloyd AR; Rawlinson WD, 2004, 'Clearance of Hepatitis C Viremia Associated with Cellular Immunity in the Absence of Seroconversion in the Hepatitis C Incidence and Transmission in Prisons Study Cohort', Journal of Infectious Diseases, 189, pp. 1846 - 1855
2004
Vollmer-Conna U; Fazou C; Cameron B; Li H; Brennan C; Luck L; Davenport T; Wakefield D; Hickie I; Lloyd A, 2004, 'Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans', Psychol Med, 34, pp. 1289 - 1297
2004
Pett SL; Williams LA; Day RO; Lloyd AR; Carr AD; Clezy KR; Emery S; Kaplan E; Mcphee D; Mclachlan AJ; Gelder F; Lewin S; Liauw WS; Williams KM, 2004, 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals', HIV Clinical Trials, 5, pp. 91 - 98
2004
Freeman A; Ffrench R; Post JJ; Harvey CE; Gilmour S; White PA; Marinos G; Van Beek IA; Rawlinson WD; Lloyd AR, 2004, 'Prevalence of Production of Virus-Specific Interferon- among Seronegative Hepatitis C-Resistant Subjects Reporting Injection Drug Use', Journal of Infectious Diseases, 190, pp. 1093 - 1097
2004
Smith A; Vollmer-Conna US; Bennett BK; Wakefield D; Hickie IB; Lloyd AR, 2004, 'The relationship between distress and the development of a primary immune response to a novel antigen', Brain Behavior and Immunity, 18, pp. 65 - 75
2004
Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome? No longer a question', Medical Journal of Australia, 180, pp. 437 - 438
2004
Freeman AJ; Ffrench RA; Post JJ; Harvey CE; Gilmour S; White PA; Marinos G; Rawlinson WD; Van Beek IA; Lloyd AR, 2004, 'Virus-specific cellular immunity is prevalent among hepatitis C-resistant injecting drug users', Journal of Infectious Diseases, 190, pp. 1093 - 1097
2004
Scroop GC; Burnet RB, 2004, 'To exercise or not to exercise in chronic fatigue syndrome?', MEDICAL JOURNAL OF AUSTRALIA, 181, pp. 578 - 579, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06457.x
2004
Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome?', Medical Journal of Australia, 181, pp. 578 - 580, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06459.x
2004
Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome? Reply', Medical Journal of Australia, 181, pp. 579 - 580
2004
Connor SJ; Paraskevopoulos N; Newman R; Cuan N; Hampartzoumian T; Lloyd AR; Grimm M, 2004, 'CCR2 expressing CD4+T lymphocytes are preferentially recruited to the ileum in Crohn's disease', Gut, 53, pp. 1287 - 1294
2004
Stafford JA; Post JJ; Kaldor JM; Pan Y; Haber P; Lloyd AR; Dolan K, 2004, 'Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, Australia', Journal of Urban Health - Bulletin of the New York Academy of Medicine, 81, pp. 448 - 452, http://dx.doi.org/10.1093/jurban/jth129
2004
Grimm M; Newman R; Hassim Z; Cuan N; Connor SJ; Wang J; Oppenheim JJ; Lloyd AR, 2003, 'Vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors', Journal of Immunology, 171, pp. 4990 - 4994
2003
Smith AJ; Bennett B; Vollmer-Conna U; Wakefield D; Hickie IB; Lloyd AR, 2003, 'The relationship between distress and the development of a primary immune response', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200402&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2003
Vollmer-Conna U; Davenport T; Hickie I; Wakefield D; Lloyd A, 2003, 'Sick, sleepy and sad', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 95 - 95, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200420&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2003
Robertson PW; Beynon S; Whybin R; Brennan CM; Vollmer-Conna US; Hickie IB; Lloyd AR, 2003, 'Measurement of EBV-1gG and t-VCA avidity aids the early and reliable diagnosis of primary EBV infection', Journal of Medical Virology, 70, pp. 617 - 623
2003
Senanayake SN; Kelly JJ; Lloyd AR; Waliuzzaman Z; Goldstein D; Rawlinson WD, 2003, 'Multicentric Castleman's Disease Treated with Antivirals and Immunosuppressants', Journal of Medical Virology, 71, pp. 399 - 403
2003
Reeves W; Lloyd AR; Vernon S; Klimas N; Jason L; Bleijenberg G; Evengard B; White P; Nisenbaum R; Unger E, 2003, 'Identification of ambiguities in the 1994 chronic fatigue syndromeresearch case definition and recommendations for resolution', BMC Health Services Research, 3, pp. 1 - 9, http://dx.doi.org/10.1186/1472-6963-3-1
2003
Grimm MC; Newman R; Hassim Z; Cuan N; Connor SJ; Le Y; Wang JM; Oppenheim JJ; Lloyd AR, 2003, 'Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors', Journal of Immunology, 171, pp. 4990 - 4994, http://dx.doi.org/10.4049/jimmunol.171.10.4990
2003
Harvey CE; Post JJ; Palladinetti P; Freeman AJ; Ffrench R; Kumar RK; Marinos G; Lloyd AR, 2003, 'Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation', Journal of Leukocyte Biology, 74, pp. 360 - 369
2003
Xue ML; Wakefield D; Willcox MD; Lloyd AR; Di Girolamo N; Cole NA; Thakur A, 2003, 'Regulation of MMPs and TIMPs by IL-1â during Corneal Ulceration and Infection', Investigative Ophthalmology and Visual Science, 44, pp. 2020 - 2025
2003
Freeman A; Pan Y; Harvey CE; Post JJ; Law MG; White PA; Rawlinson WD; Lloyd AR; Marinos G; Ffrench R, 2003, 'The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection', Journal of Hepatology, 38, pp. 349 - 356
2003
Xue ML; Thakur A; Willcox MD; Zhu H; Lloyd AR; Wakefield D, 2003, 'Role and regulation of CXC-chemokines in acute experimental keratitis', Experimental Eye Research, 76, pp. 221 - 231
2003
Smith AJ; Vollmer-Conna U; Bennett B; Wakefield D; Hickie IB; Lloyd AR, 2003, 'The effect of examination stress on the development of a primary immune response', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2003
Dore GJ; Freeman AJ; Kaldor JM; Post JJ; Harvey CE; Ffrench RA; Lloyd AR; Mehta SH; Cox AL; Strathdee SA; Vlahov D; Thomas DL, 2002, 'Immunity against hepatitis C virus infection [2] (multiple letters)', Lancet, 360, pp. 1019 - 1020, http://dx.doi.org/10.1016/s0140-6736(02)11102-0
2002
Thakur A; Xue ML; Stapleton FJ; Lloyd AR; Wakefield D; Willcox MD, 2002, 'The balance of pro- and anti-inflammatory cytokines correlates with the outcome of acute experimental Pseudomonas keratitis', Infection and Immunity, 70, pp. 2187 - 2197
2002
Kumar RK; Thomas PS; Seetoo DQ; Herbert C; McKenzie AN; Foster PS; Lloyd AR, 2002, 'Eotaxin expression by epithelial cells and plasma cells in chronic asthma', Lab Invest, 82, pp. 495 - 504, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11950906
2002
White PA; Freeman A; Marinos G; Ffrench R; Rawlinson WD; Pan Y; Lloyd AR, 2002, 'Quantification of Hepatitis C Virus in Human Liver and Serum Samples by Using LightCycler Reverse Transcriptase PCR', Journal of Clinical Microbiology, 40, pp. 4346 - 4348, http://dx.doi.org/10.1128/JCM.40.11.4346-4348.2002
2002
Post JJ; Freeman A; Harvey CE; Ffrench R; Lloyd AROLA, 2002, 'Immunity against hepatitis C virus infection', Lancet, 360, pp. 1020 - 1020
2002
Loblay R; Toulkidis V; Hickie I; Lloyd A; Phillips B; Phoon WO; Rowe K; Steven I; Wakefield D; Watson D; Stewart G; Bertouch J; Cistulli P; Darveniza P; Ellis C; Gatenby P; Gillis D; Hickie I; Lloyd A; Phillips B; Phoon WO; Rowe K; Steven I; Wakefield D; Watson DO; Toulkidis V, 2002, 'Clinical practice guidelines - 2002', MEDICAL JOURNAL OF AUSTRALIA, 176, pp. S21 - S55, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000175489800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2002
Post JJ; Konecny P; Lloyd AR; Jones PD, 2002, 'Acute Q fever and brachial neuritis: Case report and literature review', Infection, 30, pp. 400 - 402
2002
Dore GJ; Freeman A; Kaldor JM, 2002, '. Immunity against hepatitis C virus infection', Lancet, 360, pp. 1019 - 1020
2002
Bertouch J; Cistulli P; Darveniza P; Ellis C; Gatenby P; Gillis D; Hickie IB; Phillips I; Phoon W; Rowe K; Steven I; Wakefield D; Watson D, 2002, 'Chronic Fatigue Syndrome Clinical Practice Guidelines', Medical Journal of Australia, 176
2002
Smith AJ; Bennett B; Vollmer-Conna U; Wakefield D; Hickie IB; Lloyd AR, 2001, 'The effect of distress on the development of a primary immune response', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 53, pp. 175 - 175, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202876001305&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2001
Freeman A; Dore GJ; Law MG; Thorpe M; Von Overbeck J; Lloyd AR; Marinos G; Kaldor JM, 2001, 'Estimating progression to cirrhosis in chronic hepatitis C virus infection.', Hepatology, pp. 809 - 816
2001
Post JJ; Dolan K; Whybin R; Carter I; Haber P; Lloyd AR, 2001, 'Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route', Medical Journal of Australia, 174, pp. 183 - 184
2001
Freeman A; Marinos G; Ffrench R; Lloyd AR, 2001, 'Immunopathogenesis of hepatitis C virus infection', Immunology and Cell Biology, pp. 515 - 536
2001
Thakur A; Xue ML; Wang W; Lloyd AR; Wakefield D; Willcox MD, 2001, 'Expression of macrophage migration inhibitory factor during Pseudomonas keratitis', Clinical and Experimental Ophthalmology, pp. 179 - 182
2001
Xue ML; Willcox MD; Lloyd AR; Wakefield D; Thakur A, 2001, 'Regulatory role of IL-IB in the expression of IL-6 and IL-8 in human corneal epithelial cells during Pseudomonas aeruginosa colonization', Clinical and Experimental Ophthalmology, pp. 171 - 174
2001
Wilson A; Hickie IB; Hadzi-Pavlovic D; Wakefield D; Parker GB; Straus SE; Dale J; McCluskey D; Gwynneth H; Brickman A; Goldenberg D; Demitrack M; Blakely T; Wessely S; Sharp M; Lloyd AR, 2001, 'What is chronic fatigue syndome? Heterogeneity within an international multicentre study.', Australian and New Zealand Journal of Psychiatry, pp. 520 - 527
2001
Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using preblotics', Gastroenterology, 120, pp. A82 - A82, http://dx.doi.org/10.1016/s0016-5085(08)80404-0
2001
Hickie IB; Bansal AS; Kirk KM; Lloyd AR; Martin NG, 2001, 'A twin study of the etiology of prolonged fatigue and immune activation', Twin Research, pp. 94 - 102
2001
Harrigan R; Storm PA; Lloyd AR; Arens ME; Marmion BP, 2000, 'Long-term persistence of coxiella burnetii in the host after primary Q fever', Epidemiology and Infection, 124, pp. 543 - 549
2000
Freeman A; Zekry A; Whybin R; Harvey CE; Van Beek IA; De Kantzow SL; Rawlinson WD; Boughton CR; Robertson PW; Marinos G; Lloyd AR, 2000, 'Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s', Medical Journal of Australia, 172, pp. 588 - 591
2000
Hickie IB; Wilson A; Wright MJ; Bennett BK; Wakefield D; Lloyd AROLA, 2000, 'A randomized, double-blind, placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome', Journal of Clinical Psychiatry, 61, pp. 643 - 648
2000
Hadzi-Pavlovic D; Hickie IB; Wilson A; Davenport T; Lloyd AR; Wakefield D, 2000, 'Screening for prolonged fatigue syndromes: validation of the SOFA scale', Social Psychiatry and Psychiatric Epidemiology, pp. 471 - 479
2000
Di Girolamo N; Mccluskey P; Lloyd AR; Coroneo MT; Wakefield D, 2000, 'Expression of MMPs and TIMPs in Human Pterygia and Cultured Pterygium Epithelial Cells', Investigative Ophthalmology and Visual Science, pp. 671 - 679
2000
Harvey CE; Post JJ; Kumar RK; Freeman AJ; Lloyd AR; Marinos G, 2000, 'Interferon inducible protein 10 is expressed by hepatocytes in chronic hepatitis C virus infection and correlates with lobular inflammation.', HEPATOLOGY, 32, pp. 374A - 374A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622400847&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2000
Davenport MP; Grimm MC; Lloyd AR, 2000, 'A homing selection hypothesis for T-cell trafficking', Immunology Today, 21, pp. 315 - 317
2000
Freeman AJ; Dore GJ; Law MG; Thorpe M; Von Overbeck J; Lloyd AR; Marinos G; Kaldor JM, 2000, 'The natural history of chronic hepatitis C: A systematic review', HEPATOLOGY, 32, pp. 422A - 422A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622401038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2000
Cardillo R; Hassim Z; Tedla N; Lloyd AR; Grimm MC, 2000, 'VIP desensitizes chemokine receptors and impairs leukocyte trafficking and inflammation in vivo.', GASTROENTEROLOGY, 118, pp. A357 - A357, http://dx.doi.org/10.1016/S0016-5085(00)83531-3
2000
Lloyd AR; Hickie IB; Loblay RH, 2000, 'Diagnostic criteria for chronic fatigue syndrome', Medical Journal of Australia, 172, pp. 472
2000
Binotto E; Boughton CR; Hawkes R; Robertson PW; Whybin R; Duffy Y; Vollmer-Conna US; Lloyd AR, 2000, 'A serological and epidemiological re-evaluation of acute non-A non-B hepatitis from the early 1970's', Australian and New Zealand Journal of Psychiatry, pp. 668 - 674
2000
Lloyd AR; Hickie IB; Loblay RH, 2000, 'Illness or disease? The case of chronic fatigue syndrome', Medical Journal of Australia, 172, pp. 471 - 472
2000
Tedla NT; Palladinetti P; Wakefield D; Lloyd AR, 1999, 'Abundant expression of chemokines in malignant and infective human lymphadenopathies', Cytokine, 11, pp. 531 - 540
1999
Palladinetti P; Wakefield D; Lloyd AR, 1999, 'Viral chemokine receptor US28 modulates the immune response to human cytomegalovirus.', FASEB JOURNAL, 13, pp. A658 - A658, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000082132900068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1999
Koschera A; Hickie I; Hadzi-Pavlovic D; Wilson A; Lloyd A, 1999, 'Prolonged fatigue, anxiety and depression: exploring relationships in a primary care sample', Australian and New Zealand Journal of Psychiatry, 33, pp. 545 - 552, http://dx.doi.org/10.1046/j.1440-1614.1999.00593.x
1999
Hickie IB; Bennett BK; Lloyd AR; Heath A; Martin N, 1999, 'Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: a twin study.', Psychological Medicine, pp. 269 - 277
1999
Hickie IB; Bennett BK; Lloyd AR; Heath A; Martin N, 1999, 'Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: a twin study', Psychological Medicine, pp. 269 - 277
1999
Tedla NT; Dwyer JM; Truskett PG; Taub DD; Wakefield D; Lloyd AR, 1999, 'Phenotypic and functional characterisation of lymphocytes derived from normal and HIV1 infected human lymph nodes.', Clinical and Experimental Immunology, 117, pp. 92 - 99
1999
Di Girolamo N; Tedla NT; Kumar RK; Mccluskey P; Lloyd AR; Coroneo MT; Wakefield D, 1999, 'Culture and characterisation of epithelial cells from human pterygia', British Journal of Ophthalmology, pp. 1077 - 1082
1999
Hickie IB; Koschera A; Hadzi-Pavlovic D; Bennett BK; Lloyd AR, 1999, 'The temporal stability and comorbidity of prolonged fatigue: a longitudinal study in primary care.', Psychological Medicine, pp. 855 - 861
1999
Haber PS; Parsons S; Harper S; White PA; Rawlinson WD; Lloyd AR, 1999, 'Transmission of hepatitis C within Australian prisons.', Medical Journal of Australia, 171, pp. 31 - 33
1999
Verma MJ; Mukaida N; Vollmer-Conna US; Matsushima K; Lloyd AR; Wakefield D, 1999, 'Endotoxin induced uveitis is partially inhibited by AntiIL8 antibody treatment', Investigative Ophthalmology and Visual Science, pp. 2465 - 2470
1999
Grimm MC; Hassim Z; Lloyd AR; Oppenheim JJ, 1999, 'Chemokine receptors are inhibited by vasoactive intestinal peptide: Desensitization of HIV-1 co-receptors', GASTROENTEROLOGY, 116, pp. A728 - A728, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079778403161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1999
Koschera A; Hickie IB; Hadzi-Pavlovic D; Wilson AR; Lloyd AR, 1999, 'Prolonged fatigue, anxiety and depression: exploring relationships in a primary care sample.', Australian and New Zealand Journal of Psychiatry, pp. 545 - 552
1999
Wakefield D; Cuello C; Di Girolamo N; Lloyd AR, 1999, 'The role of cytokines and chemokines in uveitis', Developments in Ophthalmology, pp. 53 - 66
1999
Naif H; Li S; Alali M; Sloane A; Wu L; Kelly M; Lynch G; Lloyd AR; Cunningham AL, 1998, 'CCR5 expression correlates with susceptibility of maturing monocytes to Human Immunodeficiency Virus type 1 infection.', Journal of Virology, pp. 830 - 836
1998
Kelly M; Hassan M; Adams SE; Cunningham AL; Lloyd AR, 1998, 'Dichotomous effects of b-chemokines on HIV-1 replication in monocytes and monocyte-derived macrophages.', Journal of Immunology, 160, pp. 3091 - 3095
1998
Carr AD; Emery S; Lloyd AR; Hoy JF; Garsia R; French MA; Stewart GA; Fyfe G; Cooper DA, 1998, 'Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, milticenter study', Journal of Infectious Diseases, 178, pp. 992 - 999, http://jid.oxfordjournals.org/content/178/4/992.full.pdf+html
1998
O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GSA; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J, 1998, 'Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C', Transfusion Medicine, 8, pp. 303 - 308, http://dx.doi.org/10.1046/j.1365-3148.1998.00172.x
1998
Mikloska Z; Danis V; Adams SE; Lloyd AR; Adrian DL; Cunningham AL, 1998, 'In vivo production of cytokines and b (C-C) chemokines in human recurrent herpes simplex lesions - do herpes simplex virus-infected keratinocytes contribute to their production?', Journal of Infectious Diseases, 177, pp. 827 - 838
1998
Kelly MD; Naif HM; Adams SL; Cunningham AL; Lloyd AR, 1998, 'Cutting edge: Dichotomous effects of β-chemokines on HIV replication in monocytes and monocyte-derived macrophages', Journal of Immunology, 160, pp. 3091 - 3095
1998
Tedla NT; Wang H; McNeil HP; Di Girolamo N; Hampartzoumian T; Wakefield D; Lloyd AR, 1998, 'Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1alpha and MIP-1beta.', Journal of Immunology, 161, pp. 5663 - 5672
1998
Wang H; Tedla NT; Lloyd AR; Wakefield D; McNeil HP, 1998, 'Mast cell activation and migration to lymph nodes during induction of an immune response in mice.', Journal of Clinical Investigation, 102, pp. 1617 - 1626
1998
Di Girolamo N; Tedla NT; Lloyd AR; Wakefield D, 1998, 'Expression of matrix metalloproteinases by human plasma cells and B lymphocytes.', European Journal of Immunology, pp. 1773 - 1784
1998
Vollmer-Conna US; Lloyd AR; Hickie IB; Wakefield D, 1998, 'Chronic fatigue syndrome: an immunological perspective', Australian and New Zealand Journal of Psychiatry, pp. 523 - 527
1998
Bennett BK; Hickie IB; Vollmer-Conna US; Quigley B; Brennan CM; Wakefield D; Douglas MP; Hansen GR; Tahmindjis AJ; Lloyd AR, 1998, 'The relationship between fatigue, psychological and immunological variables in acute infectious illness.', Australian and New Zealand Journal of Psychiatry, pp. 180 - 186
1998
Cuello C; Palladinetti P; Tedla NT; Di Girolamo N; Lloyd AR; Mccluskey P; Wakefield D, 1998, 'Chemokine expression and leucocyte infiltration in Sjögren's syndrome', British Journal of Rheumatology, pp. 779 - 783
1998
Lloyd AR, 1998, 'Chronic fatigue and chronic fatigue syndrome: Shifting boundaries and attributions.', American Journal of Industrial Medicine, 105, pp. 7S - 10S
1998
Trickett AE; Kelly M; Cameron BA; Lloyd A; Ffrench RA; Dwyer JM, 1998, 'A preliminary study to determine the effect of an infusion of cryopreserved autologous lymphocytes on immunocompetence and viral load in HIV-infected patients', J Acquir Immune Defic Syndr Hum Retrovirol, 17, pp. 129 - 136
1998
O Donnell MC; Catts SV; Ward PB; Liebert BJ; Lloyd AR; Wakefield D; McConaghy N, 1998, 'Interleukin-2 and schizophrenia', Psychiatry Research, 77, pp. 65 - 66, http://dx.doi.org/10.1016/S0165-1781(97)00130-3
1998
Tedla N; Wang HW; McNeil HP; Wakefield D; Lloyd A, 1997, 'Chemokines regulate T cell recruitment to lymph nodes during contact hypersensitivity.', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 99, pp. 1006 - 1006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WH14201003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1997
Verma MJ; McCluskey P; Matsushima K; Mukaida N; Lloyd A; Wakefield D, 1997, 'Inhibitory effect of anti-IL-8 antibody on endotoxin induced uveitis', INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 38, pp. 4418 - 4418, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WN21501240&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1997
Lloyd AR, 1997, 'How to cope with chronic fatigue', Medical Journal of Australia, 167, pp. 487 - 488, http://dx.doi.org/10.5694/j.1326-5377.1997.tb126680.x
1997
Di Girolamo N; Visvanathan K; Lloyd AR; Wakefield D, 1997, 'Expression of tumor necrosis factor-alpha by human plasma cells in chronic inflammation', Journal of Leukocyte Biology, pp. 667 - 678
1997
Adams D; Lloyd AR, 1997, 'Chemokines: leucocyte recruitment and activation cytokines', Lancet, pp. 490 - 495
1997
Stewart GA; Ashton LJ; Biti RA; Ffrench FA; Bennetts BH; Newcombe NR; Benson EM; Carr AD; Cooper DA; Kaldor JM; Smith DD; Catchpole BR; Allworth A; Baker D; Batty G; Beveridge A; Bloch M; Bodsworth NJ; Clare K; Cummins E; Cunningham PH; Couldwell D; Deacon N; Doong N; Finlayson R; Furner V; Huffam SE; Kidd J; Kelly MD; Lloyd AR; Mcfarlane R; Mclean K; Mcnulty A; Mcphee D; Michelmore H; Mcmurchie M; Mutimer K; Peterson J; Price R; Quan J; Qurn J; Ree H; Robertson M; Roggensack M; Schroeder K; Spencer D; Sullivan JS; Ziegler JB, 1997, 'Increased frequency of CCR-5 delta32 heterozygotes among long-term nonprogressors with HIV infection.', AIDS, 11, pp. 1833 - 1838
1997
Hickie IB; Lloyd AR; Halliday GM; Mcritchie DA; Scott E; Mitchell PB; Wakefield D, 1997, 'Utilising molecular biological and histopathological techniques to study the dopaminergic system in patients with melancholia', Australian and New Zealand Journal of Psychiatry, pp. 27 - 35
1997
Verma MJ; Lloyd AR; Rager H; Strieter R; Kunkel S; Taub DD; Wakefield D, 1997, 'Chemokines in acute anterior uveitis', Current Eye Research, 16, pp. 1202 - 1208
1997
Catts SV; Lloyd AR; Huang XF; Dixon GJ; Chahl L; Harper C; Wakefield D; Ward PB, 1997, 'Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia', Australian and New Zealand Journal of Psychiatry, pp. 17 - 26
1997
Di Girolamo N; Lloyd AR; Mccluskey P; Filipic M; Wakefield D, 1997, 'Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts', American Journal of Pathology, 150, pp. 653 - 666
1997
Khachigian LM; Dixon GJ; Huang XF; Catts SV; Hickie IB; Wakefield D, 1997, 'Molecular biology and the major psychoses', Australian and New Zealand Journal of Psychiatry, pp. 12 - 16
1997
Vollmer-Conna US; Hickie IB; Hadzi-Pavlovic D; Tymms K; Wakefield D; Dwyer JM; Lloyd AR, 1997, 'Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome', American Journal of Medicine, 103, pp. 38 - 43
1997
Di Girolamo N; Visvanathan K; Lloyd A; Wakefield D, 1997, 'Expression of TNF-α by human plasma cells in chronic inflammation', Journal of Leukocyte Biology, 61, pp. 667 - 678, http://dx.doi.org/10.1002/jlb.61.6.667
1997
Vollmer-Conna US; Wakefield D; Lloyd AR; Hickie IB; Lemon J; Bird KD; Westbrook RF, 1997, 'Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression', British Journal of Psychiatry, 171, pp. 377 - 381
1997
O Donnell MC; Catts SV; Ward PB; Liebert B; Lloyd AR; Wakefield D; McConaghy N, 1996, 'Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder', Psychiatry Research, pp. 171 - 178
1996
Hickie IB; Hooker A; Hadzi-Pavlovic D; Bennett BH; Wilson AR; Lloyd AR, 1996, 'Fatigue in selected primary care settings: socio-demographic and psychiatric correlates', Medical Journal of Australia, 164, pp. 585 - 588
1996
Sayers TJ; Lloyd AR; Mcvicar DW; O Connor MD; Kelly J; Carter C; Carter CR; Wiltrout TA; Wiltrout RH; Smyth MJ, 1996, 'Cloning and expression of a second human natural killer cell granule tryptase, HNK-Tryp-2/ granzyme 3', Journal of Leukocyte Biology, pp. 763 - 768
1996
Digirolamo N; Verma MJ; Mccluskey P; Lloyd AR; Wakefield D, 1996, 'Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis', Current Eye Research, 15, pp. 1060 - 1068
1996
Kelly MD; Lloyd AR; Kemp RJ, 1996, 'Treating secondary outcomes .5. HIV, weight loss and wasting syndrome', MEDICAL JOURNAL OF AUSTRALIA, 164, pp. 549 - 550, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122170.x
1996
Lloyd AR; Oppenheim JJ; Kelvin DJ; Taub DD, 1996, 'Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins', Journal of Immunology, 156, pp. 932 - 938
1996
Kelly MD; Lloyd AR; Kemp RJ, 1996, '5.17 HIV, weight loss and wasting syndrome', Medical Journal of Australia, 164, pp. 549 - 550, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122170.x
1996
Lloyd A, 1996, 'HIV infection and AIDS', Papua and New Guinea Medical Journal, pp. 174 - 180
1996
Hickie IB; Lloyd AR; Wakefield D; Ricci C, 1996, 'Is there a post-infectious fatigue syndrome?', Australian Family Physician, pp. 1847 - 1852
1996
Hickie IB; Hooker A; Hadzi-Pavlovic D; Bennett BH; Wilson AR; Lloyd AR, 1996, 'Fatigue in selected primary care settings: sociodemographic and psychiatric correlates', Medical Journal of Australia, 164, pp. 585 - 588
1996
Lloyd A; Wakefield D, 1995, 'Do cytokines mediate fatigue?', Interferons and Cytokines, pp. 22 - 24
1995
Lloyd A; Taub D, 1995, 'Making leucocytes move', Today's Life Science, 7, pp. 39 - 42
1995
Digirolamo N; Mccluskey P; Lloyd AR; Wakefield D, 1995, 'Stromelysin matrix metalloproteinase-3 and tissue inhibitor of metallproteinase TIMP-1 mRNA expression in scleritis', Ocular Immunology and Inflammation, pp. 181 - 194
1995
Hickie IB; Lloyd AR, 1995, 'Are cytokines associated with neuropsychiatric syndromes in humans?', International Journal of Immunopharmocology, 17, pp. 677 - 683
1995
Hickie C; Hickie IB; Silove DM; Wakefield D; Lloyd AR, 1995, 'Delayed-type hypersensitivity skin testing: normal values in the Australian population', International Journal of Immunopharmocology, 17, pp. 629 - 634
1995
Lloyd AR; Biragyn A; Johnston JA; Taub DD; Xu LL; Michiel D; Sprenger H; Oppenheim JJ; Kelvin DJ, 1995, 'Granulocyte-colony stimulating factor and lipopolysaccharide regulate the expression of interleukin 8 receptors and polymorphonuclear leukocytes', The Journal of Biological Chemistry, pp. 28188 - 28192
1995
Sprenger H; Lloyd AR; Kelvin DJ, 1995, 'Promoter analysis of the human interleukin-8 receptor Genes, JC-8RA and IL8RB', Immunobiology, 193, pp. 334 - 340
1995
Hickie I; Hickie C; Bennett B; Wakefield D; Silove D; Mitchell P; Lloyd A, 1995, 'Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression: A preliminary report', International Journal of Immunopharmacology, 17, pp. 685 - 690, http://dx.doi.org/10.1016/0192-0561(95)00055-7
1995
Conlon K; Lloyd A; Chattopadhyay U; Lukacs N; Kunkel S; Schall T; Taub D; Morimoto C; Osborne J; Oppenheim J; Young H; Kelvin D; Ortaldo J, 1995, 'CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin‐8 and RANTES', European Journal of Immunology, 25, pp. 751 - 756, http://dx.doi.org/10.1002/eji.1830250319
1995
Hickie IB; Lloyd AR; Hadzi-Pavlovic D; Parker GB; Bird KD; Wakefield D, 1995, 'Can the chronic fatigue syndrome be defined by distinct clinical features?', Psychological Medicine, pp. 925 - 935
1995
HUANG XF; DIXON G; CATTS SV; WARD PB; WAKEFIELD D; LLOYD A, 1995, 'THE NMDA RECEPTOR COMPLEX IN THE HIPPOCAMPUS IN SCHIZOPHRENIA', SCHIZOPHRENIA RESEARCH, 15, pp. 60 - 60, http://dx.doi.org/10.1016/0920-9964(95)95190-K
1995
Hickie I; Wilson A; Hickie C; Lloyd A, 1995, 'The reply', The American Journal of Medicine, 98, pp. 421 - 422, http://dx.doi.org/10.1016/S0002-9343(99)80334-9
1995
Hickie IB; Lloyd AR; Wakefield D, 1995, 'Chronic fatigue syndrome-current perspectives on evaluation and management', Medical Journal of Australia, 163, pp. 314 - 318
1995
LLOYD A; TEDLA N; PALLADINETTI P; KELLY M; TRUSKETT P; COOKE B; DWYER J; WAKEFIELD D, 1995, 'T-CELL RECRUITMENT TO THE LYMPH-NODE OF PATIENTS WITH HIV AND HEALTHY CONTROL SUBJECTS - THE ROLE OF CHEMOKINES', FASEB JOURNAL, 9, pp. A202 - A202, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QL98701199&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1995
WILSON A; HICKIE I; LLOYD A; HADZIPAVLOVIC D; BOUGHTON C; DWYER J; WAKEFIELD D, 1994, 'CHRONIC FATIGUE SYNDROME - ROLE OF PSYCHOLOGICAL-FACTORS OVEREMPHASIZED - REPLY', BRITISH MEDICAL JOURNAL, 308, pp. 1297 - 1297, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NM14700035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1994
Sprenger H; Lloyd AR; Lautens LL; Bonner TI; Kelvin DJ, 1994, 'Structure, genomic organization, and expression of the human interleukin-8 receptor B gene', Journal of Biological Chemistry, 269, pp. 11065 - 11072
1994
Kawamura M; Mcvicar DW; Johnston JA; Blake TB; Chen YQ; Lal BK; Lloyd AR; Kelvin DJ; Staples JE; Ortaldo JR; O'Shea JJ, 1994, 'Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes', Proceedings of the National Academy of Sciences of the United States of America, 91, pp. 6374 - 6378, http://dx.doi.org/10.1073/pnas.91.14.6374
1994
Badolato R; Wang JM; Murphy WJ; Lloyd AR; Michiel DF; Bausserman LL; Kelvin DJ; Oppenheim JJ, 1994, 'Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes', Journal of Experimental Medicine, 180, pp. 203 - 209, http://dx.doi.org/10.1084/jem.180.1.203
1994
Taub DD; Tsarfaty G; Lloyd AR; Durum SK; Longo DL; Murphy WJ, 1994, 'Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment', Journal of Clinical Investigation, 94, pp. 293 - 300, http://dx.doi.org/10.1172/JCI117320
1994
Lloyd A; Gandevia S; Brockman A; Hales J; Wakefield D, 1994, 'Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise', Clinical Infectious Diseases, 18, pp. S142 - S146, http://dx.doi.org/10.1093/clinids/18.Supplement_1.S142
1994
FUKUDA K; STRAUS SE; HICKIE I; SHARPE MC; DOBBINS JG; KOMAROFF A; SCHLUEDERBERG A; JONES JF; LLOYD AR; WESSELY S; GANTZ NM; HOLMES GP; BUCHWALD D; ABBEY S; REST J; LEVY JA; JOLSON H; PETERSON DL; VERCOULEN J; TIRELLI U; EVENGARD B; NATELSON BH; STEELE L; REYES M; REEVES WC, 1994, 'THE CHRONIC FATIGUE SYNDROME - A COMPREHENSIVE APPROACH TO ITS DEFINITION AND STUDY', ANNALS OF INTERNAL MEDICINE, 121, pp. 953 - 959, http://dx.doi.org/10.7326/0003-4819-121-12-199412150-00009
1994
Fukuda K; Straus SE; Hickie I; Sharpe MC; Dobbins JG; Komaroff A; Schluederberg A; Jones JF; Lloyd AR; Wessely S; Gantz NM; Holmes GP; Buchwald D; Abbey S; Rest J; Levy JA; Jolson H; Peterson DL; Vercoulen J; Tirelli U; Evengard B; Natelson BH; Steele L; Reyes M; Reeves WC, 1994, 'The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group', Ann Intern Med, 121, pp. 953 - 959
1994
Wilson A; Hickie I; Lloyd A; Hadzi-Pavlovic D; Boughton C; Dwyer J; Wakefield D, 1994, 'Longitudinal study of outcome of chronic fatigue syndrome', BMJ, 308, pp. 756, http://dx.doi.org/10.1136/bmj.308.6931.756
1994
Lloyd A; Hickie I; Wilson A; Wakefield D, 1994, 'Immune Function in Chronic Fatigue Syndrome and Depression: Implications for Understanding these Disorders and for Therapy', Clinical Immunotherapeutics, 2, pp. 84 - 88, http://dx.doi.org/10.1007/BF03259258
1994
Lloyd A; Hicke I; Wilson A; Wakefield D, 1994, 'The reply', The American Journal of Medicine, 97, pp. 493 - 494, http://dx.doi.org/10.1016/0002-9343(94)90335-2
1994
LLOYD AR; KLIMAS N, 1994, 'IMMUNOLOGICAL STUDIES OF CHRONIC FATIGUE SYNDROME - SUMMARY', CLINICAL INFECTIOUS DISEASES, 18, pp. S160 - S161, http://dx.doi.org/10.1093/clinids/18.Supplement_1.S160
1994
Loveless MO; Lloyd A; Perpich R, 1994, 'Summary of public policy and chronic fatigue syndrome: A perspective', Clinical Infectious Diseases, 18, pp. S163 - S165, http://dx.doi.org/10.1093/clinids/18.Supplement_1.S163
1994
Sayers TJ; Wiltrout TA; Smyth MJ; Ottaway KS; Pilaro AM; Sowder R; Henderson LE; Sprenger H; Lloyd AR, 1994, 'Purification and cloning of a novel serine protease, RNK-Tryp-2, from the granules of a rat NK cell leukemia', Journal of Immunology, 152, pp. 2289 - 2297
1994
McVicar DW; Lal BK; Lloyd A; Kawamura M; Chen YQ; Zhang X; Staples JE; Ortaldo JR; O'Shea JJ, 1994, 'Molecular cloning of lsk, a carboxyl-terminal src kinase (csk) related gene, expressed in leukocytes', Oncogene, 9, pp. 2037 - 2044
1994
Johnston JA; Taub DD; Lloyd AR; Conlon K; Oppenheim JJ; Kevlin DJ, 1994, 'Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide', Journal of Immunology, 153, pp. 1762 - 1768
1994
Sprenger H; Lloyd AR; Meyer RG; Johnston JA; Kelvin DJ, 1994, 'Genomic structure, characterization, and identification of the promoter of the human IL-8 receptor A gene', Journal of Immunology, 153, pp. 2524 - 2532
1994
Wilson A; Hickie I; Lloyd A; Wakefield D, 1994, 'The treatment of chronic fatigue syndrome: Science and speculation', The American Journal of Medicine, 96, pp. 544 - 550, http://dx.doi.org/10.1016/0002-9343(94)90095-7
1994
Blatch C; Blatt T; Wilson A; Hickie I; Lloyd A; Hadzi-Pavlovic D; Boughton C; Dwyer J; Wakefield D; Goudsmit EM; Anderson N; Tannock C; Costa DC; Brostoff J; ho-Yen DO; Grant A; ho-Yen DO; Shanks M; Abbot NC; Spence VA; Lowe JG; Potts RC; Hassan AHA; Belch JJF; Beck JS; Read C; Howes S; Prince K; Shepherd C; Fleming C; Airs V; Broderick J; Woodcock S, 1994, 'Chronic fatigue syndrome Role of psychological factors overemphasised', BMJ, 308, pp. 1297, http://dx.doi.org/10.1136/bmj.308.6939.1297
1994
Lloyd A; Pender H, 1994, 'Chronic Fatigue Syndrome: Does it Need More Healthcare Resources?', PharmacoEconomics, 5, pp. 460 - 464, http://dx.doi.org/10.2165/00019053-199405060-00002
1994
Lloyd AR, 1994, 'Introduction', Clinical Infectious Diseases, 18, pp. S134 - S135, http://dx.doi.org/10.1093/clinids/18.Supplement_1.S134
1994
Lloyd AR; Klimas N, 1994, 'Summary: Immunologic studies of chronic fatigue syndrome', Clinical Infectious Diseases, 18, pp. S160 - S161, http://dx.doi.org/10.1093/clinids/18.Supplement_1.S160
1994
Lloyd AR, 1994, 'Part IV: Immunologic studies of chronic fatigue syndrome: Introduction', Clinical Infectious Diseases, 18
1994
LLOYD AR, 1994, 'IMMUNOLOGICAL STUDIES OF CHRONIC FATIGUE SYNDROME .4. INTRODUCTION', CLINICAL INFECTIOUS DISEASES, 18, pp. S134 - S135, http://dx.doi.org/10.1093/clinids/18.Supplement_1.S134
1994
Lloyd AR; Hickle I; Brockman A; Hickie C; Wilson A; Dwyer J; Wakefield D, 1994, 'A Controlled Trial of Immunologic and Cognitive-Behavioral Therapy for Patients with Chronic Fatigue Syndrome', Clinical Infectious Diseases, 18, pp. S112 - S112, http://dx.doi.org/10.1093/clinids/18.supplement_1.s112-a
1994
Smith RD; Scott A; Lloyd AR, 1993, 'The economic impact of chronic fatigue syndrome [2]', Medical Journal of Australia, 158, pp. 286 - 287, http://dx.doi.org/10.5694/j.1326-5377.1993.tb121761.x
1993
Lloyd AR; Wakefield D; Hickie I, 1993, 'Immunity and the pathophysiology of chronic fatigue syndrome.', Ciba Foundation symposium, 173
1993
LLOYD AR; WAKEFIELD D; HICKIE I, 1993, 'IMMUNITY AND THE PATHOPHYSIOLOGY OF CHRONIC FATIGUE SYNDROME', CIBA FOUNDATION SYMPOSIA, 173, pp. 176 - 192, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KL86600011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1993
Taub DD; Lloyd AR; Conlon K; Wang JM; Ortaldo JR; Harada A; Matsushima K; Kelvin DJ; Oppenheim JJ, 1993, 'Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells', Journal of Experimental Medicine, 177, pp. 1809 - 1814, http://dx.doi.org/10.1084/jem.177.6.1809
1993
Taub DD; Conlon K; Lloyd AR; Oppenheim JJ; Kelvin DJ, 1993, 'Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-Iβ', Science, 260, pp. 355 - 358
1993
Kelvin DJ; Michiel DF; Johnston JA; Lloyd AR; Sprenger H; Oppenheim JJ; Wang JM, 1993, 'Chemokines and serpentines: The molecular biology of chemokine receptors', Journal of Leukocyte Biology, 54, pp. 604 - 612, http://dx.doi.org/10.1002/jlb.54.6.604
1993
Hickie I; Hickie C; Lloyd A; Silove D; Wakefield D, 1993, 'Impaired in vivo immune responses in patients with melancholia', British Journal of Psychiatry, 162, pp. 651 - 657, http://dx.doi.org/10.1192/bjp.162.5.651
1993
Lloyd AR; Hickie I; Brockman A; Hickie C; Wilson A; Dwyer J; Wakefield D, 1993, 'Immunologic and psychologic therapy for patients with chronic fatigue syndrome: A double-blind, placebo-controlled trial', The American Journal of Medicine, 94, pp. 197 - 203, http://dx.doi.org/10.1016/0002-9343(93)90183-P
1993
LLOYD AR, 1993, 'THE ECONOMIC-IMPACT OF CHRONIC FATIGUE SYNDROME - REPLY', MEDICAL JOURNAL OF AUSTRALIA, 158, pp. 286 - 287, http://dx.doi.org/10.5694/j.1326-5377.1993.tb121762.x
1993
Lloyd A; Modi W; Sprenger H; Cevario S; Oppenheim J; Kelvin D, 1993, 'Assignment of genes for interleukin-8 receptors (Il8r) a and b to human chromosome band 2q35', Cytogenetics and Cell Genetics, 63, pp. 238 - 240, http://dx.doi.org/10.1159/000133541
1993
Hickie I; Lloyd A; Wakefield D, 1992, 'Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome', Australian and New Zealand Journal of Psychiatry, 26, pp. 249 - 256, http://dx.doi.org/10.3109/00048679209072034
1992
Wakefield D; Lloyd A, 1992, 'The role of cytokines in the pathogenesis of inflammatory eye disease', Cytokine, 4, pp. 1 - 5, http://dx.doi.org/10.1016/1043-4666(92)90028-P
1992
LLOYD A; HICKIE I; HICKIE C; DWYER J; WAKEFIELD D, 1992, 'Cell‐mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression', Clinical & Experimental Immunology, 87, pp. 76 - 79, http://dx.doi.org/10.1111/j.1365-2249.1992.tb06416.x
1992
Lloyd AR; Oppenheim JJ, 1992, 'Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response', Immunology Today, 13, pp. 169 - 172, http://dx.doi.org/10.1016/0167-5699(92)90121-M
1992
Lloyd AR; Pender H, 1992, 'The economic impact of chronic fatigue syndrome', Medical Journal of Australia, 157, pp. 599 - 601, http://dx.doi.org/10.5694/j.1326-5377.1992.tb137401.x
1992
Bell DS; Goodrich W; Apfelbaum B; Kaplan KH; Goldenberg DL; Galvin- Nadeau M; Saltzstein B; Gurwitt A; Webster W; Barrett SN; Sheeley WF; Hickie I; Lloyd A; Wilson A; Wakefield D; Fallon BA; Liebowitz MR; Klein DF; Abbey SE, 1992, 'Taking chronic fatigue syndrome seriously [6]', American Journal of Psychiatry, 149, pp. 1753 - 1757
1992
Saltzstein B; Gurwitt A; Webster W; Barrett SN, 1992, 'Taking chronic fatigue syndrome seriously.', American Journal of Psychiatry, 149
1992
Lloyd A; Hickie I; Brockman A; Dwyer J; Wakefield D, 1991, 'Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects [2]', Journal of Infectious Diseases, 164, pp. 1023 - 1024, http://dx.doi.org/10.1093/infdis/164.5.1023
1991
Lloyd AR; Gandevia SC; Hales JP, 1991, 'Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome', Brain, 114A, pp. 85 - 98, http://dx.doi.org/10.1093/oxfordjournals.brain.a101869
1991
WYLIE B, 1991, 'MUSCLE VERSUS BRAIN - CHRONIC FATIGUE SYNDROME', MEDICAL JOURNAL OF AUSTRALIA, 154, pp. 220 - 220, http://dx.doi.org/10.5694/j.1326-5377.1991.tb121051.x
1991
Lloyd A; Hickie I; Wakefield D; Dwyer J, 1991, 'The reply', The American Journal of Medicine, 91, pp. 320 - 321, http://dx.doi.org/10.1016/0002-9343(91)90141-J
1991
Lloyd A; Hickie I; Wakefield D; Dwyer JM, 1991, 'The reply', The American Journal of Medicine, 91, pp. 443 - 444, http://dx.doi.org/10.1016/0002-9343(91)90171-S
1991
Hickie I; Lloyd A; Wakefield D, 1991, 'Chronic fatigue syndrome and depression', The Lancet, 337, pp. 922 - 923, http://dx.doi.org/10.1016/0140-6736(91)90260-V
1991
Lloyd AR, 1991, 'Muscle versus brain: Chronic fatigue syndrome (Reply)', Medical Journal of Australia, 154, pp. 220, http://dx.doi.org/10.5694/j.1326-5377.1991.tb121052.x
1991
Lloyd AR; Hickie I; Boughton CR; Spencer O; Wakefield D, 1990, 'Prevalence of chronic fatigue syndrome in an Australian population', Medical Journal of Australia, 153, pp. 522 - 528, http://dx.doi.org/10.5694/j.1326-5377.1990.tb126191.x
1990
Hickie I; Parker G; Lloyd A; Wakefield D, 1990, 'Chronic fatigue syndrome (Reply)', British Journal of Psychiatry, 157, pp. 449 - 450, http://dx.doi.org/10.1192/s0007125000063273
1990
Lloyd A; Hickie I; Wakefield D; Boughton C; Dwyer J, 1990, 'A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome', The American Journal of Medicine, 89, pp. 561 - 568, http://dx.doi.org/10.1016/0002-9343(90)90173-B
1990
Lloyd A; Hickie I; Wakefield D, 1990, 'Immunological abnormalities in the chronic fatigue syndrome (Reply)', Medical Journal of Australia, 152, pp. 51 - 52, http://dx.doi.org/10.5694/j.1326-5377.1990.tb124438.x
1990
Wakefield D; Lloyd A; Brockman A, 1990, 'Immunoglobulin subclass abnormalities in patients with chronic fatigue syndrome', Pediatric Infectious Disease Journal, 9, pp. S50 - S53, http://dx.doi.org/10.1097/00006454-199008001-00009
1990
Hickie I; Lloyd A; Wakefield D; Parker G, 1990, 'The psychiatric status of patients with the chronic fatigue syndrome', British Journal of Psychiatry, 156, pp. 534 - 540, http://dx.doi.org/10.1192/bjp.156.4.534
1990
Hickie I; Silove D; Hickie C; Wakefield D; Lloyd A, 1990, 'Is there immune dysfunction in depressive disorders?', Psychological Medicine, 20, pp. 755 - 761, http://dx.doi.org/10.1017/S0033291700036424
1990
Lloyd A; Naraqi S, 1990, 'Tropical arthritis in Papua New Guinea: a reactive arthritis', Medical Journal of Australia, 153, pp. 362 - 363, http://dx.doi.org/10.5694/j.1326-5377.1990.tb136961.x
1990
Lloyd A; Mavo B; Cunningham T; Naraqi S, 1990, 'Tropical arthritis in Papua New Guinea: A reactive arthritis', Medical Journal of Australia, 152, pp. 186 - 189, http://dx.doi.org/10.5694/j.1326-5377.1990.tb125144.x
1990
AKAMA H, 1990, 'TROPICAL ARTHRITIS IN PAPUA-NEW-GUINEA - A REACTIVE ARTHRITIS', MEDICAL JOURNAL OF AUSTRALIA, 153, pp. 362 - 362, http://dx.doi.org/10.5694/j.1326-5377.1990.tb136960.x
1990
Lloyd A; Wakefield D; Smith L; Isbister J; Mcgrath M; Collings A; Bajenov N, 1989, 'RED BLOOD CELL MORPHOLOGY IN CHRONIC FATIGUE SYNDROME', The Lancet, 334, pp. 217, http://dx.doi.org/10.1016/S0140-6736(89)90399-1
1989
Roath S; Lloyd A; Wakefield D; Smith L, 1989, 'BLOOD CELL MORPHOLOGY IN CHRONIC FATIGUE SYNDROME', The Lancet, 334, pp. 805, http://dx.doi.org/10.1016/S0140-6736(89)90869-6
1989
Lloyd AR; Breit SN; Rozenberg MC, 1989, 'Recurrent fever in Sjogren's syndrome', Medical Journal of Australia, 151, pp. 163 - 167, http://dx.doi.org/10.5694/j.1326-5377.1989.tb139604.x
1989
Lloyd AR; Wakefield D; Boughton CR; Dwyer JM, 1989, 'Immunological abnormalities in the chronic fatigue syndrome', Medical Journal of Australia, 151, pp. 122 - 124, http://dx.doi.org/10.5694/j.1326-5377.1989.tb139594.x
1989
Sonawalla AB; Lance JW; Lloyd A, 1989, 'Neurological disorders in AIDS: a study of 18 cases.', Journal of the Pakistan Medical Association, 39, pp. 312 - 316
1989
Lloyd A; Abi Hanna D; Wakefield D, 1988, 'INTERFERON AND MYALGIC ENCEPHALOMYELITIS', The Lancet, 331, pp. 471, http://dx.doi.org/10.1016/S0140-6736(88)91259-7
1988
Wakefield D; Lloyd A; Dwyer J; Zaki Salahuddin S; Ablashi DV, 1988, 'HUMAN HERPESVIRUS 6 AND MYALGIC ENCEPHALOMYELITIS', The Lancet, 331, pp. 1059, http://dx.doi.org/10.1016/S0140-6736(88)91885-5
1988
Lloyd AR; Wakefield D; Boughton C; Dwyer J, 1988, 'WHAT IS MYALGIC ENCEPHALOMYELITIS?', The Lancet, 331, pp. 1286 - 1287, http://dx.doi.org/10.1016/S0140-6736(88)92107-1
1988
LLOYD A; ROBERTSON P; WAKEFIELD D; DWYER JM, 1988, 'ANTIBODIES TO HIV ARE PRODUCED WITHIN THE CENTRAL NERVOUS SYSTEM OF ALL SUBJECTS WITH ALL CATEGORIES OF HIV INFECTION', Australian and New Zealand Journal of Medicine, 18, pp. 854 - 860, http://dx.doi.org/10.1111/j.1445-5994.1988.tb01644.x
1988
Lloyd AR; Naraqi S, 1988, 'Snake bite on the scalp with rapid onset of envenomation', Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, pp. 347, http://dx.doi.org/10.1016/0035-9203(88)90477-4
1988
Lloyd A; Crane G; Rozenberg MC, 1988, 'Long-standing fevers in a young pregnant woman', Medical Journal of Australia, 149, pp. 382 - 386, http://dx.doi.org/10.5694/j.1326-5377.1988.tb120677.x
1988
Lloyd AR; Naraqi S, 1988, 'Noonan's syndrome: report of a case in a Papuan man.', Papua and New Guinea Medical Journal, 31, pp. 199 - 204
1988
RICHENS J; HUDSON B; NARAQI S; LLOYD A, 1988, 'A STUDY OF ARTHRITIS IN PAPUA NEW GUINEA', Australian and New Zealand Journal of Medicine, 18, pp. 807 - 808, http://dx.doi.org/10.1111/j.1445-5994.1988.tb00186.x
1988
Lloyd AR; Hales JP; Gandevia SC, 1988, 'Muscle strength, endurance and recovery in the post-infection fatigue syndrome', Journal of Neurology, Neurosurgery and Psychiatry, 51, pp. 1316 - 1322, http://dx.doi.org/10.1136/jnnp.51.10.1316
1988
LLOYD A; HANNA DA; WAKEFIELD D, 1988, 'INTERFERON IN THE POST INFECTION FATIGUE SYNDROME', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 18, pp. 452 - 452, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N917000417&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1988
WAKEFIELD D; LLOYD A; DWYER J; BOUGHTON C; SALLAHUDIN Z, 1988, 'THE SEROPREVALENCE OF HERPES-VIRUS TYPE-6 (HBLV) IN AUSTRALIA', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 18, pp. 454 - 454, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N917000422&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1988
LLOYD A; WAKEFIELD D; DWYER J, 1988, 'ABNORMAL-CELL MEDIATED IMMUNITY IN POST INFECTION FATIGUE SYNDROME', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 18, pp. 453 - 453, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N917000420&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1988
LLOYD A; WAKEFIELD D; DWYER J; BOUGHTON C, 1988, 'BENEFICIAL EFFECT OF HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN IN POST INFECTION FATIGUE SYNDROME', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 18, pp. 453 - 453, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N917000418&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1988
Lloyd AR; Gatenby PA; Lamond TS; Dorsch NW; Basten A, 1987, 'Moyamoya disease causing recurrent cerebrovascular episodes in a young adult', Medical Journal of Australia, 146, pp. 379 - 381, http://dx.doi.org/10.5694/j.1326-5377.1987.tb120302.x
1987
Wakefield D; Lloyd A, 1987, 'PATHOPHYSIOLOGY OF MYALGIC ENCEPHALITIS', The Lancet, 330, pp. 918 - 919, http://dx.doi.org/10.1016/S0140-6736(87)91408-5
1987
Goadsby PJ; Donaghy AJ; Lloyd AR; Wakefield D, 1987, 'Acquired immunodeficiency syndrome (AIDS) and sulfadiazine-associated acute renal failure.', Annals of internal medicine, 107, pp. 783 - 784, http://dx.doi.org/10.7326/0003-4819-107-5-783_2
1987
Boughton CR; Lloyd AR, 1987, 'The management of leprosy', Medical Journal of Australia, 146, pp. 593 - 599, http://dx.doi.org/10.5694/j.1326-5377.1987.tb120423.x
1987
Lloyd AR; Boughton CR, 1987, 'Immigrant health screening.', The Medical journal of Australia, 146, pp. 609, http://dx.doi.org/10.5694/j.1326-5377.1987.tb120430.x
1987
Kwon JA; Bretaña NA; Kronfli N; Dussault C; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd AR; Gray RT, 2023, Preparing correctional settings for the next pandemic: a modelling study of COVID-19 outbreaks in two high-income countries, , http://dx.doi.org/10.1101/2023.05.08.23289690
2023
Adhikari A; Abayasingam A; A NB; Kim HN; Lord M; Agapiou D; Maher L; Rodrigo C; Lloyd A; Bull R; Tedla N, 2023, Characterisation of antibody dependent cellular phagocytosis in patients infected with Hepatitis C virus with different clinical outcomes, , http://dx.doi.org/10.22541/au.168992839.95818489/v1
2023
Baird S; Ashley CL; Marsh-Wakefield F; Alca S; Ashhurst TM; Ferguson AL; Lukeman H; Counoupas C; Post JJ; Konecny P; Bartlett A; Martinello M; Bull RA; Lloyd A; Grey A; Hutchings O; Palendira U; Britton WJ; Steain M; Triccas JA, 2023, A unique cytotoxic CD4+T cells signature defines critical COVID-19, , http://dx.doi.org/10.1101/2023.02.17.23286059
2023
Wyller V; Selvakumar J; Havdal L; Drevvatne M; Brodwall E; Berven L; Stiansen-Sonerud T; Einvik G; Leegaard T; Tjade T; Michelsen A; Mollnes T; Lund-Johansen F; Holmøy T; Zetterberg H; Blennow K; Sandler C; Cvejic E; Lloyd A, 2022, Prevalence and predictors of long COVID among non-hospitalised adolescents and young adults: a prospective controlled cohort study, , http://dx.doi.org/10.21203/rs.3.rs-2021203/v1
2022
Cai C; Samir J; Pirozyan M; Adikari T; Gupta M; Leung P; Hughes B; Van der Byl W; Rizzetto S; Elthala A; Keoshkerian E; Palgen J-L; Peters T; Nguyen T; Louie R; Kedzierska K; Gaudieri S; Bull R; Lloyd A; Luciani F, 2021, Single cell multi-omics reveals early elevated function and multiple fates within human progenitor exhausted CD8+ T cells, , http://dx.doi.org/10.1101/2021.09.09.459584
2021
Bull R; Abayasingam A; Balachandran H; Agapiou D; Rodrigo C; Keoshkerian E; Li H; Brasher N; Christ D; Rouet R; Burnett D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Brilot F; Mina M; Post J; Hudson B; Gilroy N; Dwyer D; Sasson S; Tea F; Pilli D; Tedla N; Lloyd A; Martinello M, 2020, Long-term persistence of neutralizing memory B cells in SARS-CoV-2, , http://dx.doi.org/10.21203/rs.3.rs-92527/v1
2020
Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Group S-CS, Reduced Hepatitis C Incidence Associated with Rapid Treatment Scale-Up in Australian Prisons: Treatment-as-Prevention in the SToP-C Study, , http://dx.doi.org/10.2139/ssrn.3709824
Shih STF; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon J; Lloyd AR; Dore GJ; Wiseman V; Grebely J, Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, , http://dx.doi.org/10.2139/ssrn.4267527
Shih STF; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon J; Lloyd AR; Dore GJ; Wiseman V; Grebely J, Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, , http://dx.doi.org/10.2139/ssrn.4267510
Lloyd AR; Hickie I; Wakefield D, 2022, 'Chronic fatigue and postinfective fatigue syndromes', in Clinical Virology: Third Edition, pp. 371 - 383, http://dx.doi.org/10.1128/9781555815981.ch17
2022
Cameron B; Bierl C; Davenport T; Vollmer-Conna U; Hickie I; Wakefield D; Lloyd AR, 2021, 'Drought and Q fever: The association between trends in the incidence of infection and rainfall in rural Australia', in The Encyclopedia of Bacteriology Research Developments, pp. 1975 - 1988
2021
Chang CC; Crane M; Jaworowski A; Lloyd A; French MA; Lewin SR, 2018, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, Springer New York, pp. 1083 - 1096, http://dx.doi.org/10.1007/978-1-4939-7101-5_179
2018
Cameron B; Bierl C; Davenport T; Vollmer-Conna U; Hickie I; Wakefield D; Lloyd AR, 2017, 'Drought and q fever: The association between trends in the incidence of infection and rainfall in rural australia', in The Principles and Practice of Q Fever: The One Health Paradigm, pp. 301 - 315
2017
Lloyd A, 2017, 'Chronic Fatigue and Postinfective Fatigue Syndromes', in Clinical Virology, Fourth Edition, American Society for Microbiology, pp. 373 - 384, http://dx.doi.org/10.1128/9781555819439.ch18
2017
Lloyd AR, 2016, 'Chronic fatigue and postinfective fatigue syndromes', in Clinical Virology, pp. 371 - 384, http://dx.doi.org/10.1128/9781555819439.ch18
2016
Chang CC; Crane M; Jaworowski A; Lloyd A; French MA; Lewin SR, 2014, 'Immunopathogenesis of HIV Coinfections', in Encyclopedia of AIDS, Springer New York, pp. 1 - 15, http://dx.doi.org/10.1007/978-1-4614-9610-6_179-1
2014
Dore GJ; Temple-Smith M; Lloyd AROLA, 2009, 'Future challenges for hepatitis C', in Dore G; Temple-Smith M; Lloyd A (ed.), Hepatitis C: An Expanding Perspective, edn. 1, IP Communications, East Hawthorn, pp. 433 - 452, http://www.ipcommunications.com.au/
2009
Oldmeadow M; Lloyd AROLA, 2009, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, edn. 2, IP Communications, East Hawthorn, Victoria, Australia
2009
Oldmeadow M; Lloyd AR, 2005, 'Fatigue states following infection', in Yung A; McDonald M; Spelman D; Street A; Johnson P; Sorrell T; McCormack J (ed.), Infectious Diseases A clinical approach, edn. 2, IP Communications, East Hawthorn, Victoria, Australia, pp. 195 - 204
2005
Lloyd AR; Hickie IB; Peterson PK, 1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment.', in Current Clinical Topics in Infectious Diseases, Blackwell Science Asia, Carlton, Victoria, pp. 135 - 159
1999
Lloyd AR; Hickie IB; Petersen PK, 1999, 'Chronic fatigue syndrome: current concepts of pathogenesis and treatment', in Current Clinical Topics in Infectious Diseases, edn. Original, Blackwell Science Asia, Carlton, Victoria, pp. 138 - 159
1999
Lloyd AR; Hickie IB; Peterson PK, 1997, 'Chronic fatigue syndrome', in Clinical Virology, edn. Original, Churchill Livingstone, New York, pp. 343 - 355
1997
Lloyd AR; Wakefield D, 1997, 'Treatment of chronic fatigue syndrome', in Intravenous Immunoglobulins in Clinical Practice, edn. Original, Marcel Dekker, New York, pp. 267 - 274
1997
Lloyd AR; Hickie IB; Peterson PK, 1997, 'Chronic fatigue syndrome', in Clinical Virology, Churchill Livingstone, New York, pp. 343 - 355
1997
DWYER JM; LLOYD AR; HICKIE IB; WAKEFIELD D; BOUGHTON CR, 1991, 'The response of patients with chronic fatigue syndrome to intravenously administered gammaglobulin', in Immunotherapy with Intravenous Immunoglobulins, Elsevier, pp. 377 - 386, http://dx.doi.org/10.1016/b978-0-12-370725-3.50039-7
1991
Carson J; Dore G; Lloyd A; Grebely J; Byrne M; Cunningham EB; Amin J; Vickerman P; Martin N; Treloar C; Matthews G; Hajarizadeh B, 2022, 'Hepatitis C virus reinfection following direct acting antiviral treatment in the prison setting: the SToP-C study', in Journal of Hepatology, Elsevier BV, Vol. 77, pp. S565 - S565, http://dx.doi.org/10.1016/s0168-8278(22)01451-9
2022
Thilakanathan C; Kayes T; Di Girolamo J; Nguyen V; Lloyd A; Levy MT, 2021, 'BASELINE PREDICTORS OF POST-PARTUM HEPATITIS B E ANTIGEN SEROCONVERSION', in HEPATOLOGY, WILEY, Vol. 74, pp. 446A - 447A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188002141&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Brasher NA; Eltahla AA; Underwood A; Tedla N; Lloyd AR; Bull RA, 2020, 'B cell immunodominance in primary hepatitis C virus infection', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vol. 72, pp. E38 - E38, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000520050900030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2020
Weickert T; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks W; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd A; Stanton C; O'Donnell M; Liu D; Galletly C; Weickert CS, 2019, 'REDUCTION IN PERIPHERAL C-REACTIVE PROTEIN LEVELS WITH CANAKINUMAB ADMINISTRATION IS RELATED TO REDUCED POSITIVE SYMPTOM SEVERITY IN PATIENTS WITH SCHIZOPHRENIA AND INFLAMMATION', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, FL, Orlando, Vol. 45, pp. S318 - S318, presented at Congress of the Schizophrenia-International-Research-Society (SRIS), FL, Orlando, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1093/schbul/sbz020.578
2019
Fourati S; Silberstein FC; Howe A; De Salazar A; Popping S; Di Maio VC; Tay E; Rodrigo C; Cunningham E; Kjellin M; Sfalcin J; Gomes P; Poljak M; Lunar M; Sayan M; Mor O; Salmon D; Usubillaga R; Seguin-Devaux C; Boucher CA; Poiteau L; Lloyd A; Grebely J; Lennerstrand J; Kaiser R; Zhigalkina P; Fernando Fay F; Aragri M; Chulanov V; Garcia-Deltoro M; Cabezas J; Carlos Alados J; De Knegt RJ; Douglas M; Garcia FG; Harrigan R; Pawlotsky J-M, 2019, 'HCV RESISTANCE PATTERNS IN A WORLDWIDE NETWORK OF COHORTS OF GT-3a INFECTED PATIENTS', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 180A - 181A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653500277&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Popping S; Fourati S; Howe A; Di Maio VC; Tay E; Rodrigo C; Cunningham E; Kjellin M; Sfalcin J; Gomes P; Poljak M; Lunar M; Sayan M; Mor O; Salmon D; Usubillaga R; Omar M; Garcia-Bujalance S; Tellez F; Fuentes A; Seguin-Devaux C; Soulier A; Lloyd A; Grebely J; Aragri M; Lennerstrand J; Kaiser R; Zhigalkina P; Chulanov V; De Knegt RJ; Douglas M; Silberstein FC; Harrigan R; Garcia FG; Boucher CA; Pawlotsky J-M, 2019, 'THE GLOBAL PREVALENCE OF RESISTANCE ASSOCIATED SUBSTITUTIONS (RASS) IN "UNUSUAL" HCV SUBTYPES', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 77A - 78A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653500117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Howe A; De Salazar A; Aragri M; Popping S; Fourati S; Tay E; Rodrigo C; Cunningham E; Kjellin M; Fernando Fay F; Newton E; Sfalcin J; Gomes P; Boucher CA; De Knegt R; Poljak M; Lunar M; Salmon D; Usubillaga R; Sayan M; Mor O; Seguin-Devaux C; Lloyd A; Pawlotsky J-M; Grebely J; Lennerstrand J; Knops E; Kaiser R; Chulanov V; Rincon P; Martinez-Sapina A; Galera C; Douglas M; Silberstein FC; Harrigan R; Garcia Garcia F, 2019, 'GENOTYPE MISCLASSIFICATION NEGATIVELY IMPACT THE CHOICE OF REGIMENS AND TREATMENT OUTCOMES IN THE MANAGEMENT OF HEPATITIS C', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 318A - 319A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653501070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Weickert T; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks W; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd A; Stanton C; O'Donnell M; Liu D; Galletly C; Weickert CS, 2019, 'Reduction in Peripheral C-Reactive Protein Levels With Canakinumab Administration is Related to Reduced Positive Symptom Severity in Patients With Schizophrenia and Inflammation', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 85, pp. S44 - S45, presented at 74th Annual Meeting of the Society-of-Biological-Psychiatry (SOBP), IL, Chicago, 16 May 2019 - 18 May 2019, http://dx.doi.org/10.1016/j.biopsych.2019.03.121
2019
Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe A; Miller V; Bull RA; Ceccherini-Silberstein F; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky J-M; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S323 - S323, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30970-4
2017
Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using prebiotics', in GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 120, pp. A82 - A82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000168514700403&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2001
Connor SJ; Hassim Z; Cardillo R; Lloyd AR; Grimm MC, 2000, 'Chemokine receptor expression and function in lamina propria mononuclear cells of the human colon.', in GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 118, pp. A355 - A355, http://dx.doi.org/10.1016/S0016-5085(00)83524-6
2000
Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd A; Treloar C, 2022, 'The role of point-of-care hepatitis C RNA testing at prison intake for reducing barriers to the hepatitis C care cascade', presented at Australasian Viral Hepatitis Conference, Brisbane, 29 May 2022 - 31 May 2022
2022
Sazzad H; Arroyo B; Bull R; Lloyd A; Rodrigo C, 2021, 'Optimised approach for high throughput hepatitis C virus amplification for transmission cluster identification in Australian prisons', presented at 16th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Bowral, Australia
2021
Lafferty L; Rance J; Grebely J; Dore G; Lloyd A; Treloar C, 2021, 'Perceptions and concerns of hepatitis c reinfection in the prison setting', presented at Justice Health Conference, Public Health Association Australia, Virtual (Australia), 03 November 2021 - 04 November 2021
2021
Lafferty L; Rance J; Grebely J; Dore G; Lloyd A; Treloar C, 2021, 'Correctional Officers and Health Staff Perspectives Of Hepatitis C Treatment As Prevention Scale Up Within The Prison Setting', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Virtual (International), 13 October 2021 - 15 October 2021
2021
Lafferty L; Rance J; Dore G; Lloyd A; Treloar C, 2021, 'Scaling Up Hepatitis C Treatment within the Prison Setting: The Role of Social Capital', presented at Academic and Health Policy Conference on Correctional Health (ACCJH), Virtual (USA), 08 April 2021 - 10 April 2021
2021
Rodrigo C; Leung P; Adikari T; Riaz N; Bull R; Sigera C; Weeratunga P; Rajapakse S; Lloyd A; Fernando D, 2020, 'Resolving within-host, full length, dengue virus variants without haplotype reconstruction using Oxford Nanopore Technology', presented at ECCMID 2020, Paris, France
2020
Rodrigo C; Leung P; Bull R; Lloyd A; Luciani F, 2019, 'Using networks to study epistatic interactions of HCV', presented at 14th Scientific Workship of the Australian Center for HIV and Hepatitis Virology Research, Canungra, Australia
2019
Riaz N; Bull R; Leung P; Smith M; Barton K; Lloyd A; Rodrigo C, 2019, 'Whole genome long read sequencing of Hepatitis C virus and its applications', presented at 14th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Canungra, Australia
2019
Rodrigo C; Riaz N; Adikari T; Sigera C; Rajapakse S; Fernando D; Weeratunga P; Fink K; Bull R; Luciani F; Lloyd A, 2019, 'A single nested PCR method for full length dengue virus genome amplification', presented at 7th European Congress of Virology, Rotterdam, The Netherlands
2019
Abayasingam A; Leung P; Luciani F; Bull R; Lloyd A; Rodrigo C, 2018, 'Challenges in characterizing hepatitis C virus founder variants with deep sequencing', presented at 13th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research
2018
Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2018, 'Host IFNλ3 genotype and viral genotype are key determinants of within-host HCV genomic variation in early infection', presented at 13th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Yarra Valley, Australia
2018
Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2018, 'Genetic variability of Hepatitis C quasi-species in early infection', presented at Global Hepatitis Summit, Toronto, Canada
2018
Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2017, 'Establishment of InC3 viral sequence repository and its applications', presented at 12th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Barossa Valley, Australia
2017
Byrne M; Hajarizadeh B; Dore GJ; Treloar C; Marks P; Milat A; Bowman J; McGrath C; Bath N; Calder I; Lagios K; Grebely J; Lloyd A, 2017, 'A framework for hepatitis C virus treatment as prevention in the prison setting: the SToP-C implementation toolkit', presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31387-9
2017
Rodrigo C; Eltahla A; Bull R; Lloyd A; Luciani F, 2016, 'Bayesian evolutionary analysis of hepatitis C epidemic in Australia and North America in 20th century', presented at Australasian Viral Hepatitis Conference, GoldCoast, Australia
2016
Rodrigo C; Eltahla A; Bull R; Lloyd A; Luciani F, 2016, 'Bayesian evolutionary analysis of hepatitis C epidemic in Australia and North America in 20th century', presented at International conference in Systems Biology, Barcelona, Spain
2016
Rodrigo C; Eltahla A; Bull R; Lloyd A; Luciani F, 2016, 'Broadly neutralizing antibodies against hepatitis C envelope; using a network approach to understand co-evolution of critical residues', presented at International conference in Systems Biology, Barcelona, Spain
2016
Rodrigo C; Bretana N; Luciani F; Lloyd A; Bull R, 2016, 'Examining past and future hepatitis C virus epidemic trends in the era of directly acting antivirals', presented at Australian Society of Microbiology annual scientific meeting, Perth, Australia
2016
Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2016, 'Molecular epidemiology of full length hepatitis C virus genomes among injecting drug users with recent infection: The InC3 study', presented at 5th International Symposium on Hepatitis Care in Substance Users, Oslo, Norway
2016
Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2016, 'Trends of Hepatitis C virus infections in North America and Australia in 20th century; back projections from molecular epidemiology', presented at 5th International Symposium on Hepatitis Care in Substance Users, Oslo, Norway
2016
Rodrigo C; Eltahla A; Bull R; Luciani F; Lloyd A, 2015, 'Global molecular epidemiology of acute hepatitis infection via phylogenetic analysis of full length genomes across nine international cohorts', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia
2015
Eltahla A; Rodrigo C; Bull R; Luciani F; Lloyd A, 2015, 'Natural prevalence of HCV resistance associated variants in treatment naïve patients across six genotypes', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia
2015
Walker M; Leung P; Eltahla A; Rodrigo C; Luciani F; Foung S; Lloyd A; Bull R, 2015, 'Understanding the timing, breadth and potency of neutralising antibody responses against transmitted/founders', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia
2015
Leung P; Walker M; Rodrigo C; Eltahla A; Bull R; Lloyd A; Luciani F, 2015, 'Identification of co-evolving mutations of the Hepatitis C virus in the context of immune escape against neutralizing antibody responses using a bioinformatics workflow', presented at 8th Australasian virology society meeting, Hunter Valley, Australia
2015
Leung P; Walker M; Rodrigo C; Eltahla A; Bull R; Lloyd A; Luciani F, 2015, 'A network approach for the identification of co-evolving mutations in Hepatitis C Virus (HCV) in the context of immune escape against neutralizing antibody responses', presented at COMBINE Student Symposium, Sydney, Australia
2015
Walker M; Leung P; Rodrigo C; Eltahla A; Lloyd A; Foung S; Luciani F; Bull R, 2015, 'Characterizing neutralizing antibody responses targeting founder virus in early primary HCV infection with varying disease outcome', presented at International Symposium on Hepatitis C virus and related viruses, Strasbourg, France
2015
Kwon J; Bretaña N; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd A; Gray R, 2021, The COVID-19 Incarceration Model: a tool for corrections staff to analyze outbreaks of COVID-19, , http://dx.doi.org/10.1101/2021.02.18.21252032
2021
Zhao Y; Keoshkerian E; Li H; An H; Bull RA; Luciani F; Lloyd AR, 2021, 'Functional characterisation and transcriptomic analysis of antigen-specific CD8 T memory stem cells (TSCM) generated from clonally expanded single TSCM cells in vitro', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000753366400123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Underwood A; Wu B-R; Gupta M; Eltahla A; Luciani F; Lloyd A; Bull R, 2019, 'Defining correlates of protection against viral reinfection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY, PEOPLES R CHINA, Beijing, pp. 1053 - 1053, presented at 17th International Congress of Immunology of the International-Union-of-Immunological-Societies (IUIS), PEOPLES R CHINA, Beijing, 19 October 2019 - 23 October 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000490026903279&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin N; Mchutchison JG; Brainard D; Treloar C; Lloyd A; Dore G, 2018, 'Incidence of hepatitis C virus infection in four prisons in New South Wales, Australia: The SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S187 - S188, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30587-7
2018
Bergin ART; Hovey E; Lloyd A; Marx G; Parente P; Rapke T; de Souza P, 2017, 'Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis', in Supportive Care in Cancer, pp. 2871 - 2879, http://dx.doi.org/10.1007/s00520-017-3706-8
2017
Cunningham EB; Hajarizadeh B; Amin J; Bretana NA; Luciani F; Degenhardt L; Larney S; Dore GJ; Lloyd AR; Grebely J, 2017, 'Injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting, 2005-2014: the HITS-p study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S488 - S488, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31370-3
2017
Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin NK; Mchutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore GJ, 2017, 'Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S274 - S274, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30862-0
2017
Hajarizadeh B; Grebely J; Byrne M; Marks P; Butler T; Amin J; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore G, 2016, 'Hepatitis C virus exposure, infection and associated risk behaviours in two maximum-security prisons in New South Wales, Australia', in HEPATOLOGY, WILEY, MA, Boston, pp. 385A - 386A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016
2016
Cunningham EB; Luciani F; Hajarizadeh B; Betz-Stablein B; Bretana NA; Teutsch S; Dore GJ; Grebely J; Lloyd AR, 2016, 'STABLE INCIDENCE OF HEPATITIS C VIRUS INFECTION AMONG PEOPLE WITH A HISTORY OF INJECTING DRUG USE IN AN AUSTRALIAN PRISON SETTING, 2005-2014: THE HITS-P STUDY', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S614 - S614, presented at EASL International Liver Congress, SPAIN, Barcelona, 13 April 2016 - 17 April 2016, http://dx.doi.org/10.1016/S0168-8278(16)01138-7
2016
Casson SM; Sandler C; Bogg T; Lloyd A; Barry B, 2016, 'Capturing Activity Pacing in People with Chronic Fatigue Syndrome Using Actigraphy', in MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, LIPPINCOTT WILLIAMS & WILKINS, MA, Boston, pp. 118 - 118, presented at Annual Meeting of the American-College-of-Sports-Medicine (ACSM), MA, Boston, 31 May 2016 - 04 June 2016, http://dx.doi.org/10.1249/01.mss.0000485353.37124.aa
2016
Wu B-R; Walker MR; Eltahla A; Lloyd AR; Bull RA, 2016, 'Characterising nAb responses and B cell phenotypes in early primary HCV infection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 673 - 673, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610401543&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Rizzetto S; Elthala A; Pirozyan RM; Keoshkerian E; Brownlee C; Lloyd A; Bull R; Luciani F, 2016, 'A computational framework for simultaneous single-cell characterization of surface phenotype and gene expression profile of antigen specific lymphocytes', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 1165 - 1165, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610402743&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Pirozyan RM; Leung P; Eltahla A; Rizzetto S; Nguyen O; Kedzierska K; Lloyd A; Bull R; Luciani F, 2016, 'Characterisation of the phenotypic profile of antigen specific cytotoxic T cell responses during primary HCV infection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 689 - 690, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610401578&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Leung P; Bull R; Lloyd A; Luciani F, 2015, 'Co-evolving mutations in hepatitis C virus in the context of immune escape against neutralising antibody responses - A bioinformatic workflow for the analysis of co-evolving mutations in viral genomes', in International Workshop on Artificial Immune Systems, AIS 2015/ICSI3 2015 - Systems Immunology, Immunoinformatics and Immune-computation: Immunology without Borders, Proceedings, Sicily, Italy, presented at 2015 International Workshop on Artificial Immune Systems (AIS), Sicily, Italy, 17 July 2015 - 18 July 2015, http://dx.doi.org/10.1109/AISW.2015.7469236
2015
Segelov E, 2015, 'TOPS - a randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, presented at 2015 ASCO Annual Meeting, Chicago, 29 May 2015 - 02 June 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036902066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2015
Keech A; Sandler C; Vollmer-Conna U; Lloyd A; Barry B, 2015, 'Capturing the post-exertional exacerbation of fatigue following physical and cognitive challenge in patients with chronic fatigue syndrome.', in Physiotherapy, Elsevier, Singapore, pp. e121 - e122, presented at World Congress of Physical Therapy, Singapore, 01 May 2015 - 04 May 2015, http://dx.doi.org/10.1016/j.physio.2015.03.262
2015
Sheridan DA; Hajarizadeh B; Matthews G; Applegate TL; Douglas MW; Askew B; Neely D; Bassendine MF; Dore GJ; Lloyd AR; George J; Grebely J, 2014, 'Hepatitis C lipoviral particle levels are associated with spontaneous clearance of acute infection', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 929A - 929A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014
2014
Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2014, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies', in Antiviral Therapy, SAGE Publications, MA, Boston, pp. 425 - 434, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, http://dx.doi.org/10.3851/IMP3035
2014
Hajarizadeh B; Grady B; Page K; Kim AY; Mcgovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J, 2014, 'Factors associated with hepatitis C virus RNA levels in early chronic infection: The InC3 study', in Journal of Viral Hepatitis, Blackwell Publishing Ltd, MA, Boston, pp. 708 - 717, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, http://dx.doi.org/10.1111/jvh.12384
2014
Sandler C; Barry B; Tzar C; Lloyd A, 2014, 'Exacerbation of Fatigue following Interval and Continuous Exercise in Patients with Chronic Fatigue Syndrome', in MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, LIPPINCOTT WILLIAMS & WILKINS, GA, Atlanta, pp. 684 - 684, presented at 61st Annual Meeting of the American-College-of-Sports-Medicine, GA, Atlanta, 01 April 2014 - 04 April 2014, http://dx.doi.org/10.1249/01.mss.0000495526.97940.0a
2014
Webber K; Bennett BK; Goldstein D; Lloyd AR, 2014, 'Genetic associations of fatigue and other symptom domains after breast cancer treatment: Results from a prospective cohort study.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9537
2014
Hajarizadeh B; Grady BP; Page K; Kim AY; McGovern BH; Cox A; Rice TM; Sacks-Davis R; Bruneau J; Morris MD; Amin J; Schinkel J; Applegate TL; Maher L; Hellard M; Lloyd AR; Prins M; Dore GJ; Grebely J, 2014, 'Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 898A - 899A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014
2014
Morris MD; Rice TM; Shiboski S; Bruneau J; Cox A; Dore GJ; Grebely J; Hahn JA; Kim AY; Lloyd AR; Hellard M; Maher L; McGovern BH; Prins M; Page K, 2014, 'Historical and geographical trends in hepatitis C virus (HCV) incident infection among people who inject drugs: The International Collaboration on Incident HCV and HIV Infection among PWID (InC3 Study)', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 894A - 895A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014
2014
Doyle JS; Deterding K; Grebely J; Wedemeyer H; Davis RS; Matthews G; Rice T; Morris M; McGovern BH; Kim AY; Bruneau J; Lloyd AR; Page K; Manns M; Hellard ME; Dore GJ; Group IS, 2013, 'RESPONSE TO TREATMENT FOLLOWING RECENTLY ACQUIRED HEPATITIS C VIRUS INFECTION', in Journal of Hepatology, Elsevier, NETHERLANDS, Amsterdam, pp. s332, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), NETHERLANDS, Amsterdam, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/s0168-8278(13)60813-2
2013
Sandler C; Webber K; Friedlander M; Lewis C; Chin M; Venkateswaran R; Segelov E; Bastick P; Lynch J; Thomas D; Liauw W; Boyle F; Goldstein D; Lloyd A, 2013, 'BARRIERS TO RECRUITMENT FOR A POST-CANCER FATIGUE INTERVENTION STUDY - THE TOPS TRIAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Bennett B; Webber K; Goldstein D; Lloyd A, 2013, 'What do patients really mean when they complain of fatigue after treatment? Reliable identification of post cancer fatigue', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S283 - S283, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843602060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Huang S; Herbert C; Keoshkerian E; Lloyd A; Thomas PS, 2013, 'PROPORTION OF T REGULATORY CELLS IN THE PERIPHERAL BLOOD OF SARCOIDOSIS PATIENTS', in RESPIROLOGY, WILEY-BLACKWELL, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Huang S; Herbert C; Keoshkerian E; Lloyd A; Thomas PS, 2013, 'IFN-gamma LEVELS IN EXHALED BREATH CONDENSATE AND PERIPHERAL BLOOD OF SARCOIDOSIS PATIENTS REFLECT AN IMMUNE PARADOX', in RESPIROLOGY, WILEY-BLACKWELL, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Ahmadzai H; Cameron B; Chui JJ; Lloyd A; Wakefield D; Thomas PS, 2013, 'MEASUREMENT OF EXHALED MARKERS OF GRANULOMATOUS INFLAMMATION IN SARCOIDOSIS', in RESPIROLOGY, WILEY-BLACKWELL, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Hajarizadeh B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Grady B; Schinkel J; Maher L; Hellard M; Lloyd AR; Prins M; Grebely J; Dore GJ; Group OBOTIS, 2013, 'EARLY HCVRNA DYNAMICS AND FACTORS ASSOCIATED WITH HIGH EARLY HCVRNA LEVEL DURING ACUTE HCV INFECTION', in Journal of Hepatology, Elsevier, NETHERLANDS, Amsterdam, pp. s470 - s471, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), NETHERLANDS, Amsterdam, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/s0168-8278(13)61158-7
2013
Boelen L; Bull RA; Teutsch S; Lloyd AR; Luciani F, 2013, 'MOLECULAR EPIDEMIOLOGY AND SOCIAL NETWORK ANALYSIS TO TRACK HCV TRANSMISSION IN HIGH-RISK COMMUNITIES: INJECTING DRUG USERS IN PRISONS OF NEW SOUTH WALES, AUSTRALIA', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S193 - S193, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), NETHERLANDS, Amsterdam, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/S0168-8278(13)60473-0
2013
Baharuddin B; Simar D; Lloyd AR; Zekry A, 2013, 'Impaired T cell glucose metabolism during chronic hepatitis C virus infection', in Narci T (ed.), Journal of Gastroenterology and Hepatology, Wiley Online, Melbourne, Australia, pp. 171 - 171, presented at Australian Gastroenterology Week 2013, Melbourne, Australia, 07 October 2013 - 09 October 2013, http://dx.doi.org/10.1111/jgh.12365_14
2013
Grebely J; Page K; Sacks-Davis R; van der Loeff MS; Rice TM; Bruneau J; Morris MD; Hajarizadeh B; Amin J; Cox AL; Kim AY; McGovern BH; George J; Shoukry N; Lauer G; Maher L; Lloyd AR; Hellard M; Dore GJ; Prins M; Group OBOTIS, 2013, 'SPONTANEOUS CLEARANCE OF ACUTE HCV INFECTION IS ASSOCIATED WITH FEMALE SEX, IL28B GENOTYPE AND HCV GENOTYPE 1 INFECTION', in Journal of Hepatology, Elsevier, NETHERLANDS, Amsterdam, pp. s189, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), NETHERLANDS, Amsterdam, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/s0168-8278(13)60463-8
2013
Page K; McGovern BH; Grebely J; Kim AY; Evans J; Morris MD; Cox A; Rice TM; Sacks-Davis R; Hellard M; Bruneau J; Shoukry N; Maher L; Lloyd AR; Prins M; Dore GJ, 2013, 'IL28B Genotype is Associated with Jaundice and Elevated Aminotransferase Levels During Acute HCV Infection', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 1188A - 1188A, presented at 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, DC, Washington, 01 November 2013 - 05 November 2013
2013
Hovey EJ; De Souza P; Marx G; Parente P; Rapke T; et A, 2012, 'Phase III, randomised, double-blind, placebo-controlled study of Modafinil for fatigue in patients treated with Docetaxel-based chemotherapy', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia Pty Ltd, Australia, pp. 26 - 26, presented at ANZUP Annual Scientific Meeting, State of the art Multi-Disciplinary Care in Urological Cancers, Sydney Darling Harbour, 15 July 2012 - 17 July 2012, http://dx.doi.org/10.1111/j.1743-7563.2012.01574_3.x
2012
Luciani F; Bull RA; Cameron B; Gaudieri S; Nguyen N; Yuen D; White PA; Purcell DFJ; Foung S; Lloyd AR, 2012, 'IMMUNE RESPONSES AGAINST FOUNDER HEPATITIS C VIRUSES IN ACUTE ASYMPTOMATIC SUBJECTS', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S312 - S312, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/S0168-8278(12)60809-5
2012
Baharuddin B; Zekry A; Simar D; Palmer C; Lloyd A, 2012, 'IMPAIRED T-CELL GLUCOSE METABOLISM DURING CHRONIC HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S302 - S302, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/S0168-8278(12)60782-X
2012
Sugden PB; Hunter M; Keoshkerian E; Cameron B; Zekry A; Zaunders J; Sediki N; Kelleher T; Lloyd A, 2012, 'HEPATITIS C VIRUS-SPECIFIC EFFECTOR AND REGULATORY CD4+T CELLS IN PRIMARY INFECTION RESULTING IN CLEARANCE OR CHRONIC INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S317 - S317, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/S0168-8278(12)60824-1
2012
Grebely J; Feld JJ; Applegate T; Matthews G; Hellard M; Sherker A; Petoumenos K; Shaw I; Yeung B; Kaldor JM; Cherepanov V; Bruneau J; Lloyd A; Shoukry N; Dore G, 2012, 'PLASMA IP10 LEVEL PREDICTS SPONTANEOUS CLEARANCE IN ACUTE HCV INFECTION', in Journal of Hepatology, Elsevier, SPAIN, Barcelona, pp. s346, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/s0168-8278(12)60901-5
2012
Grebely J; Dore GJ; van der Loeff MS; Rice T; Cox AL; Bruneau J; Kim AY; George J; Maher L; Lloyd AR; Hellard M; Page K; Prins M, 2012, 'FEMALE SEX AND VARIATIONS IN IL28B ARE INDEPENDENTLY ASSOCIATED WITH SPONTANEOUS CLEARANCE OF ACUTE HCV INFECTION', in Journal of Hepatology, Elsevier, SPAIN, Barcelona, pp. s348, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/s0168-8278(12)60906-4
2012
Cameron B; Sugden P; Lloyd A, 2012, 'NK CELL ACTIVITY IN EXPOSED-UNINFECTED PRISON INMATES MAY PROTECT AGAINST HEPATITIS C INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S45 - S46, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/S0168-8278(12)60116-0
2012
Hovey EJ; De Souza PL; Marx GM; Rapke T; Parente P; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA; Lloyd AR, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803130&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Martinez D; Simar D; Palmer C; Cameron B; Nguyen N; Aggarwal V; Lloyd AR; Zekry A, 2012, 'INCREASED EXPRESSION OF SUPPRESSOR OF CYTOKINE SIGNALLING 3 IN HCV NON RESPONDERS IS ASSOCIATED WITH IMPAIRED ANTI-HCV CELLULAR IMMUNE RESPONSE', in Journal of Hepatology, Elsevier Science BV, Amsterdam, Netherlands, pp. S313 - S313, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, SPAIN, 18 April 2012 - 22 April 2012
2012
Nguyen N; Luciani F; Cameron B; Keoshkerian E; Zekry A; Lloyd A, 2012, 'T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, pp. S313 - S313, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/S0168-8278(12)60813-7
2012
Bennett BK; Lloyd AR; Webber K; Friedlander M; Goldstein D, 2012, 'Predictors of resilience in women treated for breast cancer: A prospective study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009802389&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Applegate T; Gaudieri S; Pham S; White P; Grebely J; Hellard M; Suppiah V; George J; Lloyd A; Dore G; Matthews GV, 2011, 'Impact of host and viral characteristics on treatment outcome within hepatitis C transmission clusters in HIV-positive individuals with recently acquired HCV', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, pp. A87 - A87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687677600071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Gaudieri S; Applegate T; Tschochner M; Plauzolles A; Pfafferott K; Lucas M; Diepolder H; Ulsenheimer A; Mallal S; Grebely J; Hellard M; Lloyd A; Kaldor J; Dore G; Matthews GV, 2011, 'Signature resistance mutations to directly acting antiviral agents occur at low prevalence in treatment-naive subjects with recently acquired hepatitis C infection', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, pp. A86 - A86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687677600070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Gaudieri S; Applegate T; Tschochner M; Plauzolles A; Pfafferott K; Lucas M; Diepolder H; Ulsenheimer A; Mallal S; Grebely J; Hellard M; Lloyd A; Kaldor J; Dore G; Matthews GV, 2011, 'Signature resistance mutations to directly acting antiviral agents occur at low prevalence in treatment-naive subjects with recently acquired hepatitis C infection', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Los Cabos, MEXICO, pp. A86 - A86, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, Los Cabos, MEXICO, 07 June 2011 - 11 June 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375700091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Applegate T; Gaudieri S; Pham S; White P; Grebely J; Hellard M; Suppiah V; George J; Lloyd A; Dore G; Matthews GV, 2011, 'Impact of host and viral characteristics on treatment outcome within hepatitis C transmission clusters in HIV-positive individuals with recently acquired HCV', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Los Cabos, MEXICO, pp. A87 - A87, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, Los Cabos, MEXICO, 07 June 2011 - 11 June 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375700092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Matthews G; Applegate TL; Tschochner M; Plauzolles A; Mallal SA; Grebely J; Hellard M; Lloyd AR; Kaldor JM; Dore GJ; Gaudieri S, 2011, 'ULTRA DEEP SEQUENCING ANALYSIS OF TREATMENT NAIVE INDIVIDUALS WITH RECENTLY ACQUIRED HEPATITIS C INFECTION DEMONSTRATES WIDESPREAD AMINO ACID VARIATION AT KEY PROTEASE AND POLYMERASE SITES OCCURRING AT LOW FREQUENCY', in HEPATOLOGY, WILEY-BLACKWELL, CA, San Francisco, pp. 1343A - 1344A, presented at 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), CA, San Francisco, 04 November 2011 - 08 November 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295578004555&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Wood J; Heywood A; Lloyd A; Dennington P; Ziegler J, 2011, 'RATES OF INCREASES FOR IVIG USE IN NSW AND AUSTRALIA', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295520600076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Feld JJ; Grebely J; Applegate T; Matthews GV; Hellard M; Suppiah V; Sherker A; Petoumenos K; Shaw I; Yeung B; Rawlinson W; Booth D; Kaldor JM; Lloyd AR; Dore GJ, 2011, 'IP-10 IS ASSOCIATED WITH EARLY VIRAL KINETICS, BUT NOT SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S455 - S455, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)61154-9
2011
Grebely J; Matthews GV; Hellard M; Suppiah V; Petoumenos K; Applegate T; Yeung B; Rawlinson W; Feld J; Lloyd AR; Booth D; Kaldor JM; George J; Dore GJ, 2011, 'IL28B GENOTYPE HAS VARIABLE INFLUENCE ON EARLY VIRAL KINETICS, BUT NO INFLUENCE ON SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S524 - S524, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)61330-5
2011
Luciani F; Bull R; Mcelroy K; Pham S; Cameron B; Chopra A; Gaudieri S; Cooper D; Lloyd A; White P, 2011, 'EVOLUTIONARY DYNAMICS OF HEPATITIS C VIRUS DURING VERY EARLY INFECTIONS: VIROLOGICAL AND IMMUNOLOGICAL INSIGHTS', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S18 - S18, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)60040-8
2011
Gaudieri S; Applegate T; Tshochner M; Plauzolles A; Pfafferott K; Lucas M; Diepolder H; Ulsenheimer A; Mallal S; Grebely J; Hellard M; Lloyd A; Kaldor J; Dore G; Matthews G, 2011, 'SIGNATURE RESISTANCE MUTATIONS TO DIRECTLY ACTING ANTIVIRAL AGENTS OCCUR AT LOW PREVALENCE IN TREATMENT NAIVE SUBJECTS WITH RECENTLY ACQUIRED HEPATITIS C INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S184 - S185, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)60455-8
2011
Bennett BK; Goldstein D; De Souza PL; Wilken N; Friedlander M; Hickie IB; Scott E; Rogers N; Lloyd AR, 2010, 'What part does sleep disturbance play in post-cancer fatigue? Findings from a prospective cohort study', in Journal of Clinical Oncology, American Society of Clinical Oncology, United States, pp. 93s
2010
Grebely J; Dore GJ; van der Loeff MS; Cox AL; Bruneau J; Kim AY; Lloyd AR; Hellard M; Page K; Prins M, 2010, 'FACTORS ASSOCIATED WITH SPONTANEOUS CLEARANCE DURING ACUTE HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, AUSTRIA, Vienna, pp. S411 - S411, presented at 45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, AUSTRIA, Vienna, 14 April 2010 - 18 April 2010, http://dx.doi.org/10.1016/S0168-8278(10)61064-1
2010
Palmer CS; DeHart M; Zhang X; Feilotter H; Lloyd AR; Zekry A, 2010, 'SERUM PROTEOMIC PROFILES ASSOCIATED WITH IL28B GENOTYPE AMONG CHC PATIENTS', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 727A - 728A, presented at 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 29 October 2010 - 02 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288775601164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Palmer CS; DeHart M; Zhang X; Feilotter H; Lloyd AR; Zekry A, 2010, 'HEPATIC MICRORNA 135A*REGULATES HEPATIC TRIGLYCERIDE STORAGE AND IS REPRESSED DURING HCV INFECTION', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 727A - 727A, presented at 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 29 October 2010 - 02 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288775601163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Matthews GV; Alavi M; Grebely J; Petoumenos K; Yeung B; Hellard M; Lloyd A; van Beek I; Kaldor J; Haber P; Dore GJ, 2010, 'Depression prior to and during treatment for recent hepatitis C virus (HCV) infection among HCV and HCV/HIV participants in the ATAHC study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A21 - A21, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431500027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Matthews GV; Alavi M; Grebely J; Petoumenos K; Yeung B; Hellard M; Lloyd A; van Beek I; Kaldor J; Haber P; Dore GJ, 2010, 'Depression prior to and during treatment for recent hepatitis C virus (HCV) infection among HCV and HCV/HIV participants in the ATAHC study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A21 - A21, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431200041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Webber K; Goldstein D; Bennett BK; Boyle F; De Souza PL; Wilken N; Friedlander M; Lloyd AR, 2010, 'Late fatigue after adjuvant therapy for early breast cancer is largely unrelated to cancer or its treatment: 5 year follow-up of a prospective cohort study', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia Pty Ltd, Australia, pp. 53 - 60, presented at ., -
2010
Matthews G; Grebely J; Pham ST; Hellard M; Marks P; Rawlinson W; Kaldor J; Lloyd AR; White PA; Dore GJ, 2009, 'EPIDEMIOLOGY OF RECENTLY ACQUIRED HEPATITIS C VIRUS (HCV) INFECTION IN HCV AND HCV/HIV INFECTED PARTICIPANTS IN THE ATAHC STUDY', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 668A - 668A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456000775&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Palmer CS; Zhang X; Feilotter H; Lloyd AR; Zekry A, 2009, 'THE MICRORNA MIR-923 IS HIGHLY ABUNDANT AND DIFFERENTIALLY EXPRESSED BETWEEN NORMAL AND FATTY LIVERS', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 1185A - 1185A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001904&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Yan KK; Palmer CS; Lloyd AR; Zekry A, 2009, 'RELATIONSHIP OF RETINOL BINDING PROTEIN-4 WITH LIVER INJURY IN MORBIDLY OBESE SUBJECTS', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 789A - 789A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Aggarwal V; Palmer CS; Yan KK; Lloyd AR; Zekry A, 2009, 'STATINS AND LIVER INJURY IN MORBIDLY OBESE SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 789A - 789A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; van Beek I; McCaughan GW; White PA; Ffrench RA; Rawlinson W; Lloyd AR; Kaldor J, 2009, 'TREATMENT OF RECENT HEPATITIS C VIRUS INFECTION IN A PREDOMINANTLY INJECTION DRUG USER COHORT: THE ATAHC STUDY', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 723A - 723A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456000887&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Palmer CS; Lloyd AR; Zekry A, 2009, 'HEPATIC MICRORNAS EXPRESSION IN OBESE SUBJECTS WITH CHRONIC HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 940A - 940A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456001376&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
White PA; Grebely J; Flynn J; Matthews G; Renkin M; Yeung B; Rawlinson WD; Kaldor JM; Hellard M; Lloyd AR; Ffrench R; Dore GJ, 2008, 'NATURAL HISTORY OF HCV SUPERINFECTION AND REINFECTION', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1056 - 1057, presented at Hepatology
2008
Matthews G; Grebely J; White PA; Renkin M; Marks PB; Ffrench R; Rawlinson WD; Kaldor JM; Hellard M; Lloyd AR; Dore GJ, 2008, 'INCIDENCE AND RISK FACTORS FOR HCV SUPERINFECTION AND REINFECTION IN INDIVIDUALS TREATED FOR ACUTE/EARLY CHRONIC HCV INFECTION', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1844 - 1845, presented at Hepatology
2008
Aggarwal V; Palmer C; Nguyen ND; Lloyd AR; Zekry A, 2008, 'Differential expression of interferon stimulating genes in obese subjects receiving treatment for chronic hepatitis C', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A282 - A282, presented at Journal of Gastroenterology and Hepatology, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2008
Palmer C; Nguyen ND; Lloyd AR; Zekry A, 2008, 'Effect of obesity on the intrahepatic cytokine/chemokine responses in chronic hepatitis C', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A285 - A285, presented at Journal of Gastroenterology and Hepatology, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2008
Matthews G; White PA; Hellard M; Grebely J; Marks P; Yeung B; Kaldor JM; Lloyd AR; Danta M; Dore GJ, 2008, 'Evidence of sexual transmission of hepatitis C virus infection among HIV-positive men who have sex with men in the Australian trial in acute hepatitis C (ATAHC) study', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A365 - A366
2008
Lloyd AR; Cameron BA; Elliott LN; Galbraith SA; Li H; Teutsch S; Dolan K; Levy MT; Haber PS; Rawlinson WD; Kaldor JM; Ffrench R, 2008, 'Correlates of HCV seronegative-immune status in high risk IDU prison inmates', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A356 - A356
2008
Aggarwal V; Palmer CS; Lloyd AR; Zekry A, 2008, 'EFFECT OF OBESITY ON INTERFERON STIMULATED GENES EXPRESSION IN CHRONIC HCV INFECTION', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 864A - 865A, presented at 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, CA, San Francisco, 31 October 2008 - 04 November 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259757401628&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2008
Grebely J; Matthews G; White PA; Renkin M; Flynn J; Ffrench R; Kaldor JM; Hellard M; Lloyd AR; Dore GJ, 2008, 'Incidence and risk factors for HCV reinfection and superinfection in individuals treated for acute/early chronic HCV infection', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A343 - A344
2008
Hellard M; Matthews G; Petoumenos K; Grebely J; Haber PS; Van Beek IA; Marks P; Lloyd AR; Kaldor JM; Dore GJ, 2008, 'Factors associated with uptake of treatment for acute and early chronic hepatitis C virus infection', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A344 - A344
2008
Hellard M; Grebely J; Matthews G; Haber PS; Petoumenos K; Yeung B; Van Beek IA; Lloyd AR; Kaldor JM; Dore GJ, 2008, 'Impact of illicit drug use on response to therapy during treatment for acute and early chronic HCV infection', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A337 - A338
2008
Flynn J; White PA; Grebely J; Kaldor JM; Hellard M; Dore GJ; Lloyd AR; Ffrench R, 2008, 'Immunity to acute hepatitis C and the influence of early therapy', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A356 - A356
2008
Maher L; Dore G; Treloar C; Rawlinson W; White P; Dolan K; Zekry A; Madden A; Loveday S; Kaldor J; Lloyd A, 2008, 'Preparedness for candidate hepatitis C vaccine trials in people who inject drugs: challenges and opportunities', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A358 - A358
2008
Lloyd AR; Teutsch S; Scheuer N; Dolan K; McCredie L; Ffrench R; Levy MT; Haber PS; Rawlinson WD; Kaldor JM, 2008, 'Predictors of HCV incidence in IDU prison inmates', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A346 - A347
2008
Bennett BK; Goldstein D; Friedlander ML; Boyle F; De Souza PL; Wilken N; Hickie IB; Scott E; Lloyd AR, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer', in Psycho - Oncology, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S36 - S37, presented at Psycho-Oncology 2008, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257874200071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2008
Matthews G; Hellard M; Haber PS; Yeung B; Marks PB; Sasadcusz J; Baker DA; McCaughan G; White PA; Rawlinson WD; Lloyd AR; Kaldor JM; Dore GJ, 2008, 'Frequency of RVR and its utility as a predictor of treatment outcome in individuals treated within the Australian Trial in Acute Hepatitis c (ATAHC)', in Journal of Hepatology, Elsevier Science BV, Amsterdam, Netherlands, pp. S303 - S303, presented at Journal of Hepatology
2008
Matthews G; Hellard M; Haber PS; Yeung B; Marks P; Rawlinson WD; Lloyd AR; Kaldor JM; Dore GJ, 2008, 'Frequency of rapid virological response and its utility as a predictor of treatment outcome in individuals treated within the Australian trial in acute hepatitis C (ATAHC)', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A337 - A337
2008
Chow SS; Hall B; Jones C; Craig ME; Catteau J; Lloyd AR; Rawlinson WD, 2008, 'IP-10 and IL-1Ra elevation in cytomegalovirus-infected vs normal midtrimester amniotic fluids', in Cytokine, Academic Press Ltd Elsevier Science Ltd, London, England, pp. 323 - 323
2008
White PA; Grebely J; Matthews G; Flynn J; Renkin M; Kaldor JM; Lloyd AR; Hellard M; Ffrench R; Dore GJ, 2008, 'Natural history of HCV reinfection and superinfection', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A355 - A355
2008
Palmer CS; Nguyen N; Lloyd AR; Zekry A, 2008, 'EFFECT OF STEATOSIS ON THE INTRAHEPATIC CYTOKINE/CHEMOKINE RESPONSES IN CHRONIC HCV', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 789A - 789A, presented at 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, CA, San Francisco, 31 October 2008 - 04 November 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259757401463&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2008
Vollmer-Conna US; Piraino BF; Cameron BA; Lloyd AR, 2008, 'Common polymorphisms in neurobehavioural genes influence the emotional response to acute infectious illness', in Australian and New Zealand Journal of Psychiatry, Sage Publications, United Kingdom, pp. A79 - A79, presented at Australian and New Zealand Journal of Psychiatry
2008
Palmer C; Nguyen ND; Lloyd AR; Zekry A, 2008, 'EFFECT OF STEATOSIS ON THE INTRAHEPATIC CYTOKINE/CHEMOKINE RESPONSES IN CHRONIC HCV', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1080 - 1081, presented at Hepatology
2008
Aggarwal V; Palmer C; Lloyd AR; Zekry A, 2008, 'EFFECT OF OBESITY ON INTERFERON STIMULATED GENES EXPRESSION IN CHRONIC HCV INFECTION', in Hepatology, John Wiley & Sons Inc, Hoboken, NJ, USA, pp. 1248 - 1249, presented at Hepatology
2008
Hellard M; Dore G; Haber P; Marks P; Matthews G; Yeung B; Nguyen O; Pan Y; Ffrench R; McCaughan G; Van Beek I; White P; Dolan K; Rawlinson W; Lloyd A; Kaldor J, 2006, 'Australian trial in acute hepatitis C: preliminary findings', in JOURNAL OF CLINICAL VIROLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S139 - S139, presented at 12th International Symposium on Viral Hepatitis and Liver Disease, FRANCE, Paris, 01 July 2006 - 05 July 2006, http://dx.doi.org/10.1016/S1386-6532(06)80430-0
2006
Ffrench RA; Flynn J; Goy K; Hosseiny P; Pan Y; Rawlinson WD; White PA; Nguyen O; Hellard M; Kaldor JM; Dore GJ; Lloyd AR, 2006, 'Comprehensive analysis of IFN-gamma and IL-2 production by T cells in acute and chronic HCV infection', in Journal of Clinical Virology, Elsevier Science BV, Amsterdam, Netherlands, pp. S123 - S123, presented at Journal of Clinical Virology, Melbourne
2006
Reeves WC; Lloyd A; Vernon SD; Klimas N; Jason LA; Bleijenberg G; Evengard B; White PD; Nisenbaum R; Unger ER, 2003, 'Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution', in BMC health services research, pp. 25
2003
Harvey CE; Freeman AJ; Marinos G; Ffrench R; Lloyd AR, 2002, 'T lymphocytes, NK and NK-T cells co-expressing the chemokine receptors CXCR3 and CXCR6 are enriched in the HCV infected liver.', in HEPATOLOGY, W B SAUNDERS CO, MASSACHUSETTS, BOSTON, pp. 227A - 227A, presented at 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), MASSACHUSETTS, BOSTON, 01 November 2002 - 05 November 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000178301700244&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2002
Freeman AJ; Post JJ; Harvey CE; Pan Y; White PA; Marinos G; Rawlinson WD; Ffrench R; Lloyd AR, 2002, 'Cellular immunity in people resistant to HCV infection.', in HEPATOLOGY, W B SAUNDERS CO, MASSACHUSETTS, BOSTON, pp. 263A - 263A, presented at 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), MASSACHUSETTS, BOSTON, 01 November 2002 - 05 November 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000178301700383&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2002
Smith AJ; Bennett B; Vollmer-Conna U; Hickie IB; Lloyd AR, 2002, 'The effect of distress on the development of a primary immune response.', in PSYCHOSOMATIC MEDICINE, LIPPINCOTT WILLIAMS & WILKINS, pp. 166 - 167, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000173760200384&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2002
Thakur A; Xue ML; Stapleton FJ; Lloyd AR; Wakefield D; Willcox MD, 2001, 'The balance of pro- and anti-inflammatory cytokines correlates with the outcome of acute experimental Pseudomonas keratitis', in Investigative Ophthalmology and Visual Science, Association of Research Vision Ophthalmology Inc, Rockville, MD, USA, pp. 513 - 513, presented at ARVO 2001: Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, 29 April 2001 - 04 May 2001
2001
Hapartzoumian T; Tedla N; Rosen D; Wakefield D; Lloyd A, 1999, 'The role of chemokines and their receptors in the regulation of T lymphocyte trafficking to lymph nodes and the outcome of the immune response', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A658 - A658, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000082132900067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1999
McCluskey PJ; Monshat K; Beck R; Lloyd A; Wakefield D, 1999, 'Gene expression in grafted, liposomally transfected corneas', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, pp. S250 - S250, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079269201320&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1999
Di Girolamo N; Mccluskey P; Lloyd AR; Wakefield D, 1997, 'Matrix metalloproteinases and mast cell tryptase in scleritis.', in 4th International Symposium on Uveitis, Yokohama, Japan, pp. 103 - 105, presented at 4th International Symposium on Uveitis, Yokohama, Japan, 01 October 1997
1997
Di Girolamo N; Lloyd AR; Mccluskey P; Wakefield D, 1997, 'Metalloproteinases and mast cell tryptase in scleritis', in 4th International Symposium on Uveitis, Yokohama, Japan, presented at 4th International Symposium on Uveitis, Yokohama, Japan, 01 October 1997
1997
Cuello C; Lloyd AR; Wakefield D, 1997, 'Chemokines in ocular inflammation', in Ohno S; Aoki K; Usui M; Uchio E (eds.), 4th International Symposium on Uveitis, ELSEVIER SCIENCE BV, Yokohama, Japan, pp. 41 - 44, presented at 4th International Symposium on Uveitis, Yokohama, Japan, 01 October 1997, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000074178800010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
1997
BADOLATO R; WANG JM; MURPHY WJ; LLOYD AR; MICHIEL DF; BAUSSERMAN LL; OPPENHEIM JJ; KELVIN DJ, 1994, 'SERUM AMYLOID-A HAS CHEMOATTRACTANT ACTIVITY FOR MONOCYTES AND POLYMORPHONUCLEAR CELLS', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A234 - A234, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994ND19601350&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1994
Oppenheim JJ; Lloyd A; Taub D; Wang JM; Murphy B, 1994, 'Attractive properties of chemokines and their receptors', in International Journal of Immunopathology and Pharmacology, pp. 219 - 220
1994
JOHNSTON JA; TAUB D; LLOYD AR; CONLON K; OPPENHEIM JJ; KELVIN DJ, 1994, 'HUMAN T-LYMPHOCYTE CHEMOTAXIS AND ADHERENCE INDUCED BY VASOACTIVE-INTESTINAL-PEPTIDE', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A479 - A479, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994ND19602771&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1994
Lloyd AR; Johnston J, 1993, 'Cytokines and cytokine receptors in health and disease. A summary of the National Heart, Lung and Blood Institute Frontiers in Basic Sciences Symposium, December 2-3, 1992', in Cytokine, pp. 399 - 406, http://dx.doi.org/10.1016/1043-4666(93)90029-5
1993
TAUB DD; LLOYD AL; CONLON K; MURPHY W; LONGO DL; KELVIN DJ; OPPENHEIM JJ, 1993, 'PREFERENTIAL CHEMOTAXIS AND ADHESION OF T-CELL SUBSETS IN RESPONSE TO MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (MIP-1-ALPHA), MIP-1-BETA, AND RANTES', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, pp. A46 - A46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KX95600257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1993
LLOYD A; JOHNSTON J; CHATTOPADHYAY U; SPRENGER H; OPPENHEIM JJ; KELVIN D, 1993, 'IL-8 RECEPTOR EXPRESSION AND REGULATION IN HEMATOPOIETIC-CELLS BY G-CSF AND LPS', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, pp. A126 - A126, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KX95600723&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1993
Hickie IB; Hickie C; Bennett BH; Wakefield D; Silove DM; Mitchell PB; Lloyd AR, 1993, 'Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression - a preliminary report', in International Journal of Immunopharmocology, Elsevier Science, UK, presented at Psychoimmune networks on Health and Disease, Sydney, 01 April 1993 - 03 April 1993
1993
Wilson AR; Hickie IB; Lloyd AR; Hadzi-Pavlovic D; Wakefield D, 1993, 'Cell-mediated function and the outcome of chronic fatigue syndrome', in International Journal of Immunopharmocology, Elsevier Science, UK, presented at Psychoimmune networks on Health and Disease, Sydney, 01 April 1993 - 03 April 1993
1993
Taub DD; Lloyd AR; Wang JM; Oppenheim JJ; Kelvin DJ, 1993, 'The effects of human recombinant MIP-1α, MIP-1β, and rantes on the chemotaxis and adhesion of T cell subsets', in Advances in Experimental Medicine and Biology, pp. 139 - 146, http://dx.doi.org/10.1007/978-1-4615-2952-1_15
1993
Hickie C; Hickie IB; Silove DM; Wakefield D; Lloyd AR, 1993, 'Delayed-type hypersensitivity skin testing - normal values in the Australian population (17)', in International Journal of Immunopharmocology, Elsevier Science, UK, presented at Psychoimmune networks on Health and Disease, Sydney, 01 April 1993 - 03 April 1993
1993
SPRENGER H; LLOYD AR; KELVIN DJ, 1993, 'ISOLATION AND CHARACTERIZATION OF IL-8 TYPE-I AND TYPE-II RECEPTOR GENES', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, pp. A126 - A126, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KX95600720&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1993
LLOYD A; TAUB D; WANG JM; JOHNSTON J; OPPENHEIM J; KELVIN D, 1993, 'FUNCTIONAL AND PROMISCUOUS CHEMOKINE RECEPTORS ENCODED BY HUMAN CYTOMEGALOVIRUS', in JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION AMER SOC EXP BIOL, pp. 131 - 131, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993ME18500586&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1993
LLOYD A; TAUB D; CONLON K; MATSUSHIMA K; OPPENHEIM J; KELVIN D, 1993, 'REGULATION OF T-CELL SUBSET ADHESION BY CHEMOKINE FAMILY MEMBERS', in JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KN46500332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1993
LLOYD A; BIRAGYN A; JOHNSTON J; TAUB D; SPRENGER H; OPPENHEIM J; KELVIN D, 1993, 'IL-8 RECEPTOR REGULATION IN POLYMORPHONUCLEAR LEUKOCYTES BY G-CSF AND LPS', in JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION AMER SOC EXP BIOL, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993ME18500087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1993
PALLADINETTI P; BROCKMAN A; HALES J; GANDEVIA S; WAKEFIELD D; LLOYD A, 1993, 'CYTOKINE PRODUCTION IN PATIENTS WITH CHRONIC FATIGUE SYNDROME', in JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION AMER SOC EXP BIOL, pp. 54 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993ME18500123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1993
OPPENHEIM JJ; WANG JM; LLOYD AW; ANDERSON AO, 1991, 'ROLE OF INFLAMMATORY CYTOKINES IN ALLERGY', in Miyamoto T; Okuda M (ed.), PROGRESS IN ALLERGY AND CLINICAL IMMUNOLOGY, VOL 2, KYOTO, HOGREFE & HUBER PUBLISHERS, JAPAN, KYOTO, pp. 445 - 450, presented at 14TH INTERNATIONAL CONGRESS OF ALLERGOLOGY AND CLINICAL IMMUNOLOGY, JAPAN, KYOTO, 13 October 1991 - 18 October 1991, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992BX58P00080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
1991
Lloyd AR, 1990, 'Muscle versus brain: Chronic fatigue syndrome', in Medical Journal of Australia, pp. 530 - 534, http://dx.doi.org/10.5694/j.1326-5377.1990.tb126193.x
1990
Cunningham EB; Hajarizadeh B; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Bretana NA; Dolan K; Lloyd AR; Grebely J, 2018, 'A161 ONGOING INCIDENT HEPATITIC C VIRUS INFECTION AMONG PEOPLE WITH A HISTORY OF INJECTING DRUG USE IN AN AUSTRALIAN PRISON SETTING', Vol. 1, pp. 278 - 280, http://dx.doi.org/10.1093/jcag/gwy008.162
2018
2009, Hepatitis C: An Expanding Perspective, Dore GJ; Dore G; Lloyd AROLA, (eds.), IP Communications, East Hawthorn
2009

Member, Order of Australia (A.M): “For service to medicine and the community, particularly through provision of hepatitis services in prisons, and research in infectious diseases”.

The focus of VISP is investigation of the immunological and virological determinants of pathogenesis of RNA virus infections, particular hepatitis C, dengue virus and SARS CoV-2. These studies are funded by an NHMRC Program Grant and NHMRC Investigator Grants to two early and senior career researchers, Dr Chaturaka Rodrigo and A/Professor Rowena Bull. The studies are based on samples collected from clinical cohorts, including: the previous NHMRC Project funded HITS-p cohort (Hepatitis C Incidence and Transmission Study in prisons); the NHMRC Partnership Project funded Surveillance and Treatment of hepatitis C in prisoners (SToP-C) projects; and the NHMRC Project Grant funded Study of Hepatitis C Treatment and Reinfection in People who inject drugs in the prisons (SHARP-p), the University of Colombo Dengue cohort, and the Snow Foundation funded COSiN cohort studying immunological outcomes after SARS CoV-2 infection. The studies examine samples from these cohorts are based on cutting edge cellular and molecular assay techniques including next generation sequencing of viruses, multi-colour flow cytometry to characterise virus-specific B and T cell responses, neutralisation assays, enzyme-linked immunospot (ELISpot) and mutliplex cytokine detection assays, as well as high throughput single cell transcriptomics.

The clinical aspects of the research program are focused firstly on the prison context where chronic viral hepatitis is prevalent. Initial studies included the development and evaluation of an innovative nurse-led model of hepatitis care in the New South Wales (NSW) prisons, which has now been rolled out across the state. In the Surveillance and Treatment of hepatitis C in prisoners (SToP-C) project the efficacy of scale-up of testing and antiviral treatment in prevention of new hepatitis C infections (that is treatment-as-prevention; TasP) has been examined in four NSW prisons. This world-first study demonstrated halving of the transmission rate. Ongoing studies include mathematical modelling of the impact of scale-up in the prisons on the community at large, and the cost-effectiveness of the intervention. The Study of Hepatitis C Treatment and Reinfection in People who inject drugs in the prisons (SHARP-p) is a prospective cohort study following prisoners receiving antiviral treatment for chronic hepatitis C for reinfection - to estimate the incidence and predictors of this outcome in the prison context.

The second clinical program is studying determinants of the severity and course of fatigue states after common acute infections (i.e. post-infective fatigue syndrome; PIFS), and in more established chronic fatigue states. This research is conducted in close collaboration with the UNSW Fatigue Clinic which offers cognitive-behavioural therapy (CBT) and graded exercise therapy (GET) treatment interventions. The PIFS research is based on data and samples previously collected in the Dubbo Infection Outcomes Study which was funded by the Centers for Disease Control, USA and NHMRC, and also on data samples from the international Collaborative on Fatigue Following Infection (COFFI) which includes more than 10 comparable prospective post-infective cohorts. The current focus is on epidemiological studies to identify reliable predictors of PIFS and on genetic association of PIFS - funded by the Mason Foundation.

Infectious diseases and immunology.